project_id string | case_id string | case_submitter_id string | selected_normal_wgs string | source_center string | state string | a260_a280_ratio string | normal_tumor_genotype_snp_match string | ribosomal_rna_28s_16s_ratio string | rna_integrity_number string | age_at_index string | days_to_birth string | days_to_death string | ethnicity string | gender string | race string | vital_status string | year_of_birth string | year_of_death string | age_at_diagnosis string | ajcc_clinical_m string | ajcc_pathologic_n string | ajcc_pathologic_stage string | ajcc_pathologic_t string | classification_of_tumor string | days_to_diagnosis string | icd_10_code string | last_known_disease_status string | morphology string | primary_diagnosis string | prior_malignancy string | prior_treatment string | progression_or_recurrence string | site_of_resection_or_biopsy string | synchronous_malignancy string | tissue_or_organ_of_origin string | tumor_grade string | year_of_diagnosis string | treatment_or_therapy string | alcohol_history string | is_ffpe string | composition string | days_to_collection string | days_to_sample_procurement string | initial_weight string | pathology_report_uuid string | portion_submitter_id string | percent_lymphocyte_infiltration string | percent_monocyte_infiltration string | percent_necrosis string | percent_neutrophil_infiltration string | percent_normal_cells string | percent_stromal_cells string | percent_tumor_cells string | percent_tumor_nuclei string | text string | embedding_shape list | embedding unknown | analyte_type string | days_to_last_follow_up string | weight string | sample_id string | sample_submitter_id string | portion_id string | slide_id string | slide_submitter_id string | section_location string | concentration string | spectrophotometer_method string | oct_embedded string | preservation_method string | no_matched_normal_low_pass_wgs string | no_matched_normal_targeted_sequencing string | no_matched_normal_wgs string | no_matched_normal_wxs string | selected_normal_low_pass_wgs string | selected_normal_targeted_sequencing string | selected_normal_wxs string | creation_datetime string | portion_number string | specimen_type string | ajcc_pathologic_m string | ajcc_staging_system_edition string | intermediate_dimension string | longest_dimension string | shortest_dimension string | cigarettes_per_day string | pack_years_smoked string | years_smoked string | analyte_type_id string | figo_stage string | analyte_id string | analyte_submitter_id string | aliquot_id string | aliquot_submitter_id string | sample_type string | sample_type_id string | tissue_type string | tumor_descriptor string | ajcc_clinical_t string | ann_arbor_b_symptoms string | ann_arbor_clinical_stage string | ann_arbor_extranodal_involvement string | aliquot_quantity string | aliquot_volume string | experimental_protocol_type string | ajcc_clinical_n string | ajcc_clinical_stage string | primary_gleason_grade string | secondary_gleason_grade string | igcccg_stage string | analyte_volume string | masaoka_stage string |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TCGA-TGCT | 4a380e03-667a-4d08-9a8c-e537a5900291 | TCGA-ZM-AA05 | true | 23 | released | 1.87 | Yes | 0.35 | 7.2 | 36 | -13295 | null | not hispanic or latino | male | white | Alive | 1975 | null | 13295 | M0 | NX | Stage IIC | T2 | not reported | 0 | C62.9 | not reported | 9061/3 | Seminoma, NOS | no | No | not reported | Testis, NOS | No | Testis, NOS | Not Reported | 2011 | null | Not Reported | false | Not Reported | 919 | 0 | 200.0 | 91933905-9569-4998-A326-D314234C1808 | TCGA-ZM-AA05-01A-12 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-TGCT; case submitter id: TCGA-ZM-AA05; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.35; rna integrity number: 7.2; age at index: 36; days to birth: -13295; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1975; age at diagnosis: 13295; ajcc clinical m: M0; ajcc clinical n: N3; ajcc clinical stage: Stage IIC; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIC; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1126.0; icd 10 code: C62.9; igcccg stage: Good Prognosis; last known disease status: not reported; morphology: 9061/3; primary diagnosis: Seminoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Testis, NOS; synchronous malignancy: No; tissue or organ of origin: Testis, NOS; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 919; days to sample procurement: 0; initial weight: 200.0; portion submitter id: TCGA-ZM-AA05-01A-12; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "I9SfvkYvuT7fwGS+w3WzPCqlJD4NSt4+roYLvlMgEj46jgq+Bu4OvkGi2z7qpAg9IdO9OpNvf74oRmG+vu1rPrn0jL2urcI9eM4dvpWbOz7EBpa9L6bTPkkbNj4mNo+94Nxzvsw7qb0PL4s+EFplPlzWjj1+02U9pavqPbKZGz7w96e+UFyeviExmDy0m7E+DrhivgBEUr7Wcfo9XYc5vDooLj6WaZ8+Yn4KPmoWir5OxdC+ePCVPVJDGb37lwy+2PRUPrQ8371Iy9u9q8vSvTxNp70popm+bjkbPcbRIL0J3Oy87S6Evpfjyj4Ocj8/UdJCvBIMojzE6gq+Gzb1PugHEr4Bn3A+gj+Wvm7oiL4LTZw+P80UvkhSGb6TLSc+0VlQPuUwqD61YCy+Pg+VvWzCgL0OTvU9Y5pHvq9BLz52Qaw9S+cgvtvQELw+bv+9uh6DvqDKmL7wMiq7Ve6tvrlT4T50u62+7BkBPowgeD56f1o+s2bzPLL6nLv6sSG9Yf4cvOMEor7M5Io+BBkEPq0Y6z69lK47itf4vHTBVz23j/I9VeOOvQairD3sSoq9bOoQvtryKL6aj0c+yMrkPsTWzDu5zH09SUNzvbFKAD7lEfY9bdmWvb9o9r59iVk9eHREPnU6HD+unDW+2+mavikrQzxdq2e+7mfyPt2pCT7H8gW/6i2rvUMm2L31W4y+vvqBPUKwGj4U1p2+RI2cPnqxer8YKB2+Ji+lvkd8UD12bxI9pkEJPgd65T1a78Y+JOxEvTrxzj6LS6i+/QdHvg0uVr681o4+Q6uTvv3Ehz04gMY9g4P1vqWysL1/Zs++962lPqUTjzvaihY9cxWlPt0Rl7pHwbu8Ely0Pct4Jj68gZC+eDI3vSZ9/T3Pokq+ZrpLPvha4Dvg7yy+iCGfvvkegz6ainO9IRWBPs4TNLuXVLi9vPaLPX61B70NYwY/8lMIvnaPCj8o/JW+G/HPPNzQqLyBt5m9ENQcvqO0ML+hJPQ8ktwJPtyS2r05wIE+lqGFPj1J2bsM0vg97OM0vSAB471vIhO+z0eHvK1UH75geAa/ahX+vh+NK75HSGy9kc2gPnV4ZTw4hbK+XRtvvf+WXL7RQlu+RwvzviQVFz6QYds+KrZGPgAcYD0brlG+tP/DvjxiWz08Vk6+RK37PU6fEb9QDsg9/XyKvjUAGL7M+hS90TCwvf6Hu75ymAc/xnuLPfTBDT5hrBK+qbdQvpK7hD1ZbJq+JKjmvX6xTb16ms69pmtGPseIWj5tfW09vflwPkEIib10JE2+nPc5vaUOYT2GJck9gS4rvFlet75Snjw9ntM8PKuaGj7SuT69tBy2PuwGUL4tUbXAz5E6Pc2oHD8VCC4+W/mCvrSyYr550i2+TFYgPvPNKLx0THK96C3nPXeNVb4dqy4+IXGKvUqIAT4YL0C+vXSIPpGIzz20gh2+3EyLvdq1Sz5tAi0/lGuWvTy5xD0viG8+y0TovbWZODx8twY+sH1kvYbhDT4xrtS8H+yUvn8H773FM6G+UkXTvoylIruWLhK9NEUKvvKp2rzBxMm9jutkPQevnD7iHVk+pJfEPM2p5701YJA8TDOePpdMqz6YzZg+lXkPPpLnqD29Vrs+Ulm4viAYfr6ORMY9mA6iPYAhEj79Tj6+2kQaPVkfv76yfBw97igavotS6T1jyRc9xP94vupX5j7m0IK+P8nuvWKDFD65T2c9FybVPsREv74S+vc9jmeXPt8QlD5OeD6+0fZFPqTaRb6Rdmk9Z7WAPUcciz6xEnE9lWyxvZHuUz5kid89ht2lvWOvCb+3JIu+WSz+vYYPkL6MsNo+HI5KPoP5Kr78DBw7aGzCPndKDT7j2Lo90SSfPlXmQj5+xgk+etmYPkvmgD2uCJu+JJTRPJUybz0tFn0+AZ8DvuKpg75/YUK8chFYPWMvEr6gf5w+JZuZPVewC76XdEW+jn66vSsJgj6kfIW97kxmPrr4Vb5uqxC/iwACvkMbaL4YUOw9WkkIvwxhOz4EdLq9f4o1PlBtFj/9ouS9u2SvPQldoL3uzPc+z6QSvqcf/z1i0Z0+1f+gvcTKbD5yi3M+BOOHvr74Bj5bKpM9gThJviYfFL9r6Qw9wraiPG/HHTyX/D29slwsvs5fB79YwIw+76OWPmbBpD2WZQc9Yop+vlW4zj6XWkO+B090vbUwtDzq1U49sSTJvX8u2j4q9R698OovPmEpPj7YjU49sfXuPag8Jb7XIVY8G6wDv+Ym8T0CMT6/SbXEPf5Bw76zDO0+tzF5vgH2b73LcSO9cloxvj8RrL6NgYy+MJFZPW/qwL4hvwg+VlWWvnVpf71CANw9wlb9PcR2ED4L8UM8xHCJvknTkT7PnJ0/2ScJPbH/l70bWIm+9M3bvuXUqDwIuAQ9iF3nPvZdP73umqe+oIiovked1b16qaU+dFRVPptsMz7aUDQ9Pa9OPRJ2q7sLWNg8KMzSvlsvPL6oj8a+YRnAPe0RT75knuI7HFYCPGs8BD5tfpm7yc5DvqtuD77JXhi8+mwavcfFqD741ZU+8zYxPldjBz4NyCk+6mLYvtm/CD3hlU++EMSCPrBVnb4ChnU+yD9FPqQKej6q9mY+UFL5PVcFPD6GG4U+k7vlvb+Efj1v+7+9yF4QvAyvpj31qQO+f1+1PtxPVj2Lb7W+lTFVvHfERj69w989W2jdPYkz0b5mJQY9V9NePrhe1r3YapM9MyyHPb3ZUD1O8hi+s3s+vaPexT2Oq+i97JKfvZraVLxg+/Y9lbi9voHAUb5pr9C9tfbDPVV7bj4GSnm9H68IvpdmVb0N/ak++Yu0PZNtmzxZsgw/32QnviDX5b1ceUs+9N+JvlFmXD7mm7S70XShviq3BrxO+rO9W2u8PW+j3L1rnRk96JZNvr5YAT9G8me+WR2bPu7/pr7o3D69l6Qcvv29JT0o0Ku+TpVsPlr/vzxCZCe+XW2WPnjGqD6R2xW/OUIFvu1oAr6XRim+9lOTPtH/n71NFbI+RbL1vTpQcDzajmy+M1knPpVURr6N6yw+w2usPDNLor2MvnM9MI/NPAM56D1IAVS/i4WPPa2Zyr3P2WO++khXPgZTVb5yKZ2+rT7DvZ/pub3ArYg+gyB0vvxkTj7HhZe9F87ZPTOZLL4IK8e9AHxUvBQlC72w+Tc+eqeevWTuFL5ZWyS+euKovmAPGb7L9Za+CgRMvkiu3j2TVXk+7KoMvvyDEL44aZ++wqDGPmn/BLtbqEC+oFvAPlynAr9icw8+VdWSvmUi0r7N6qy+ZpNvPmZkhD/dsYy9pHyXPoK56zwLz+m9xAKRvpxSpD7BxaK9He2FPhR4br40say+zmXTPFlNVD1gz0Y/zVHSvd1mr76OGwA/BD7RPShtEr661BI9wrGqPsvWDr7QFpM+H2B/viEZSj5QWZu9eEJWPnb70D4tHx68u8mFvCGCVbwpRYW+Psvmvnow8LwB1K+9uxA5vf9Mmr3vBXm+SdZNPiVDJz4mt6q+FZOUPvS2Cz6jt22+nyeHvoznb77PJ7y+Pp+WvNIUWT3WOOu+chqzvshnnz2aNwI+yDmyPuz+yD5o9Ac8DbrXvR64s75pYWs+NN8UvrRno77jA5091AQGvaW/5L2kD2++UCfHPfC4UT5TtK2+jlvuPVOkxr5buS8+i9sAPurpPL5EWdY9GotgPqkKmb2a5fa9SbkIu9mu1z366Pu+iB0FvpoxKL5t8Du+qTwFvkcjc767BZ4+JZoLPfoEhD71h+o9FLECv4IOcL0bYt6+Sf9yPS2BZ75QPpA9AFDqvtBevT3DUtg+QSTlPgtLJb5BGjy+zjJmvvplTb4C1cM+UnkrPgF43L0pifa9+MxrPaouDD60OqS+IQzIPXL+2z5ZN+29HgNNvT7ToD2VXgo+GcsCvsEvVT4Yg8K+6As8PuoPub2v/Sk+ml2tvqVswDwc4fw97eo7PlNG6D5uhsU+eRAjvSZ4475Rnve97pLlvb0cSz4h39i9CTDGP3/o1D4vhtU+9IIKPhLYcr7Qyvg+CJIXP0PptT064CI+rhGBPsbN3j4NoaG9jJLTuiYbEz9OUq2+3TWEvUUNrr90BJK96i2YOr/SGT+rTSQ/hsQ6vsuhuL6liIO+4lY1vq9zDr7axb09rj8dPwThYL5GegM+dF1dPoh23LwoSlo+42lqPgZwSb4J6r49n8FSvZcfoL7qnbC8VvqdvRihDz5/+qW+IfbXvYSIFz7Q6YS+pE6LPhbTqT6lQqO+bTN6vnX5Gj71W9U9Vt+PvmCFCj/IK8q8HIwzPq7PfD7hsa2+wtbcvSSJa746fuW9jRd8vjfiSr74aFQ+cJWRvn7pEz3S/vQ8GHjHvqlsAD6rpBY+81cSvZq1Cj5b+W8+3JWfPJEbiL4NUg++O1SovU7z0D0pdWm+VxXPvnRaJD9Rwwo/6aeLPuXmAb4tExI9pCSCPqTl0D2JFIc8WNbHvhLdEr4k3G8+wb2nvtnk/zwGA7Y+l849PSjkBj1ZlOS9xF0DPs/R3D1MB/29qAZqPvfjWL4jncq9IL+gvs9+3DxgH6q+Ae5WvTIrgz1p+K6+DLGAvWWpW769VqQ+Y3sFPmQ4KL7RWKQ9pAsKvrCyn755FA0++TMKu+3Tob4omxG8V3gbPqpw9z3N+hO9eDPkPMiJ7727abs+DY2bPti5Wr5MjQY/P8Lhvaucb7yKPr2+TBeFvjN1ub5CKJ2+K1+hvgcQV75CTha+yxyNOvMCGr6BHBK81s1zPdzSxD65dKm+5iQvPC+g6Ty8ZtG86EhGPgK/KL6Mp3a+XeCUPtzOUr1w1tw8R6loPpfHQb7EgMa8fNZWvqhCET6/8Nk+4J2dvnjOED5bPCI+wWyBPYjUxj7uOfY9IMHPvi1quT7L2ew9PdylvsZLOL60ypu9lAaIvBsECD4/zIY9FNLLPTe3MbzsYQ0+FvlHPhQVkjySsz2++LPmvNGF6zxWCAA9NBh4PHOIHr7NonS9kObjPZpOCD91OSc9GteXPe6+w706QCe+Hea9PQnrJr6+C/e9es2nvuxnq71XO3G+0V0kPJP0AT4HDWA+G9ljv3rrLb63Tsq9sgOMPkxk+T3rKMw8TqqGvmJwvDwuOks+HHQCvvdBgL4h+WY+3AGYPhDn/b1FvS2+W/bwPTiQ6T3E+AO+3bkjPitBUz6KInq+ucZxPhvwfD6Ve5W9EKCRviFHX76Dxr89oVQIPx0UQry/Evo8elKWPs2wgL4QI4a+sko+Pi2Sx76hL4W+ldzqvskjgj75PaK8f0c2PvyEMT7hNik9TB7ivQRd4b7kMAI9ciRWvo4uYj4KCuI9FvUNvaY4jr6zOK4+P12vPr/jF75XplY+07tdPj97Xj1kX9y+WuWFvnbitT0qEGy+JEbku9pehj6DAu69yfiBPUNaFj6RAsQ97VCAPOGDDT4Cv8u+paMkvg==" | null | 1126.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | N3 | Stage IIC | null | null | Good Prognosis | null | null |
TCGA-TGCT | 61544d30-175b-45bc-86bd-9ad45bebb840 | TCGA-ZM-AA06 | true | 23 | released | 1.91 | Yes | 0.52 | 7.3 | 45 | -16719 | null | not hispanic or latino | male | white | Alive | 1966 | null | 16719 | M0 | NX | Stage IB | T2 | not reported | 0 | C62.9 | not reported | 9061/3 | Seminoma, NOS | no | No | not reported | Testis, NOS | No | Testis, NOS | Not Reported | 2011 | null | Not Reported | false | Not Reported | 1022 | 0 | 50.0 | 39C6A721-71D7-4B88-AE64-83FAD250E974 | TCGA-ZM-AA06-01A-12 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 75.0 | project id: TCGA-TGCT; case submitter id: TCGA-ZM-AA06; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.52; rna integrity number: 7.3; age at index: 45; days to birth: -16719; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1966; age at diagnosis: 16719; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IB; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage IB; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1498.0; icd 10 code: C62.9; igcccg stage: Good Prognosis; last known disease status: not reported; morphology: 9061/3; primary diagnosis: Seminoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Testis, NOS; synchronous malignancy: No; tissue or organ of origin: Testis, NOS; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1022; days to sample procurement: 0; initial weight: 50.0; portion submitter id: TCGA-ZM-AA06-01A-12; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 75.0; | [
1024
] | "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" | null | 1498.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | N0 | Stage IB | null | null | Good Prognosis | null | null |
TCGA-TGCT | e9d6e631-a4d9-4855-a8b3-b11e3be63cfc | TCGA-ZM-AA0B | true | 23 | released | 1.96 | Yes | 0.57 | 7.0 | 32 | -11820 | null | not hispanic or latino | male | white | Alive | 1980 | null | 11820 | M0 | NX | Stage IA | T1 | not reported | 0 | C62.9 | not reported | 9061/3 | Seminoma, NOS | no | No | not reported | Testis, NOS | No | Testis, NOS | Not Reported | 2012 | no | Not Reported | false | Not Reported | 573 | 0 | 200.0 | 2469E63F-275E-4A1C-A391-CD15E71C409B | TCGA-ZM-AA0B-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 70.0 | project id: TCGA-TGCT; case submitter id: TCGA-ZM-AA0B; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.96; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.57; rna integrity number: 7.0; age at index: 32; days to birth: -11820; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1980; age at diagnosis: 11820; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IA; ajcc clinical t: T1; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage IA; ajcc pathologic t: T1; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 838.0; icd 10 code: C62.9; last known disease status: not reported; morphology: 9061/3; primary diagnosis: Seminoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Testis, NOS; synchronous malignancy: No; tissue or organ of origin: Testis, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 573; days to sample procurement: 0; initial weight: 200.0; portion submitter id: TCGA-ZM-AA0B-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 70.0; | [
1024
] | "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" | null | 838.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T1 | null | null | null | null | null | null | N0 | Stage IA | null | null | null | null | null |
TCGA-TGCT | 43cdb4df-06db-4252-a25a-04def9d24c6d | TCGA-ZM-AA0D | true | 23 | released | 1.88 | Yes | 0.78 | 7.8 | 34 | -12738 | null | not hispanic or latino | male | white | Alive | 1978 | null | 12738 | M0 | NX | Stage IA | T1 | not reported | 0 | C62.9 | not reported | 9061/3 | Seminoma, NOS | no | No | not reported | Testis, NOS | No | Testis, NOS | Not Reported | 2012 | no | Not Reported | false | Not Reported | 472 | 0 | 160.0 | BD545A62-1073-4A83-BE63-6A2835CD4365 | TCGA-ZM-AA0D-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-TGCT; case submitter id: TCGA-ZM-AA0D; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.78; rna integrity number: 7.8; age at index: 34; days to birth: -12738; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1978; age at diagnosis: 12738; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IA; ajcc clinical t: T1; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage IA; ajcc pathologic t: T1; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 848.0; icd 10 code: C62.9; last known disease status: not reported; morphology: 9061/3; primary diagnosis: Seminoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Testis, NOS; synchronous malignancy: No; tissue or organ of origin: Testis, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 472; days to sample procurement: 0; initial weight: 160.0; portion submitter id: TCGA-ZM-AA0D-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 848.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T1 | null | null | null | null | null | null | N0 | Stage IA | null | null | null | null | null |
TCGA-TGCT | 89d95f32-019c-48e7-b804-566285a8a2a6 | TCGA-ZM-AA0E | true | 23 | released | 1.85 | Yes | 1.42 | 7.5 | 39 | -14255 | null | not hispanic or latino | male | white | Alive | 1973 | null | 14255 | M0 | NX | Stage IA | T1 | not reported | 0 | C62.9 | not reported | 9061/3 | Seminoma, NOS | no | No | not reported | Testis, NOS | No | Testis, NOS | Not Reported | 2012 | no | Not Reported | false | Not Reported | 435 | 0 | 240.0 | 42E5710C-CA70-4996-ADAC-D2FA1932B20E | TCGA-ZM-AA0E-01A-12 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 70.0 | project id: TCGA-TGCT; case submitter id: TCGA-ZM-AA0E; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.42; rna integrity number: 7.5; age at index: 39; days to birth: -14255; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1973; age at diagnosis: 14255; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IA; ajcc clinical t: T1; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage IA; ajcc pathologic t: T1; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 811.0; icd 10 code: C62.9; last known disease status: not reported; morphology: 9061/3; primary diagnosis: Seminoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Testis, NOS; synchronous malignancy: No; tissue or organ of origin: Testis, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 435; days to sample procurement: 0; initial weight: 240.0; portion submitter id: TCGA-ZM-AA0E-01A-12; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 70.0; | [
1024
] | "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" | null | 811.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T1 | null | null | null | null | null | null | N0 | Stage IA | null | null | null | null | null |
TCGA-TGCT | 0bd2551f-4060-43b2-bee3-956e7e09db31 | TCGA-ZM-AA0F | true | 23 | released | 1.84 | Yes | 0.69 | 8.1 | 35 | -12973 | null | not hispanic or latino | male | white | Alive | 1978 | null | 12973 | M0 | NX | Stage IA | T1 | not reported | 0 | C62.9 | not reported | 9061/3 | Seminoma, NOS | no | No | not reported | Testis, NOS | No | Testis, NOS | Not Reported | 2013 | no | Not Reported | false | Not Reported | 316 | 0 | 410.0 | 84D4CE57-7725-4595-8725-0F3F0BF3A855 | TCGA-ZM-AA0F-01A-21 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 65.0 | project id: TCGA-TGCT; case submitter id: TCGA-ZM-AA0F; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.84; concentration: 0.16; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.69; rna integrity number: 8.1; age at index: 35; days to birth: -12973; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1978; age at diagnosis: 12973; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IA; ajcc clinical t: T1; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage IA; ajcc pathologic t: T1; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 681.0; icd 10 code: C62.9; last known disease status: not reported; morphology: 9061/3; primary diagnosis: Seminoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Testis, NOS; synchronous malignancy: No; tissue or organ of origin: Testis, NOS; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 316; days to sample procurement: 0; initial weight: 410.0; portion submitter id: TCGA-ZM-AA0F-01A-21; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 65.0; | [
1024
] | "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" | null | 681.0 | null | null | null | null | null | null | null | 0.16 | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T1 | null | null | null | null | null | null | N0 | Stage IA | null | null | null | null | null |
TCGA-TGCT | 97ca0157-0096-4b0c-a3e7-bab59078d2d6 | TCGA-ZM-AA0H | null | 23 | released | 1.87 | Yes | 2.09 | 8.1 | 50 | -18419 | null | not hispanic or latino | male | white | Alive | 1960 | null | 18419 | M0 | NX | Stage IS | T3 | not reported | 0 | C62.9 | not reported | 9061/3 | Seminoma, NOS | no | No | not reported | Testis, NOS | No | Testis, NOS | Not Reported | 2010 | null | Not Reported | false | Not Reported | 1422 | 0 | 20.0 | 379CA566-4F13-4FF6-8D90-60175AAC9362 | TCGA-ZM-AA0H-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 10.0 | 90.0 | 90.0 | project id: TCGA-TGCT; case submitter id: TCGA-ZM-AA0H; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.09; rna integrity number: 8.1; age at index: 50; days to birth: -18419; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1960; age at diagnosis: 18419; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IS; ajcc clinical t: T3; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage IS; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1736.0; icd 10 code: C62.9; last known disease status: not reported; morphology: 9061/3; primary diagnosis: Seminoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Testis, NOS; synchronous malignancy: No; tissue or organ of origin: Testis, NOS; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 1422; days to sample procurement: 0; initial weight: 20.0; portion submitter id: TCGA-ZM-AA0H-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0; | [
1024
] | "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" | null | 1736.0 | 20.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3 | null | null | null | null | null | null | N0 | Stage IS | null | null | null | null | null |
TCGA-TGCT | d6c4198b-6c69-40e5-a8eb-b2de3ac0b2b7 | TCGA-ZM-AA0N | true | 23 | released | 1.9 | Yes | 0.71 | 7.7 | 44 | -16094 | null | not hispanic or latino | male | white | Alive | 1969 | null | 16094 | M0 | NX | Stage IB | T2 | not reported | 0 | C62.9 | not reported | 9061/3 | Seminoma, NOS | no | No | not reported | Testis, NOS | No | Testis, NOS | Not Reported | 2013 | no | Not Reported | false | Not Reported | 191 | 0 | 290.0 | 9770AC5E-899D-4337-ABBD-A59E5FCF229C | TCGA-ZM-AA0N-01A-21 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 75.0 | project id: TCGA-TGCT; case submitter id: TCGA-ZM-AA0N; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.71; rna integrity number: 7.7; age at index: 44; days to birth: -16094; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1969; age at diagnosis: 16094; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IB; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage IB; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 634.0; icd 10 code: C62.9; last known disease status: not reported; morphology: 9061/3; primary diagnosis: Seminoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Testis, NOS; synchronous malignancy: No; tissue or organ of origin: Testis, NOS; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 191; days to sample procurement: 0; initial weight: 290.0; portion submitter id: TCGA-ZM-AA0N-01A-21; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 75.0; | [
1024
] | "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" | null | 634.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | N0 | Stage IB | null | null | null | null | null |
TCGA-UVM | 2bf47a88-df0a-4102-af2e-998c3d252b9c | TCGA-RZ-AB0B | true | 23 | released | 1.87 | Yes | 1.4 | 8.7 | 47 | -17514 | 149 | not reported | female | white | Dead | 1966 | 2013 | 17514 | MX | null | Stage IV | T4b | not reported | 0 | C69.80 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Overlapping lesion of eye and adnexa | No | Overlapping lesion of eye and adnexa | Not Reported | 2013 | not reported | Not Reported | false | Not Reported | 126 | 0 | 80.0 | B839359A-1DDA-4FC9-AF63-73FB092ED394 | TCGA-RZ-AB0B-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 97.0 | project id: TCGA-UVM; case submitter id: TCGA-RZ-AB0B; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 8.7; age at index: 47; days to birth: -17514; days to death: 149; ethnicity: not reported; gender: female; race: white; vital status: Dead; year of birth: 1966; year of death: 2013; age at diagnosis: 17514; ajcc clinical m: MX; ajcc clinical n: NX; ajcc clinical stage: Stage IV; ajcc pathologic m: M1; ajcc pathologic stage: Stage IV; ajcc pathologic t: T4b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C69.80; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Overlapping lesion of eye and adnexa; synchronous malignancy: No; tissue or organ of origin: Overlapping lesion of eye and adnexa; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 126; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-RZ-AB0B-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 97.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M1 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | NX | Stage IV | null | null | null | null | null |
TCGA-UVM | 5019e7f1-db46-4a07-9e7b-b6e5d1481b84 | TCGA-V3-A9ZX | true | 23 | released | 1.82 | Yes | 1.36 | 7.8 | 56 | -20539 | null | not hispanic or latino | male | white | Alive | 1957 | null | 20539 | MX | NX | Stage IIB | T2b | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2013 | no | Not Reported | false | Not Reported | 15 | 0 | 150.0 | CB5480FC-4BE1-478D-BEB5-39D74FD3F2E8 | TCGA-V3-A9ZX-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 10.0 | 90.0 | 90.0 | project id: TCGA-UVM; case submitter id: TCGA-V3-A9ZX; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.36; rna integrity number: 7.8; age at index: 56; days to birth: -20539; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1957; age at diagnosis: 20539; ajcc clinical m: MX; ajcc clinical n: NX; ajcc clinical stage: Stage IIB; ajcc clinical t: T2b; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T2b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 470.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 15; days to sample procurement: 0; initial weight: 150.0; portion submitter id: TCGA-V3-A9ZX-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0; | [
1024
] | "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" | null | 470.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T2b | null | null | null | null | null | null | NX | Stage IIB | null | null | null | null | null |
TCGA-UVM | 2112a42a-9b85-475a-a31b-4ce7751cdeb9 | TCGA-V3-A9ZY | true | 23 | released | 1.83 | Yes | 1.69 | 8.5 | 54 | -19894 | null | not hispanic or latino | male | white | Alive | 1959 | null | 19894 | MX | NX | Stage IIB | T3a | not reported | 0 | C69.30 | not reported | 8771/3 | Epithelioid cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2013 | no | Not Reported | false | Not Reported | 4 | 0 | 20.0 | 163AE028-0550-4AEF-89A3-83600276EE4B | TCGA-V3-A9ZY-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-V3-A9ZY; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.69; rna integrity number: 8.5; age at index: 54; days to birth: -19894; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1959; age at diagnosis: 19894; ajcc clinical m: MX; ajcc clinical n: NX; ajcc clinical stage: Stage IIB; ajcc clinical t: T3a; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 459.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8771/3; primary diagnosis: Epithelioid cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 4; days to sample procurement: 0; initial weight: 20.0; portion submitter id: TCGA-V3-A9ZY-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 459.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3a | null | null | null | null | null | null | NX | Stage IIB | null | null | null | null | null |
TCGA-UVM | 029cc59c-60df-4411-a044-3a2eeee7b110 | TCGA-V4-A9E5 | true | 23 | released | 1.89 | Yes | 1.34 | 8.7 | 51 | -18948 | null | not hispanic or latino | female | white | Alive | 1957 | null | 18948 | M0 | N0 | Stage IIIB | T4b | not reported | 0 | C69.30 | not reported | 8720/3 | Malignant melanoma, NOS | no | No | not reported | Choroid | No | Choroid | Not Reported | 2008 | no | Not Reported | false | Not Reported | 1923 | 0 | 80.0 | 8EBDD431-36DB-4197-B4BA-A6F212CAC1C1 | TCGA-V4-A9E5-01A-11 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9E5; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.34; rna integrity number: 8.7; age at index: 51; days to birth: -18948; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1957; age at diagnosis: 18948; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIB; ajcc clinical t: T4b; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T4b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2499.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 1923; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-V4-A9E5-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 2499.0 | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4b | null | null | null | null | null | null | N0 | Stage IIIB | null | null | null | null | null |
TCGA-UVM | b5c516ba-4785-41dc-bd07-b129d47808dd | TCGA-V4-A9E7 | true | 23 | released | 1.86 | Yes | 1.84 | 8.3 | 76 | -28025 | 415 | not reported | male | white | Dead | 1935 | 2012 | 28025 | M0 | N0 | Stage IIIA | T4a | not reported | 0 | C69.30 | not reported | 8771/3 | Epithelioid cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2011 | null | Not Reported | false | Not Reported | 711 | 0 | 40.0 | 83D9F1B8-553B-47E7-83D9-5663FCEF17A1 | TCGA-V4-A9E7-01A-11 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9E7; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.84; rna integrity number: 8.3; age at index: 76; days to birth: -28025; days to death: 415; ethnicity: not reported; gender: male; race: white; vital status: Dead; year of birth: 1935; year of death: 2012; age at diagnosis: 28025; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T4a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8771/3; primary diagnosis: Epithelioid cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 711; days to sample procurement: 0; initial weight: 40.0; portion submitter id: TCGA-V4-A9E7-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | null | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4a | null | null | null | null | null | null | N0 | Stage IIIA | null | null | null | null | null |
TCGA-UVM | df941bc1-6356-4f2e-a3f5-ae190266b441 | TCGA-V4-A9E8 | true | 23 | released | 1.84 | Yes | 1.56 | 7.5 | 49 | -18073 | 808 | not hispanic or latino | male | white | Dead | 1962 | 2013 | 18073 | M0 | N0 | Stage IIIA | T4a | not reported | 0 | C69.30 | not reported | 8771/3 | Epithelioid cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2011 | null | Not Reported | false | Not Reported | 699 | 0 | 50.0 | E143312E-761C-4465-8357-CC44E3987CFD | TCGA-V4-A9E8-01A-11 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9E8; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.56; rna integrity number: 7.5; age at index: 49; days to birth: -18073; days to death: 808; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1962; year of death: 2013; age at diagnosis: 18073; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T4a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8771/3; primary diagnosis: Epithelioid cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 699; days to sample procurement: 0; initial weight: 50.0; portion submitter id: TCGA-V4-A9E8-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | null | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4a | null | null | null | null | null | null | N0 | Stage IIIA | null | null | null | null | null |
TCGA-UVM | 418152bd-7d33-4f0a-b890-2356b30d6f44 | TCGA-V4-A9E9 | true | 23 | released | 1.91 | Yes | 1.26 | 7.2 | 50 | -18387 | null | not hispanic or latino | male | white | Alive | 1962 | null | 18387 | M0 | N0 | Stage IIIA | T4a | not reported | 0 | C69.30 | not reported | 8772/3 | Spindle cell melanoma, NOS | no | No | not reported | Choroid | No | Choroid | Not Reported | 2012 | no | Not Reported | false | Not Reported | 675 | 0 | 70.0 | C8E6E160-2B5D-466D-8C44-42516303F5A9 | TCGA-V4-A9E9-01A-11 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9E9; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.26; rna integrity number: 7.2; age at index: 50; days to birth: -18387; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1962; age at diagnosis: 18387; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T4a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1246.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8772/3; primary diagnosis: Spindle cell melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 675; days to sample procurement: 0; initial weight: 70.0; portion submitter id: TCGA-V4-A9E9-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 1246.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4a | null | null | null | null | null | null | N0 | Stage IIIA | null | null | null | null | null |
TCGA-UVM | a9fe64a9-6d22-4e9f-96f3-f16af7d298f8 | TCGA-V4-A9EA | true | 23 | released | 1.88 | Yes | 1.32 | 7.2 | 66 | -24234 | null | not hispanic or latino | male | white | Alive | 1946 | null | 24234 | M0 | N0 | Stage IIIA | T4a | not reported | 0 | C69.30 | not reported | 8772/3 | Spindle cell melanoma, NOS | no | No | not reported | Choroid | No | Choroid | Not Reported | 2012 | no | Not Reported | false | Not Reported | 666 | 0 | 60.0 | 98EC98E0-F65F-40F7-A499-E9F6C8DF6C02 | TCGA-V4-A9EA-01A-11 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9EA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.32; rna integrity number: 7.2; age at index: 66; days to birth: -24234; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1946; age at diagnosis: 24234; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T4a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1348.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8772/3; primary diagnosis: Spindle cell melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 666; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-V4-A9EA-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 1348.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4a | null | null | null | null | null | null | N0 | Stage IIIA | null | null | null | null | null |
TCGA-UVM | eeab0529-31e6-4edb-bd2c-a21f2a169381 | TCGA-V4-A9EC | true | 23 | released | 1.89 | Yes | 1.25 | 8.2 | 75 | -27655 | null | not hispanic or latino | female | white | Alive | 1937 | null | 27655 | M0 | N0 | Stage IIB | T3a | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2012 | no | Not Reported | false | Not Reported | 615 | 0 | 40.0 | A2A74023-0861-4C39-B9D1-FC97AA980C5E | TCGA-V4-A9EC-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 10.0 | 90.0 | 95.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9EC; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.25; rna integrity number: 8.2; age at index: 75; days to birth: -27655; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1937; age at diagnosis: 27655; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 743.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 615; days to sample procurement: 0; initial weight: 40.0; portion submitter id: TCGA-V4-A9EC-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 95.0; | [
1024
] | "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" | null | 743.0 | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3a | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | 367869f9-bbe7-4e57-a16f-f2b63f2de697 | TCGA-V4-A9ED | true | 23 | released | 1.89 | Yes | 1.06 | 7.6 | 45 | -16528 | null | not hispanic or latino | male | white | Alive | 1967 | null | 16528 | M0 | N0 | Stage IIIA | T3b | not reported | 0 | C69.40 | not reported | 8772/3 | Spindle cell melanoma, NOS | no | No | not reported | Ciliary body | No | Ciliary body | Not Reported | 2012 | no | Not Reported | false | Not Reported | 566 | 0 | 50.0 | 0A53BD62-157E-4D8D-B88A-6ACA3DAD61D0 | TCGA-V4-A9ED-01A-11 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9ED; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.06; rna integrity number: 7.6; age at index: 45; days to birth: -16528; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1967; age at diagnosis: 16528; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T3b; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T3b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1078.0; icd 10 code: C69.40; last known disease status: not reported; morphology: 8772/3; primary diagnosis: Spindle cell melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ciliary body; synchronous malignancy: No; tissue or organ of origin: Ciliary body; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 566; days to sample procurement: 0; initial weight: 50.0; portion submitter id: TCGA-V4-A9ED-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 1078.0 | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3b | null | null | null | null | null | null | N0 | Stage IIIA | null | null | null | null | null |
TCGA-UVM | edbf6720-467e-4928-b1cb-0e7336358d18 | TCGA-V4-A9EE | true | 23 | released | 1.92 | Yes | 1.37 | 8.1 | 86 | -31421 | 398 | not hispanic or latino | male | white | Dead | 1926 | 2013 | 31421 | M0 | N0 | Stage IIB | T3a | not reported | 0 | C69.30 | not reported | 8771/3 | Epithelioid cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2012 | no | Not Reported | false | Not Reported | 537 | 0 | 40.0 | 780F5B34-05FF-44A1-B9F4-062D737246FD | TCGA-V4-A9EE-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 10.0 | 90.0 | 95.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9EE; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.37; rna integrity number: 8.1; age at index: 86; days to birth: -31421; days to death: 398; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1926; year of death: 2013; age at diagnosis: 31421; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8771/3; primary diagnosis: Epithelioid cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 537; days to sample procurement: 0; initial weight: 40.0; portion submitter id: TCGA-V4-A9EE-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 95.0; | [
1024
] | "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" | null | null | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3a | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | a18d3ba3-e2f4-4144-9c25-2019cad193f4 | TCGA-V4-A9EF | true | 23 | released | 1.76 | Yes | 1.25 | 7.4 | 56 | -20763 | null | not hispanic or latino | male | white | Alive | 1956 | null | 20763 | M0 | N0 | Stage IIIB | T4b | not reported | 0 | C69.30 | not reported | 8772/3 | Spindle cell melanoma, NOS | no | No | not reported | Choroid | No | Choroid | Not Reported | 2012 | null | Not Reported | false | Not Reported | 535 | 0 | 60.0 | 816380AA-CC87-4221-B41C-9A02E2201D02 | null | null | null | null | null | null | null | null | null | project id: TCGA-UVM; case submitter id: TCGA-V4-A9EF; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.76; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.25; rna integrity number: 7.4; age at index: 56; days to birth: -20763; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1956; age at diagnosis: 20763; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIB; ajcc clinical t: T4b; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T4b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1165.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8772/3; primary diagnosis: Spindle cell melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 535; days to sample procurement: 0; initial weight: 60.0; sample id: 9bf89fdd-8255-4e8a-a8be-7e593b0720fe; sample submitter id: TCGA-V4-A9EF-01Z; portion id: 2d8b8015-2117-5d13-81f7-003a3124ea55; slide id: 6365cf03-0eae-4490-bd60-30778f00e6ca; slide submitter id: TCGA-V4-A9EF-01Z-00-DX1; section location: Not Reported; | [
1024
] | "XVHWvhpYvj5KRAS+GXyrvAg5bD4/Huk+DAVDvlRAVj6gWeu9asYgvg/soz4urZU9bXvwPEDNH74hWnm+b1x1PoHKZDtwMpY9efCyvW18aj4BT0S937HbPk9+hj7gRiu+G9OBvkB4Ar6HpH4+7mRDPvrDGTy9cAE+JP7TPcNMXz6QHp++V1yTvnpN9TzMhsY+VV6AvkNCar4nIxM+JD/bvHdgDD4n9oU+vlwQPiUinr4RZ9G+rtO1PTQIF70UfSy+SS11Pl0f9b1caeW9vwBmvtT3g72sk4G+DEjJPDqBGjzH6b28ymqRvoCryz4HTT8/k1dmPDb0F71rPLu9NyLMPvm53b3Vt6E+SiCbvh9CV77fP40+jU9uvnHE/b07MzQ+E5mBPg/9uD53n16+ylpsu0Alkr08+cQ93CxnvuvNPz7D5cE9xyQCvrzX1D3dXgC++FNxvr2Ib77/nDS9KzTDvuGg4D5pN7W+yiVyPi87lj4xi50+oKw6vVOzmj3AGdy9g7i/vUK1mr6QhXY+nFTgu9NYAD9Ct5G9Uionvb1J0j2vduQ9prHJvYtpsjzAyvG9YtqkvYZZ+b3R8V0+fH7dPlQYNz1O/cQ9+n4+vckE0T0GIyU+UEX9veIG8L4H6Qc90rpPPvNeOD/l32C+2K+xvtddhr0KfS6+p0TLPrCy4z1ijQS/P1UUvWxLDr1df5a+aIQMPad7pD3NOZe+UCeOPk9Kb78qjdG9CYe4voufKLtrlPI8ydMmPsW8FT4yjbA+cXQtvI0czD7fSau+ImiXvpNugb7PIas+GYKLvtkN5z208kE9nojvvtWA1b3mehW/BiuUPs9csr1skng8SbGUPrwOoz0bR506aCHsPY1s8D0z55m+SHjSvVfMWT4oUda9MX4iPm2Nfb3DrPi9MYFLvoTbWj7e45C9OXp7PltUTbwaP/W9cZsGPbqXMT7RSAw/iqdnO+J6Dj+p862+v7vNPWDpirsbb5q9G1sSvi65Er9gN/S8BE4MPjsG/70bml0+l4F4PrDfLr1G2VG6TCScvUodML5TRwi+ajYQvbGmxr0iKO6+8eD9vkyNZr596xM8r95TPjj9272mMom+S06GvU3vh76GmZi+2A3fvuASbz0t2sU+w7QOPqKhED5lULC+bQKNvuO41D1KcQe+bpoCPrmXF782+gY+DGyCvtjTJ77o6t69TjnSvUMnwr7hYhU/x1YJPWpOFT6fss+9zopjvnOcEzwDd6y+gNhXvXzzDL05cGe9A899PoB9TD4LSp89NNytPrMc/7rUI26+o/esvb5s1DwnTzM+8eGzvQhxxb51los90EcDvFql/z1fH6q9SguEPqpI6r1zHLDA2TvbPTFf7T4ACOA9WRaRvoUxTL4QD0q+h0GmPVLI2byeZoo7DzofPlHtFL6Mai0+OHmDvSZNpD2npw++iE1WPl4CpD3lTLi9cfP8vMbTtD3WhR8/Y4Y0vmlsfj1/CY0+y9NlvfegRD5l1Yc9L6CVvdTMPj48NBO9ZXCpvvCG+b2pgMK+EtHlvgxgvj1e8yO9SYsovpS2Ab1B3As8LNfcPaF9hj7dpT8+kc5iPM7CBr4uGI69KzeMPttnoz5vWGY+uUZTPpAJ3z3Zj7g+8Xm3vp4mVb5tjGA+GWPNPV6UHz7vrvK9mHuhvI6Vxb62cNm8y+vwvfD7IT6Y0q88zUAAvhNbCD/AKjO+ldPevDSBKz557wQ+sQQIP2mYwL72EqQ9K3GwPh5FvD7PMCy+EdKPPmC2l76UYuo94hUNvWnbsz4VGJk8XuEmvCTykT4ywHo+shiUvTHJFL/lapi+yvEHvu1ogr6gNuU+R/99PruJCL6rFFq8VmztPo2bGz7Up809QwKlPgNWbT7rsis+L1+lPm3vlj20VrK+WrQovPhzzz3UVoE+pZravWu7Yr7OKBy9gh3gPSNNXr6kUI0+PkzIPSUPFL7ZCI2+2Ls2vYtmaj6J0Gc7gF5pPnPJbb7Xjw6/IxpBvkSNXb4pQWM9mYcCvzDMJz4jUYi80m1XPitOID8w8Z29NOr2PN9oyrymYgM/wq47voDu6D3A49w+5VfcvXfpaz7i2kM+sMB8vrcZoj1zPAs+HfpSvm0XCb+Uzos9WPK1O4AhoL3ChaO90urYvd0p3b5x7IQ+uCCbPkdyVz7WppY7ZwAivhQM2D7yMoO+4ouBvXOxVr0bDrI9i5ObvYyGxz7HEQa9AozJPUyBZD79mB8+SCIAPvTdQr6DvqE9/H0NvzncoDzXu06//K7pPVzOsL7DdwQ/Wcxrvv5jJr1Mfqi9ya1QvprqjL6+voy+LwJtPbiXub4q7iQ+KJiYvvc3qb2M4CQ+7xE9Pug6Mj4zmY09nDqBvmbWZj5H/5g/USMIPYKO87z0UoO+ojLYvuB0cz10xYS8SpL4PrT/QTyohK++rm2JvmPonb0ovbA+Gj0QPtuBEz5Tvh881hAZPcuxDzy7BNk7hgQHvyxT5b2PtNe+WR9XPu5O4L2FLzg9sEaePGXcGT7FdA69H+sGvnsLF77Wfam92cUYPJyLqz663Zw+k7Q/PtcZID4OlyA+TSXevhvNnz0LagS+HHB/PmhVvr6w2pw+TZlLPm49mD6zTUQ+ZBtjPLGbeT4t00U+GXv3Opd7iD3Ap6u9JCELvTItDz7YTj6+ZhtxPihMkz0jU7i+FblePfsiaD6OoSg9V5cZPjrEFL8nvfQ9ZhlRPqy3oL1c2oA9X9X2PI6+g73QSu299NOEvc2VIT07miC+5NDtvdKPAT0q6qQ9D52fvoOqXb5tuuS9ePKqPQk5dz684wu+jhjZvWBaXjpakn4+n3/fPfYUlr28fiI/tbkyvrIXxb3Ajkw+syxevou0Fz57yaW9WxSYvknu4byv3RW93lwpPT/t6b04Aiq9cVh8vhZyxz6OZoW+9/mrPsyPur5yf7u9xAKfvShptjxRf+S+DWNPPqcDvD12902+8AO+PjC5nD5TWgi/eq4Mvt3M+r0evN69Ujx7PjQ6C73VzcE++EshvT9xcjz/nVS+Ekj5PNwfbb7Pm0s+6xOJveFtDr6OUq49xvemvNgmOz7ZTDG/WAfhPZwu7r1MbYe+QcOMPkCAmr4MPZS+J0uJvCb2ob3pcpk+jyNuvog7GT4JUSS8boo0PvlXgb7H/z69lu/fPI5GgT3mStM9GnN9vZfUTb4DZvO9gCKjvl2Ch73tGZ2+A4QWvuLuHD6sikY+dVgivg+i9r1ULZ++lOntPhX8wLxG/Fm+GP2KPnTqA7+tyLg9w61+vuMj2757Ibi+Mi2EPtGkhT9zMBe9D0+XPkuz2z0tOMa9qGtlvq3zqj6ZRNm9rxeEPlL2i770oYe+a3gDvLXkRb0cT2I/Z6B4vvb6kr4FGto+tVsOPFnXE75+C4E9T3qlPhG1C76KnJM+IndMvjAJrj3M0229pQySPpe+pT7CzmY9pjL7vDQVmL23AZi+WFTrvnOeA75ouMG9MxtIvQVeIr6la3m+aEm6PZZA/z1Rx8C+IyCvPoZqKz7lwaG+vKNavkAah77L1c++MeoevgFnGD7y2bq+7b3LvhfTlj2TCDQ+8qmFPscikT6F1XG860Tdvddav75bhrU+pYtRvetWxr6PvxI+58ujPIWB8L18loK+dWfrPadbHj7SH7m+Tn0PPrWNor4GkWk+ErxdPmqVM75v2Pg9n3SFPo3Dor1M5Ma9bSAEvdrfAT5Bk+K+p0ODvinnML763A6+IDbtvWRNlb6gvZU+W/l2vCPpLj7rZRc+eHkUvyMHtD1HR6m+qsZ7O4wCeL45Ai0+E9HMvpfyLbw6uOQ+2lPWPkA5HL4U6EC+3Yd6vs98Sb7217g+N/5pPiGCNr7oghC+h6+YPdTpYz6kVoy+ru4BO9e9sT4ZNdy9VpYWvLsGET6nrmg9dhonvpKC5T2KeoO+trLrPRxIF77dxww+vJqavgHqAj5RViA+lhILPpYpAz9RnKs+hdugvWv0xr63GVW+3jO6vY13Wz6qWQq+AdHNP2FcpT75EsU+zygxPsVhPr5cDe8+dQQJP2GCoz2ObZc9mdWcPrdNAj/e0vG92OAEvpWcJT+N7bK+mimnvThon7++tou9vvmEPcR0HD/ZACg/huVxvrR7ob4gzom+o0IgvoIfE75vi7w90DEIP8EjPr4lkp09SQNKPqFYxb0frzs+BsCNPtfMgr66X/s9tEaDu2MonL7derS8PB0Evexn5T1MYKm++/sXvtQr7T3eMIK+lTxePgf2jz4shK6+zLqCvrPeGz1sxXo9X87Avm5j+D7eEU+99B5aPiH6hD7r5ZO+3et/vfkeRr7A2xW+DriGvmGQmb5ftII+GcemvmX4hrrzhLU9syy6vs90Uz5yGiE+YUCJvXFlqD3vfQs+s1BIPb/jiL5ywKy9FHLvvYRN2j1GeKW+kdrBvpgSBz/xjgE/qHxcPgT9071vqKo7FkiKPomw0z3vNGk9Rv3rvtrbQb5iIFY+RQygvvHUZT29rYM+4mcJPSzW1Tx/c1W+u58yvHoNLz6hYay9Ji1mPukEcb65wi69h3m7vssaHT2ElZG+c7KKvQoZWT33AL2+D2q0vUDpar5X5ng+ZaeHPdTHLr6BkIC7tHluvQIKj77JCDY+ePE5vWxkr779kQy9+VTqPTH3FD77maA7x/yAPcbg9L3RlqQ+FiShPh+iLL7bUBE/aE0Kvmwjk72hVNe+CQZ0vtMG0L7P0ne+XCZuvsIPd746NzS+MAoEPfiPOb6v2wQ8JBgGuez4+T6gZtu+Py7kPEagSj1enj+9GjhcPvNlML4Tq4i+WH6pPuZcrrz9Uoc86ZZSPr7vUr5ehgM9+3tjvrZUYT2aPsI+4Z+AvuyrWz2dUBc+4zwWPaF6zD67Mn09L8IWvxkToj6TAwo+X7VrvlBBF77hpbu9hlFkPdMFkz7P99M9PN0rPpEm2D1ttRE+6HUJPlQDoLvfXRO+4IZ3Pd/0s7x/ZyO9TXNCPVnpS77uHyy93CQAPZXs9z5PKuM9ws68u81Bur0n/2C9eN7LPdc15L3yPAW98iqWvjMuKr4R/nK+CrMYPKdxWj4hO1Q+gCJtv3ut871Qpwu+f9sGPuzC5z0CGc270p+kvmVc+TwWvTc+TRoDvmyQkr5SBHU+9TF0PuLmPr4Da1++4ZEnPqP6jz1VwUi+xNNYPuOHhD7oWwq+Q/5dPom0iT4juum9qXRpvhwcNb6FPuU9gzcVP2UUtbtn7PI9zNufPrMWS76V6nm+UaauPfh37779QNa9uy+vvuc1ST5WCjI9V11qPrbTHD5E1Ks8/W+PvUu9Bb+4ag88QcJxvq6GjD7IMMg9u13hvWJeh75OWMQ+EeyuPux9rr0etBk+5+2BPoG/Sz0PO7O+wMuIvmuQSj3FSTK+dRQTvvfxST6P7xO+YCYIPkCNET4w4tg9fyBpO42f5z37rOK+xnUKvg==" | null | 1165.0 | 20.0 | 9bf89fdd-8255-4e8a-a8be-7e593b0720fe | TCGA-V4-A9EF-01Z | 2d8b8015-2117-5d13-81f7-003a3124ea55 | 6365cf03-0eae-4490-bd60-30778f00e6ca | TCGA-V4-A9EF-01Z-00-DX1 | Not Reported | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4b | null | null | null | null | null | null | N0 | Stage IIIB | null | null | null | null | null |
TCGA-UVM | 5e54122f-1c4d-45cc-8842-cd1c1df0eed8 | TCGA-V4-A9EH | true | 23 | released | 1.87 | Yes | 1.27 | 7.6 | 53 | -19573 | null | hispanic or latino | male | white | Alive | 1959 | null | 19573 | M0 | N0 | Stage IIIB | T4c | not reported | 0 | C69.30 | not reported | 8772/3 | Spindle cell melanoma, NOS | no | No | not reported | Choroid | No | Choroid | Not Reported | 2012 | no | Not Reported | false | Not Reported | 474 | 0 | 90.0 | C0F9EB5A-8CBD-4BDB-A67C-B205AC198A42 | TCGA-V4-A9EH-01A-11 | 2.0 | 0.0 | 5.0 | 0.0 | 0.0 | 0.0 | 95.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9EH; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.27; rna integrity number: 7.6; age at index: 53; days to birth: -19573; ethnicity: hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1959; age at diagnosis: 19573; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIB; ajcc clinical t: T4c; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T4c; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 670.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8772/3; primary diagnosis: Spindle cell melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 474; days to sample procurement: 0; initial weight: 90.0; portion submitter id: TCGA-V4-A9EH-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 95.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 670.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4c | null | null | null | null | null | null | N0 | Stage IIIB | null | null | null | null | null |
TCGA-UVM | b533e555-90cf-4657-80c6-15b67da8ad26 | TCGA-V4-A9EI | true | 23 | released | 1.89 | Yes | 1.5 | 8.5 | 78 | -28562 | 389 | not hispanic or latino | male | white | Dead | 1934 | 2013 | 28562 | M0 | N0 | Stage IIIB | T4c | not reported | 0 | C69.30 | not reported | 8771/3 | Epithelioid cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2012 | null | Not Reported | false | Not Reported | 483 | 0 | 50.0 | E7477E21-C96C-4003-92C3-86896441757A | TCGA-V4-A9EI-01A-11 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9EI; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 8.5; age at index: 78; days to birth: -28562; days to death: 389; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1934; year of death: 2013; age at diagnosis: 28562; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIB; ajcc clinical t: T4c; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T4c; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8771/3; primary diagnosis: Epithelioid cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 483; days to sample procurement: 0; initial weight: 50.0; portion submitter id: TCGA-V4-A9EI-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | null | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4c | null | null | null | null | null | null | N0 | Stage IIIB | null | null | null | null | null |
TCGA-UVM | d9ccba9b-6bf0-44d9-8097-a97ab747f0bd | TCGA-V4-A9EJ | true | 23 | released | 1.89 | Yes | 1.63 | 8.1 | 38 | -13958 | null | not hispanic or latino | male | white | Alive | 1974 | null | 13958 | M0 | N0 | Stage IIB | T3a | not reported | 0 | C69.30 | not reported | 8772/3 | Spindle cell melanoma, NOS | no | No | not reported | Choroid | No | Choroid | Not Reported | 2012 | no | Not Reported | false | Not Reported | 399 | 0 | 50.0 | 3677656F-1D21-4DE4-8DB5-F1681A72FA80 | TCGA-V4-A9EJ-01A-11 | 2.0 | 0.0 | 5.0 | 0.0 | 0.0 | 0.0 | 95.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9EJ; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.63; rna integrity number: 8.1; age at index: 38; days to birth: -13958; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1974; age at diagnosis: 13958; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 746.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8772/3; primary diagnosis: Spindle cell melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 399; days to sample procurement: 0; initial weight: 50.0; portion submitter id: TCGA-V4-A9EJ-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 95.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 746.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3a | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | 4464418c-ec35-4826-b3d5-152ac2a27a04 | TCGA-V4-A9EK | true | 23 | released | 1.88 | Yes | 0.95 | 7.5 | 37 | -13731 | null | not hispanic or latino | female | white | Alive | 1975 | null | 13731 | M0 | N0 | Stage IIB | T3a | not reported | 0 | C69.30 | not reported | 8772/3 | Spindle cell melanoma, NOS | no | No | not reported | Choroid | No | Choroid | Not Reported | 2012 | no | Not Reported | false | Not Reported | 377 | 0 | 60.0 | 9495F79F-3227-454F-942C-05CEC78273B5 | TCGA-V4-A9EK-01A-11 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9EK; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.95; rna integrity number: 7.5; age at index: 37; days to birth: -13731; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1975; age at diagnosis: 13731; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1028.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8772/3; primary diagnosis: Spindle cell melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 377; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-V4-A9EK-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 1028.0 | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3a | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | 8de236f1-c029-44df-a2a9-319145488baa | TCGA-V4-A9EL | true | 23 | released | 1.89 | Yes | 1.06 | 7.3 | 60 | -22150 | null | not hispanic or latino | male | white | Alive | 1952 | null | 22150 | M0 | N0 | Stage IIIA | T4a | not reported | 0 | C69.30 | not reported | 8771/3 | Epithelioid cell melanoma | yes | No | not reported | Choroid | Not Reported | Choroid | Not Reported | 2012 | yes | Not Reported | false | Not Reported | 376 | 0 | 50.0 | 036B1D86-3517-47E4-B285-BACE886AC434 | TCGA-V4-A9EL-01A-11 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9EL; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.06; rna integrity number: 7.3; age at index: 60; days to birth: -22150; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1952; age at diagnosis: 22150; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T4a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 982.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8771/3; primary diagnosis: Epithelioid cell melanoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: Not Reported; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 376; days to sample procurement: 0; initial weight: 50.0; portion submitter id: TCGA-V4-A9EL-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 982.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4a | null | null | null | null | null | null | N0 | Stage IIIA | null | null | null | null | null |
TCGA-UVM | 711eb720-4cb7-48de-9350-5c729bf9f0da | TCGA-V4-A9EM | true | 23 | released | 1.88 | Yes | 1.43 | 8.2 | 53 | -19413 | null | not hispanic or latino | male | white | Alive | 1959 | null | 19413 | M0 | N0 | Stage IIIA | T4a | not reported | 0 | C69.30 | not reported | 8771/3 | Epithelioid cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2012 | null | Not Reported | false | Not Reported | 367 | 0 | 70.0 | 3EA19BCF-5CE1-4C19-9C21-BEE6D9E45C74 | TCGA-V4-A9EM-01A-11 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9EM; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.43; rna integrity number: 8.2; age at index: 53; days to birth: -19413; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1959; age at diagnosis: 19413; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T4a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 966.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8771/3; primary diagnosis: Epithelioid cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 367; days to sample procurement: 0; initial weight: 70.0; portion submitter id: TCGA-V4-A9EM-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 966.0 | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4a | null | null | null | null | null | null | N0 | Stage IIIA | null | null | null | null | null |
TCGA-UVM | bcb87378-9f43-45e4-bdf2-f6dfa6ac5b8c | TCGA-V4-A9EO | true | 23 | released | 1.75 | Yes | 1.3 | 8.0 | 74 | -27190 | null | not hispanic or latino | male | white | Alive | 1939 | null | 27190 | M0 | N0 | Stage IIIA | T4a | not reported | 0 | C69.40 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Ciliary body | No | Ciliary body | Not Reported | 2013 | no | Not Reported | false | Not Reported | 272 | 0 | 60.0 | 04475A61-A4E9-482C-B0B8-48B852636AE3 | TCGA-V4-A9EO-01A-12 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9EO; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.75; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 8.0; age at index: 74; days to birth: -27190; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1939; age at diagnosis: 27190; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T4a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 773.0; icd 10 code: C69.40; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ciliary body; synchronous malignancy: No; tissue or organ of origin: Ciliary body; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 10.0; composition: Not Reported; days to collection: 272; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-V4-A9EO-01A-12; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 773.0 | 10.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4a | null | null | null | null | null | null | N0 | Stage IIIA | null | null | null | null | null |
TCGA-UVM | a6ff0b7a-1d04-4a64-af43-5011a4487cb2 | TCGA-V4-A9EQ | null | 23 | released | 1.93 | Yes | 1.26 | 9.1 | 64 | -23408 | 455 | not hispanic or latino | male | white | Dead | 1946 | 2011 | 23408 | M0 | N0 | Stage IIIA | T4a | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2010 | null | Not Reported | false | Not Reported | 1262 | 0 | null | 141E5856-DC2C-4684-BC4E-509E43B3914E | TCGA-V4-A9EQ-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9EQ; source center: 23; state: released; a260 a280 ratio: 1.93; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.26; rna integrity number: 9.1; age at index: 64; days to birth: -23408; days to death: 455; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1946; year of death: 2011; age at diagnosis: 23408; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T4a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 1262; days to sample procurement: 0; portion submitter id: TCGA-V4-A9EQ-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "Dp6Wvuekyz4XHGy+ubmRPY+mHD5AX+8+mc08vmqADz4nNfC97cUgvt+V0j5hARQ9Ntlxu2kvfL6UMlO+4chpPqT4jL0JnMc97/ctvjT1cT6vF/m9h2zpPktgPj7fCcy9+gSFvgPEqL2yEXU+kT9OPnFaMT2+8Hs92iK0PcTUCD6PDbK+CgWJvslnyrwRoLw+zbxYvhMzVr43cQI+rcgDvf1JBj4u1aI+R0AePtgJlr6IJ9++qiwJPsadcL1KWgG+L31TPrLmAL51LsG9jbkrvo8bfL0yGXe+xbLzPFBr5LqgCrq8ggY+vrFk4j4YSjk/kIecvIW6crwdt7C9pa7pPhUxIb6Q2II+LMqsvrGwmb4uYoE+O904vkzOHr7g8QU+AppPPvKIuj5CQCS+4F0mvb8Tob2Bbs09VY9WvlzXEj7chzU99ywDvtlXFD0O+ji+lvmVvkq4hb5p+8e8lfexvv6K2D4g1ca+xM8RPtEjfD5TXGc+dZcAvTocIj0sDr29LsSXPOdEgr4V4m8+pgmqPT2b9z6dbK644yyCvA+fBD3yPA4+FhXavVvPjz3pk8O9YowBvryP3b2+Vkk+JvHkPtGRqjzxDME9YuTIvcKtgT39CPs9uOTKvXB16r7mmWs9lr1QPoesHj8k2t69SUaVvhQTYbwHgkW+k2cFP1fMyz08gvW+NIWNvXyjob2/EYm+fg+6PQlIEj7fHZW+R2+NPoc7dL8E5Qq+c6qvvsyjKz10wNE8YFzrPT15/D0VdcI+lIHivF8HzT6twJC+yJxhvtE+ib5FkZI+FudkvudGkD1Mdpo9ubzvvr0X0b2cKdG+qYafPuI0gLxjBVY8MYKlPuhZUjql26S7jSKqPToGQj5sf6C+FTybObZWEz7TCDu+bE0pPo8JF73HKRG+NA6NvtP6aj4j7l+9Xs6CPtk0jrwrX9q9tXawPDjcg70GRfk+tZ62vfHbAT86hIe+R6j6PGfOOj1G0j29L37nvYGZIr9X1M08ePHAPUHSqL2iq5Q+/paVPv54YjxEgAg+usldvCx64L3vrgC+TU+0vDxLLL6HiOu+d5X+vhVsJL5NO548IhuDPtUxCTyykpu+MdKSvc8fZb7SC1u+QF/nvqlMdT3I6tk+LY0VPjkEqz3Cszm+Qh3Bvv2USD32/Dq+/ZYcPqbnD7/Qd4w9EWaCvm9rzb1lOUG9zKTGvXwkrL7QHgU/jD/APP5rAz5aZAW+9ilmvtzq+z2j8py+Qy4AvpjOubw7WLe9ow5VPnY/XT75tZY9CwOPPhNOn71nXGm+87IUvbph+jxgz6w9m3CBuTWDyr5geIY9E5ZMPba4LD5Q6229NY+8Pj+hjb7jTrPAmaSfvH31DD+8tUo+ZOFTvuLYVr6cqyC+OmYtPlVJzDwoEi69zKumPcJoR74GyuE989eIvYsw0D3Yigu+JrmXPi5BEj2IdAO+QyQBvfdFdD5ZtCg/nMNxvV9+nT3/5oc+Jf80vt9bjT04iQ0+8ZFBvRoaKz73PqG7FL2avlWVRL7UzJm+qRPMvrkTND3zu5a86R/4vYCeAb4DHqa92CEOPVjppT5POTo+ayVnu7LzK75CBFI9pYKZPlb+nD7gsHY+DjDVPZWWyT3+trU+z7mxvpi5E75iuu093Z3APaiRrz0yt0S+Tw5KPalVtr7NaNU8WJT7vbWy6D06wx09JoxdvhzX1j6EGI6+FnC/vbhO0z3STL08xzXoPmPev77GfCU+jeyQPmcNjD7LEj2+ijJkPr0NKL71TUY9+8jOPLj8hj6WXcM9T1Z1vZOicz66giw+gdQgvcRAE7/Rcaq+1q4vvqlLhb6TxgA/W40iPqgSDL7TZhO9Srm9PjSEAz4k7Po9yqGRPnw2Wj4rJN09aNmvPnMtVD100J6+EhQpvAO2pT1p2oE+vOv2vZstcb6jJQ29JFHOPWYhLr7l8JU+TrxlPb1p7b3LFYC++w+1vR5eVj7E6Ia9hzxPPmsxRr6lGRC//xkavsueY77Epbg9vF7xvvGHaj4+46m9gSwbPpc8Jj9OxwS+40bWPeHMW71rYPc+FFEfvh2Foj21Lak+eIcFviDBXj4acRg+X60svkyqFT55bAQ+1Tosvr58EL87P0A9At7COwYcND0H8Je9zJ5GvqEL9L4RVHo+8pqcPswM5D0uwhw9qo5svirWsz77c2u+F15nvS98Eb3AEKA9I7ZHvgau5T4MUem8YDxdPph+aj7QeWI9Z+8FPtblcb7p/de8yZYNv/0l1T3QUjK/3tjlPSrOnb6RIvE+PgBSvhGOpr3liau9I3tdvlQOsb7tUoW+fJQiPUdvzb5pDMU9yo+TvifBIr3ilhE+M14GPupFGT5+o008U/GMvq0zZT6EgaM/X8UmPbYSgL11eYm+BLH3vvrwKz0NGs06v5XVPqoWYLse0K6+SJKtvr7S071AGJs+PmpqPrC/Hz5KkI89TxwQPWOiUb3p2ZM8V5Tvvp5LMb7xG7++wRn/PU7cSb4qOqM7FunqvI/3BT74yw29az9Qvjpf2b2pFFm9PSURvEofrD5185I+pQE4Pj+tHz5cbzU+fCvOvtF8Cj2uK1a+pvFYPjxHnr6wHIc+8+xPPi6kiT5XvGE+QrP6PZ0BEz6cN3s+rPasvRuWXz0T47W9BupYPRzd7z1xvii+2HSlPuuScz1bpbC+ycYmvdJyXD6Hwhc9NFcWPpezyL598K08bJY5Pv3V5b0q5OI9xiVuORKVOD1Q9g2+cYravBv+Iz1bDNC96fOkvfi9CL0b5Ow9qWy3vkONGL4wD/y9H0ASPu/3aD475T+9h+YivosIWrzeIJU+9WCPPQhIjrzBKw4/CyjivTtFi73IwEo+gFR/vrCHSz50DGa9H9aavisJ6rxg6CO9uIBrPSgd9r3MSn88b9ZFvqHC+z6tco++UGudPqrqv77chZW9bM8QvmesmD3qwa6+tQpbPsoiHT0jPiC+L82JPqiYjD6gFRy/BxPovdDItr3Elx2+E3+YPjJsWb1EYaA+lbjKvXNK5ztqEFq+NatSPvXpPb7rVRI+vVIDPZAJlL1FE7A9MulXuAbP9z0r4FK/NHvEPZPQ+71ozWW+sDxvPuoKJ75HrI6+X/L2vQcHKr5vcmU+RAFkviKaRD5+dzy9/3iUPSBD3b2mfOC9SElVO5sgP7ySVjQ+jZWsvW0xC765fha+0bOavoFS/b0gKI++dylUvjy6BD4OKHk+FVw3vqkrMb6+x6C+O/zPPgF1rzxt4XG+jtGWPl7rDL+MfBY+aLtUvmhVzr6IgcO+LEZgPoiIhj/Hs4i9qq6fPn7HhT1BjsS8mKJ9vmPthz5Ay+S9JsONPooYar6tQKe+iDgUO5VE2Ltsb1A/xWNyvdhvrb42cQo/NEtwPcu6272BLQ09KqqlPi+BGb5fnoM+VPJmvuHFIz6ZXuO9E0xDPsqmwz5Mh+08ElpmvahlZbtcY5y+GX3PvpwzGb1PWtC9dbe9vO+b373rV0y+6JktPvghTT6mQLm+KoKWPq2KCD6YmoK+1o9svhmASr6QQ8a+iFoxvVW6DD4X9d2+sJC8vm+dpD1Zbu09elabPljRvT6PUMS8ougHvnA/nb41p3M+t+4KvpDvnL4N7sw9/faBvNktCr6MWk2+zIXcPWTEFj4w3Zm+aUQHPkFSqb5gqBY+A88fPnGqUb4mkdo9tZtzPkulur0DAie+CioSPV8d3T1oP+q+SCIvvgNXHb6+x3e+n04fvmPZib6Mz6Q+D05Zu5oBgT7ZFdM9HyAIv11jMz2Wzd++fm/gPZ0iPb7iH6U9HqvevpgG4z3iCOk+mzzfPtYRPr5fT2S+jLR5vpcVir75K7Q+esJpPkpFrL0doeC93Ic9PaKcKD2mhIe+dTucPRJy1j73V8C98xLUvXkWjD0GYsM9af0tvt2oID763bS+SKxOPq0aDL6VXCE+L/6qvp7DuzwN7i4+cDE2PkDl7z5EJa8+WjZXvU424b7i0Z699zIyvQrmLT4Tsge+2CHCP7hexD7UHN8+E9c0PmRYdL5gDAk/hfIJP7p+qj0NjSk+lFh+Pg6P2T5sGRu7hktvvfpmGz9/U7C+pqyYvSRJq7/gi6K96YMPPUChED+XJSg/+S5Fvl5Yrr5mOUm+vsgpvon/EL73u9M9GNwmP3dHQ75sH+c9Wz9UPixk0bynv0M+kYlGPp/GWL47hdQ9jfRfvbDvl75pS0G7Ww04vdFmrz264Ky+jEndvTqsCz5DxJS+P0WNPqfLlD6tlpi+ceaBvg3qmT3Cetg9FWWbvkAU8j6fruy8SvdJPjx2TT64FqO+9VelvZ8NN77mkNC90GWLvqigbr6suFc+dMCovgaUOz2V9rM8zOqwvjCE6z1XDhs+IX4ova2HAj41N2U+TB+APGGyWL5leCm+YEgAvmQfwT0bIUe+vHO6vkPKKD8FDPg+p/N/PuoGRL6/gVE9JcWAPvVKxz3dfjc9WOm5vl/AM74TpWE+4Pi+vpLAyjxhBpk+F1c8PVl8sDyToOe9r7VkPc6yJD6k1Ba+fTySPuawRr75Ziy9b36+vhcd6TuNvoq++hFIvTf7jT1Cma2+zawvvdkvYb7upqE+QqfwPbXjIr6y39w9PxADvmHVgr7QqvQ9aBwCPQqjkL6cHz4909wvPlyiLz6V2A29qOStPd2o+L252qY+1ICDPoiaLr5QyAI/rgKyvSm+RL2FIrq+Af2BvtVixb7yN5y+Y4mHvoA9Wb67WQG+RQ2yPOn/F77f6XC9ZslLPTxLyT54ZbK+rSe1PeAOIzxzTpm8n5UtPiNPQr7uXC6+VOegPnFz1rzMe209Gw+BPofbKL6uEES99YJTvmSV4T3mlN0+M7uIvnJyFT4HhDQ+ontAOmcfuD5I+/Q9+1fjvpbLuj6+sp095By4vq6DP74sU/e979y4vBPeGz4iGZY9csT1PdpAnr2yf709ZzlqPpV0hbz1ftq96iQHvBvLOz1jyV09GIJCPVNWHr7SQ6O97KazPbj6DD+LBoU9pukKPaUvq72cBSS+hHO0PS5UUL4IctW9U+6Wvq6REb7mY2u+szpoPE3fQT6U1W4+kP5gv8AiAb4lh/i9CT9ePgKNED7J6I46X3p6vnSo7jvOqUA++64CvgpBa74Bk3Q+fHCjPscz4r1lNgu+UNUIPgp74T3/SPO9yPUMPlfpQT7TeHS+mzaOPvzIlz6KRsa9iMmJvsnlY76tdAY+cizlPnVeIL1GGUY9Gm2PPhkEbb7uZlK+rkgKPuzWu77Ey3S+lWvTvmCYhD5z8kw8qqEnPoyO7z26w589KBOmvSQc375drd68cSdUvu1KVz6FdiY+1hRhvLVqk759CJs+SPCZPlK8Kr7Ckic+IDJuPhZA1TzuOdq+Sr5pvrg2jT3GWTO+WC01vaVKZT4CxOC9AoouPbItCD4wKUw9eRbHO71oAT4NbdS+g681vg==" | null | null | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4a | null | null | null | null | null | null | N0 | Stage IIIA | null | null | null | null | null |
TCGA-UVM | c510a423-6ab1-431e-9248-d2ac91fdedba | TCGA-V4-A9ES | true | 23 | released | 1.92 | Yes | 1.78 | 9.4 | 54 | -20054 | null | not hispanic or latino | female | white | Alive | 1957 | null | 20054 | M0 | N0 | Stage IIIA | T3b | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2011 | null | Not Reported | false | Not Reported | 901 | 0 | 40.0 | D3687ED1-758F-45DE-B4FD-A91A5435F89B | TCGA-V4-A9ES-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9ES; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.78; rna integrity number: 9.4; age at index: 54; days to birth: -20054; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1957; age at diagnosis: 20054; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T3b; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T3b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1511.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 901; days to sample procurement: 0; initial weight: 40.0; portion submitter id: TCGA-V4-A9ES-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "Cc2fvraTzT74mGS+7CF/PeSpND7xNu0+RBYnvkPwGj7SMAa+tskcvv+71j7wW3k9UmHfurWcgr5H4Wu+XA5xPptoab1wxs49XhYtvqxvaz7oQaK9rMLsPguWSz4ik9C9CiCOvqC9u738HIQ+3mlKPjNdQz2E+509T3i3Pc0tIj5wArK+fjGHvgVIAb2aH8A+5mFRvqAqaL6dhRI+u8n2vBD4KT4BS6c+nk0bPmj3jL5IY9y+FxzHPU0+X7256t69/8M3PlGpDb7zctm9LpEoviSLeL3l6oK+JVSBPCHx17xsesW8wV1QviZ88D7iHT8/CXD5ugwFQLxbqLe9J47lPtafEb4XxYc+JyafvtAepL6Bxoo+4RtSviyoFr6wQxc+LpFLPnydsT5/Uyu+do9YvXmri717puc9OtdtvrvFHT7Z2Ic8u38ZvqCgWz2EUhy+2xSKvg5/gL6Pyj+95NOmvoGT5D7uLri+xF8pPlxngT6g/Gk+dLgWvHkKfDxsKp29yC1AvJ47hb4pmo4+BO/pPfnb9z65En67aGEZuwL1Iz2ECA4+QAzPvVBChT1w75W9XNMfvloS/L0NfD4+2o/xPvbJsTzhC7I9T1rhvaXTlz2SiQY+JsOpvbja876raBI9MuI7PicqIT9+fQ++Jvikvv1mAr1Y2ku+7pj/Pt261z1CQwW/p5dTvb0/6L2wi4a+B1q+PUW8DD62naS+EK+IPgYVd790DPa9KJqsvoYnuDwEGNY8PdgFPtw/5T3cF8Y+h8wJvRKyzz6EZ6O+r0dxvuWrhL6NHIw+jJt2vjCEaD2n+M49VJnuvgtylr1j2NS+gwKaPg3Y+jvmUps8BZmiPiqE4rhSvf27OQyePSvRHD7TnJS+fPAUvf20Gj5sdVK+7oJMPuTCt7wNoyi+1Z6Lvvhjej5n/yK9BYOSPi7dLr0dmu69UJYPPUz35rxB3/c+XbK4vaQU/j5yvoK+Lw0BPciIuDwiNoK9az/+vcBrJr+H9ag8bsKwPaT/0r04RIc+CXeVPmVHhbw5CQc+viYOvbziB75ZUBq+68navJosK75wb/W+HgYGv6QrGr6yC7w86k+JPkim3DtdXaS+8tF8vasMX75NrlS+trj1vmI6pT2Eu94+axgWPu6V0T2I80K+3hncvhV6VD1gwTS+QDguPiatEL9wc6I95OZ3vjFk972q7E297vvWvfSHr77pCQ4/NIfNPG9GCj5Mei2+HdRzvkSK3j1NyaC+UT7wvQtwBr0W3se9ca1RPoWqbD50BKo9ROyIPm89d72cI3i+fbcZvRefWzxyarM9+0mGO6OexL7NCKI9lBD8PHWlID6uax69gEa/Pr1Fgr5QGLTAlCZXPIYEET97/0A+t4JnvtirSL7VTSK+OmxBPtkSSjw92We9FMiMPQHXW76tQQE+P3yNvdK21j0hZBa+yAeGPk2BLD2xZ8+9ZDLHvIe9Wz63qSs/34WMvWFLhz10SI8+qGYcvlmPVj1AAR4+uQmLvXz7Jz5ZdxW9SUCovoSUOb625Ji+fOzXviAHXLw9+0K8ib4AviW+0L3PcLm9RSUkPUIurT6rAD4+m1WuvHeFC76u2AU9XHKZPg74oj6PjHQ+yyHaPe29yj3BiLc+2ba6vqS0IL6DdPA9mFvXPciJAD7pZlG+ThdxPaW+sL5uLkM9P8zevXuJ0z2EpAU92mhZvmfn4T6kA5a+EUWpvdFP4z0lJkY7tI/kPo18wr53JhQ+Qg6TPuEDlj6OqTi+x7VxPhKmOb4Du3k91geXPO8Bjz56pJc9qlWRvZ81TD66ERo+sfJlvTBaEb/KR7u+n2RBvuhajr4qSvY+TUoyPuxrGb7yvva8IbDAPkmXET7HrdQ9SG6YPik+cT5OKAU+e4ezPuKRqz1MZ5C+E/2jvJ0WrD0i6JE+k4DrvfOqeb7lpDa9uQ/OPUWjJb5OT6Y+i6PGPbJy+b1jV3K+SJ+0vX7xcj6ypEq9ImdJPvQMU76oBxK/6aYHvorlZb5u8LY9dJYCv+oFUj6uzs69fhUoPhrzHz+0KAq+vhrBPRhoe70bkwE/iGUbvlWrtT3o+qk+bIXmvRnbWj7d6jA+IEMzvrSnAD4LfwY+t9cnvmRyE78rNkI92VQPvElBDz3jlKC9sW1JvqcL+L7CgYY+NayjPmHW6j0xHHc9V9hTvr1uzD4TQGm+n2ZYvTj3W7wncl49RTIivnc+7T7Vza28flBQPlDQaj5rrFo9ctIZPjSzZb4j1c286mwNvwX0BD7MSjm/WCsNPp1eob4KuPc+zIxuvvLbWL3PiKy9eT5dvhWDv75dP4e+yjgQPalozL5myLo9cd6JvoXKgb0ZGgg+g+gGPn6/Gz5241g7oROJvlQdfj6Z76I/CGEQPVdcd700xIS+YM/zvlgcOz24rCY8We3VPmA6Ybzem66+8uimvr8Yjr00kqE+Z1pcPiQLFD6MpLs9bY58PVQa47yiNWs9TEfovjCQP77SVMS+1B4EPiKoSr4H8zU9IeE+O/6m+z0vi6K8AYhBvta8E7467f28+2yNvHjArz6d6Zw+Md4zPtp1AD4rdS4+A2rgvhwG4TyRGkq+7i5oPlmUob7eoY0+I9VEPjnZkT4eGlU++HvsPe6xKT7FUm4+R/jivSAuhD1jNpy9YosTPZOo2j1D/hW+YxuiPhqeYT0axLK+vs14uyvoUT48/4I9QDgVPsumzb6UGt88pDc2PsuK4r1HgrE9FS2DPNn49zy5ove92CGZuzwebD0hIAu+az+ovfoJFb1cdQE+89utvpUvGb42lp+9Z+0EPkYiXT65ApW97kADvuMZXrzf05A+wENuPVrKjry3thI/aI/gve+jwr1BX1E+jEmIvhIfPj4W1Y+9+oWtvkFZYLwHzYO9AtOePRoo7r36/nM888s4vm5KAD+y9Zy+k1adPl24vr5r74S9fE0evq6Omz3u+66+FZdvPmIcnzy72CK+IgubPsv7lD4HUxy/MGHnvYl9yr2QSDG+qkmfPlyqYb3RerA+2FWlvSzACT1/R2S+gRBNPhqCNr4MUQ4+aNEoPUTXn73ddr49QNrpPCvO0D1j31W/eQK1PfBZxb2+UnO+NwuAPokLO74aOpi+bWPuvYBWE77Q24U+2b9mvvxFQD56V0a9/Z2iPfDUA76Mugm+mj3XO2C7hTx4iEs+dW2tvSKZDL7EDxK+he+QvjZD/r1OyIy+B1dIvlw++D3zRlw+4bs/vhqFQr5ID5++kk3RPoLG0TtNBHK+J8WjPsFtEr9H1Bw+0EJhvn8L076u38G+k4BdPju6hD+vsre9xjWZPnGcrz2JJaa8qoF9vppUjT6RPdK9cHOHPt4AZr6UMp6+/RgAua2O9TuA2VM/s+2pvdFAqb66rws/3/5/PYEn2r1opPM8bIquPvwqN77cpIA+9zR1vlz3LD75mJe9EqNlPoKpzj5yW1c90I8tvUbKYrvIjpm++HzUvoHU97wYAPa9Gq0EvWentb1SRFq+W/85PuBEHz4SsLi+JQOiPuvH9z0IJ4a+qppzvm/JTr7KH8i+cdZvvXQPzz1dFN++AFzHvtW8rz1SfNA9NsOYPrf2vj7XGSG9ZSQKvoSCmL4d6mY+XK38vWlLqL7vdco9V6zVvDO9Cr5vkVq+A/fiPQXHJT4iV52+tgL9PVjhtr654Cc+d4AJPvBSTL7XIQo+U0R4PgS6073Gxvq9TqSiPAxo0j2RqPW+GNQXvrnOJr7KPF++S7klvpjzhb46CaU+OQ6lOwhahT6XZN49dhoLv65rmjysSNi+t/myPfWzWL6bcso9ipTxvrGktD13bfE+D4XqPjT3L75FSVe+uBh6vqXhe75cUcU+mutiPrIyyb0ECv29qrljPTzYcT24eIe+ByOaPeVT3D7Rrfe9j7/XvRHtjD0GWrg9i94ovl/xJz7pcKy+o7ccPqie1r3NFjg+sJeovrrZyjxXSCs+sp86PtbP9T4rZrg++LcqvcON5L444fG9w8FpvS80UD4caLm9+dvFP3U9wT60td4+yJxHPtB4gr7ojQM/wlISP4zLrj1ukww+hb+GPkrT3D6+0Ya8NQFMvYlGGj/a66W+aJmSvV7Crb/BxEq9nQEXPXG0FT+EhCo/6o4tviSktL6MhFe+qj0rvqmD/r30Yu894F4mPzRpUr7GmtY9yshfPrQPKb1Czkw+u5RhPjqwSL6pNqg9VNM7vbtwlb5lE5O7ttw+vSlPsT3MeLa+zPCvvUI0LT5gd46+7LOAPmVupD5ucp6+zouGvg9t9D0WZPk9HQalvrkNAj/oBve8rNs1PheXVj5xUau+aSesvbnbLr5U/Aa+WXaHvotmfL4XF3E+rHecviHxFT1ityY8yqiwvtDu4j1K9x0+ZetBvQH5/z0+2Hk+ZWrYPJaMaL57pS2+wpzFvVtBnD27P0++jyHCvosULT+pAwA/ScBqPp0jOr7KTHg9H+VuPv8CBj5xPP48VaXMvi19I746k2g++jS1viLEuTxMC5o+qDWgPMwBNj3XTeS9XMyYPWZdJD69oA++VS2JPtTvWL58aZ69V0u6vgD0mzyAbaC+a2eTvdWJaT0rk7C+8NZ1vYQoTb7Y2aA+qRECPie/Mr732ug9EzAUvoQAh75S0M891IEFPPIXmL6VWxw9EPAqPo71PD7lilK9NGiEPcPwDr6HRag+el+EPso1Tb6fogg/ERaHvSQbNr3eFsy+8X+IvgGKvb5k8pK+RLSPvo1wX77dFwS+feP7PDTPCL44hgy9dj+OPVh1yz7BIam+XK66PcISQ7xf2UW7vbwmPmgAQr7NwT6+OJefPhzZsryC6U89DCNtPlk4Kb70w9m8INJOvoBF6D2M59w+pAOIvrf1Bz4VBjQ+zKiOO006yj5HMN49DcTdvk/3uj65O8U9GZOvvjRRQ75t1vm9sZiTvHoXED5CoaU9IE7jPVjshr2DlqM9CR1HPgUfHTv+cQK+GrpxO8K+uz1Bi1U9QLI3PeMrDb5Eia+9cfCSPRPxED8Ga9Y8vKc0Pcx8uL2ieSW+vGKXPY5SNr7NMde9UnyYvtlv+71T8Xa+qjL3u5gjSj6wqVY+Qp9kv8OH8r05RgG+tz51Pt6pBz5MAZs8UFyGvj+b57rkykg+UGTwvbJnf758O3Y+LK6lPnP5Ab7GCRq+FEDwPYZ7zT2UvQ2+OqoYPqRFPT7BRHG+5zSRPunxjz6fiea9mTKKvmrNVr5C4wU+193uPsA0vrxIalg9Vn2RPvNrbr4rzlq+YzrfPXd2yb6BLoK+oD7WvvgUjz7FwXu8xyIkPt8K6j02To49PCTdvTKa3b69HGY614tkvuhzWz5ILx4+9oOHvV0al77r2J0+yxWdPg73H768Dxw+E5qEPg65Mj2dktS+eQRuvpNkhz0pI1K+B5QrvRbEVD5WBfW9TqAbPd7KAj5rl0U8+U3fPNPoIj6QbeW+osEyvg==" | null | 1511.0 | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3b | null | null | null | null | null | null | N0 | Stage IIIA | null | null | null | null | null |
TCGA-UVM | 5383fb57-69c2-4b34-af7f-c67208efb2b5 | TCGA-V4-A9ET | true | 23 | released | 1.89 | Yes | 1.88 | 9.3 | 57 | -21113 | null | not hispanic or latino | male | white | Alive | 1954 | null | 21113 | M0 | N0 | Stage IIIB | T4b | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2011 | null | Not Reported | false | Not Reported | 746 | 0 | 30.0 | 7D7514B8-A5CE-48D5-8B83-BC06F1718696 | TCGA-V4-A9ET-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9ET; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.88; rna integrity number: 9.3; age at index: 57; days to birth: -21113; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1954; age at diagnosis: 21113; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIB; ajcc clinical t: T4b; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T4b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1362.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 746; days to sample procurement: 0; initial weight: 30.0; portion submitter id: TCGA-V4-A9ET-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 1362.0 | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4b | null | null | null | null | null | null | N0 | Stage IIIB | null | null | null | null | null |
TCGA-UVM | df685f8c-645a-47ae-a471-63bf1973a0ae | TCGA-V4-A9EU | true | 23 | released | 1.96 | Yes | 1.6 | 9.4 | 83 | -30409 | null | not hispanic or latino | female | white | Alive | 1928 | null | 30409 | M0 | N0 | Stage IIIC | T4d | not reported | 0 | C69.40 | not reported | 8771/3 | Epithelioid cell melanoma | no | No | not reported | Ciliary body | No | Ciliary body | Not Reported | 2011 | no | Not Reported | false | Not Reported | 736 | 0 | 55.0 | 74589A94-394C-40EC-BA77-D36B41E059ED | TCGA-V4-A9EU-01A-11 | 2.0 | 0.0 | 10.0 | 0.0 | 0.0 | 0.0 | 90.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9EU; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.96; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.6; rna integrity number: 9.4; age at index: 83; days to birth: -30409; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1928; age at diagnosis: 30409; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIC; ajcc clinical t: T4d; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIC; ajcc pathologic t: T4d; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 709.0; icd 10 code: C69.40; last known disease status: not reported; morphology: 8771/3; primary diagnosis: Epithelioid cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ciliary body; synchronous malignancy: No; tissue or organ of origin: Ciliary body; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 736; days to sample procurement: 0; initial weight: 55.0; portion submitter id: TCGA-V4-A9EU-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 10.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 90.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 709.0 | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4d | null | null | null | null | null | null | N0 | Stage IIIC | null | null | null | null | null |
TCGA-UVM | da6f0ed2-a6d5-4d87-823e-122ebd59aaba | TCGA-V4-A9EV | true | 23 | released | 1.9 | Yes | 1.7 | 9.4 | 59 | -21855 | 1269 | not hispanic or latino | female | white | Dead | 1953 | null | 21855 | M0 | N0 | Stage IIIA | T4a | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2012 | no | Not Reported | false | Not Reported | 679 | 0 | 80.0 | E2B9489B-520E-4BBB-ADF1-4981E1C3374D | TCGA-V4-A9EV-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9EV; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 9.4; age at index: 59; days to birth: -21855; days to death: 1269; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1953; age at diagnosis: 21855; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T4a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 836.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 679; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-V4-A9EV-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 836.0 | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4a | null | null | null | null | null | null | N0 | Stage IIIA | null | null | null | null | null |
TCGA-UVM | 6be5176c-4980-4663-adff-d04f05737da0 | TCGA-V4-A9EW | true | 23 | released | 1.88 | Yes | 1.66 | 9.6 | 44 | -16140 | null | not hispanic or latino | female | white | Alive | 1968 | null | 16140 | M0 | N0 | Stage IIIA | T4a | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2012 | yes | Not Reported | false | Not Reported | 606 | 0 | 30.0 | 7C41C1C2-D937-4DFC-9A8D-5E2944A7CC71 | TCGA-V4-A9EW-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9EW; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.88; concentration: 0.16; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.66; rna integrity number: 9.6; age at index: 44; days to birth: -16140; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1968; age at diagnosis: 16140; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T4a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1211.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 606; days to sample procurement: 0; initial weight: 30.0; portion submitter id: TCGA-V4-A9EW-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 1211.0 | 30.0 | null | null | null | null | null | null | 0.16 | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4a | null | null | null | null | null | null | N0 | Stage IIIA | null | null | null | null | null |
TCGA-UVM | 892e7630-b11e-47bd-987c-327d33258e11 | TCGA-V4-A9EX | true | 23 | released | 1.89 | Yes | 1.5 | 9.1 | 55 | -20447 | 730 | not hispanic or latino | female | white | Dead | 1957 | 2014 | 20447 | M0 | N0 | Stage IIIA | T4a | not reported | 0 | C69.30 | not reported | 8771/3 | Epithelioid cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2012 | null | Not Reported | false | Not Reported | 606 | 0 | 60.0 | 24B158B0-2477-4843-9CA8-467A8ACD547A | TCGA-V4-A9EX-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 10.0 | 0.0 | 90.0 | 90.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9EX; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 9.1; age at index: 55; days to birth: -20447; days to death: 730; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1957; year of death: 2014; age at diagnosis: 20447; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T4a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8771/3; primary diagnosis: Epithelioid cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 606; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-V4-A9EX-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 0.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0; | [
1024
] | "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" | null | null | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4a | null | null | null | null | null | null | N0 | Stage IIIA | null | null | null | null | null |
TCGA-UVM | 15d19ccc-52b8-41f6-b1c1-2cc55691aed5 | TCGA-V4-A9EY | true | 23 | released | 1.82 | Yes | 1.33 | 8.2 | 66 | -24187 | null | not hispanic or latino | female | white | Alive | 1946 | null | 24187 | M0 | N0 | Stage IIIA | T4a | not reported | 0 | C69.30 | not reported | 8772/3 | Spindle cell melanoma, NOS | no | No | not reported | Choroid | No | Choroid | Not Reported | 2012 | no | Not Reported | false | Not Reported | 463 | 0 | null | 9C41C5B6-1CDA-4857-B9EC-FE888545783F | TCGA-V4-A9EY-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 97.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9EY; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.33; rna integrity number: 8.2; age at index: 66; days to birth: -24187; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1946; age at diagnosis: 24187; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T4a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 837.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8772/3; primary diagnosis: Spindle cell melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 463; days to sample procurement: 0; portion submitter id: TCGA-V4-A9EY-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 97.0; | [
1024
] | "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" | null | 837.0 | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4a | null | null | null | null | null | null | N0 | Stage IIIA | null | null | null | null | null |
TCGA-UVM | 39e494bc-7710-4f9f-98b0-0f509f7aef1a | TCGA-V4-A9EZ | true | 23 | released | 1.9 | Yes | 1.22 | 8.9 | 78 | -28619 | null | not hispanic or latino | female | white | Alive | 1934 | null | 28619 | M0 | N0 | Stage IIB | T3a | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2012 | no | Not Reported | false | Not Reported | 442 | 0 | 40.0 | 29F3D730-2FE0-4490-B09E-22A90A36B9FA | TCGA-V4-A9EZ-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9EZ; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.22; rna integrity number: 8.9; age at index: 78; days to birth: -28619; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1934; age at diagnosis: 28619; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 599.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 442; days to sample procurement: 0; initial weight: 40.0; portion submitter id: TCGA-V4-A9EZ-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 599.0 | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3a | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | 92fca97d-6123-46a7-9c34-7a6f877fe612 | TCGA-V4-A9F0 | true | 23 | released | 1.87 | Yes | 1.04 | 7.3 | 59 | -21675 | 945 | not hispanic or latino | male | white | Dead | 1953 | null | 21675 | M0 | N0 | Stage IIIB | T4b | not reported | 0 | C69.40 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Ciliary body | No | Ciliary body | Not Reported | 2012 | null | Not Reported | false | Not Reported | 428 | 0 | 30.0 | 4705E851-FE91-4FCF-94FC-4872A381DED4 | TCGA-V4-A9F0-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 90.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9F0; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.04; rna integrity number: 7.3; age at index: 59; days to birth: -21675; days to death: 945; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1953; age at diagnosis: 21675; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIB; ajcc clinical t: T4b; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T4b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 733.0; icd 10 code: C69.40; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ciliary body; synchronous malignancy: No; tissue or organ of origin: Ciliary body; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 428; days to sample procurement: 0; initial weight: 30.0; portion submitter id: TCGA-V4-A9F0-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 90.0; | [
1024
] | "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" | null | 733.0 | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4b | null | null | null | null | null | null | N0 | Stage IIIB | null | null | null | null | null |
TCGA-UVM | 94f3d9b0-0ee4-4f6a-a8ff-ce7a4d8fab76 | TCGA-V4-A9F1 | true | 23 | released | 1.92 | Yes | 1.4 | 8.5 | 46 | -16852 | null | not hispanic or latino | female | white | Alive | 1966 | null | 16852 | M0 | N0 | Stage IIB | T3a | not reported | 0 | C69.30 | not reported | 8771/3 | Epithelioid cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2012 | null | Not Reported | false | Not Reported | 409 | 0 | 60.0 | B34668F2-C885-426D-9DDC-C310C8DF9616 | TCGA-V4-A9F1-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9F1; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 8.5; age at index: 46; days to birth: -16852; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1966; age at diagnosis: 16852; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 938.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8771/3; primary diagnosis: Epithelioid cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 409; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-V4-A9F1-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 938.0 | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3a | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | 411ddf79-fe92-44ad-8d10-eeb703f11be7 | TCGA-V4-A9F2 | true | 23 | released | 1.92 | Yes | 1.26 | 8.4 | 78 | -28832 | null | not hispanic or latino | female | white | Alive | 1934 | null | 28832 | M0 | N0 | Stage IIIA | T3b | not reported | 0 | C69.40 | not reported | 8772/3 | Spindle cell melanoma, NOS | no | No | not reported | Ciliary body | No | Ciliary body | Not Reported | 2012 | no | Not Reported | false | Not Reported | 385 | 0 | 30.0 | 9CD19F68-3AF3-402C-9FBF-D103337991D0 | TCGA-V4-A9F2-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9F2; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.26; rna integrity number: 8.4; age at index: 78; days to birth: -28832; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1934; age at diagnosis: 28832; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T3b; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T3b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 734.0; icd 10 code: C69.40; last known disease status: not reported; morphology: 8772/3; primary diagnosis: Spindle cell melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ciliary body; synchronous malignancy: No; tissue or organ of origin: Ciliary body; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 385; days to sample procurement: 0; initial weight: 30.0; portion submitter id: TCGA-V4-A9F2-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 734.0 | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3b | null | null | null | null | null | null | N0 | Stage IIIA | null | null | null | null | null |
TCGA-UVM | e21d8018-8fe9-4c92-8b36-28d7d3f7df2b | TCGA-V4-A9F3 | true | 23 | released | 1.94 | Yes | 1.63 | 9.5 | 49 | -17997 | 873 | not hispanic or latino | female | white | Dead | 1963 | null | 17997 | M0 | N0 | Stage IIIA | T4a | not reported | 0 | C69.30 | not reported | 8771/3 | Epithelioid cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2012 | null | Not Reported | false | Not Reported | 366 | 0 | 40.0 | B9FDCA7F-FA12-4FAB-B0B2-92FA9125E6FE | TCGA-V4-A9F3-01A-11 | 30.0 | 2.0 | 3.0 | 0.0 | 0.0 | 0.0 | 97.0 | 65.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9F3; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.94; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.63; rna integrity number: 9.5; age at index: 49; days to birth: -17997; days to death: 873; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1963; age at diagnosis: 17997; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T4a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 670.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8771/3; primary diagnosis: Epithelioid cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; weight: 25.0; composition: Not Reported; days to collection: 366; days to sample procurement: 0; initial weight: 40.0; portion submitter id: TCGA-V4-A9F3-01A-11; percent lymphocyte infiltration: 30.0; percent monocyte infiltration: 2.0; percent necrosis: 3.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 97.0; percent tumor nuclei: 65.0; | [
1024
] | "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" | null | 670.0 | 25.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4a | null | null | null | null | null | null | N0 | Stage IIIA | null | null | null | null | null |
TCGA-UVM | 4b9fd822-17aa-4a22-8e17-175a72931d5d | TCGA-V4-A9F4 | true | 23 | released | 1.96 | Yes | 1.77 | 9.2 | 41 | -15332 | null | not hispanic or latino | male | white | Alive | 1972 | null | 15332 | M0 | N0 | Stage IIIA | T4a | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2013 | no | Not Reported | false | Not Reported | 316 | 0 | 80.0 | 5D2ABEAA-D18A-4B35-BBAF-9E1B34D0E07C | TCGA-V4-A9F4-01A-11 | 10.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | 98.0 | 88.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9F4; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.96; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.77; rna integrity number: 9.2; age at index: 41; days to birth: -15332; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1972; age at diagnosis: 15332; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T4a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 634.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 316; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-V4-A9F4-01A-11; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 0.0; percent necrosis: 2.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 98.0; percent tumor nuclei: 88.0; | [
1024
] | "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" | null | 634.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4a | null | null | null | null | null | null | N0 | Stage IIIA | null | null | null | null | null |
TCGA-UVM | bbf07e1f-8c17-4c2e-89ed-38332d82e455 | TCGA-V4-A9F5 | true | 23 | released | 1.92 | Yes | 1.05 | 8.8 | 85 | -31314 | null | not hispanic or latino | female | white | Alive | 1928 | null | 31314 | M1b | N0 | Stage IV | T4e | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2013 | no | Not Reported | false | Not Reported | 289 | 0 | 70.0 | 540291A7-2C24-4DC4-93B8-8D6C0DFB344C | TCGA-V4-A9F5-01A-11 | 3.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | 98.0 | 96.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9F5; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.05; rna integrity number: 8.8; age at index: 85; days to birth: -31314; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1928; age at diagnosis: 31314; ajcc clinical m: M1b; ajcc clinical n: N0; ajcc clinical stage: Stage IV; ajcc clinical t: T4e; ajcc pathologic m: M1b; ajcc pathologic n: N0; ajcc pathologic stage: Stage IV; ajcc pathologic t: T4e; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 203.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 289; days to sample procurement: 0; initial weight: 70.0; portion submitter id: TCGA-V4-A9F5-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 2.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 98.0; percent tumor nuclei: 96.0; | [
1024
] | "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" | null | 203.0 | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M1b | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4e | null | null | null | null | null | null | N0 | Stage IV | null | null | null | null | null |
TCGA-UVM | 64422cc5-5e5b-4ef9-a9e2-214cebf8dfbc | TCGA-V4-A9F7 | true | 23 | released | 1.9 | Yes | 1.36 | 9.3 | 78 | -28822 | null | not hispanic or latino | female | white | Alive | 1933 | null | 28822 | M0 | N0 | Stage IIB | T3a | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2011 | no | Not Reported | false | Not Reported | 747 | 0 | 50.0 | 39C2720B-D889-4D48-81EF-6DBC0D8A512C | TCGA-V4-A9F7-01A-11 | 6.0 | 0.0 | 1.0 | 0.0 | 0.0 | 1.0 | 98.0 | 93.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9F7; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.36; rna integrity number: 9.3; age at index: 78; days to birth: -28822; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1933; age at diagnosis: 28822; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1256.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 747; days to sample procurement: 0; initial weight: 50.0; portion submitter id: TCGA-V4-A9F7-01A-11; percent lymphocyte infiltration: 6.0; percent monocyte infiltration: 0.0; percent necrosis: 1.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 1.0; percent tumor cells: 98.0; percent tumor nuclei: 93.0; | [
1024
] | "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" | null | 1256.0 | 20.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3a | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | 64bd88bd-1d5a-4569-9f46-f668d448c336 | TCGA-V4-A9F8 | true | 23 | released | 1.89 | Yes | 1.54 | 9.1 | 68 | -25168 | null | not hispanic or latino | male | white | Alive | 1944 | null | 25168 | M0 | N0 | Stage IIIA | T4a | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2012 | no | Not Reported | false | Not Reported | 402 | 0 | 30.0 | FF4405CC-4BEA-4F7E-A85A-55A64478525A | TCGA-V4-A9F8-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.0 | 95.0 | 95.0 | project id: TCGA-UVM; case submitter id: TCGA-V4-A9F8; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.54; rna integrity number: 9.1; age at index: 68; days to birth: -25168; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1944; age at diagnosis: 25168; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T4a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 597.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 402; days to sample procurement: 0; initial weight: 30.0; portion submitter id: TCGA-V4-A9F8-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 95.0; percent tumor nuclei: 95.0; | [
1024
] | "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" | null | 597.0 | 20.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4a | null | null | null | null | null | null | N0 | Stage IIIA | null | null | null | null | null |
TCGA-UVM | 6103e640-8b62-4e39-908b-b62a0debeb0e | TCGA-VD-A8K7 | true | 23 | released | 1.84 | Yes | 1.43 | 8.5 | 39 | -14294 | null | not reported | male | not reported | Alive | 1972 | null | 14294 | M0 | NX | Stage IIIA | T4a | not reported | 0 | C69.30 | not reported | 8772/3 | Spindle cell melanoma, NOS | no | No | not reported | Choroid | No | Choroid | Not Reported | 2011 | no | Not Reported | false | Not Reported | 798 | 0 | null | 29FC671C-98D1-4A34-8FC7-5C667E5FDB36 | TCGA-VD-A8K7-01B-11 | 1.0 | 0.0 | 0.0 | 0.0 | 50.0 | 0.0 | 50.0 | 60.0 | project id: TCGA-UVM; case submitter id: TCGA-VD-A8K7; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.43; rna integrity number: 8.5; age at index: 39; days to birth: -14294; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1972; age at diagnosis: 14294; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T4a; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1459.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8772/3; primary diagnosis: Spindle cell melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 798; days to sample procurement: 0; sample id: 1b626599-ec44-409d-8123-ed69d8442c19; sample submitter id: TCGA-VD-A8K7-01B; portion id: c4781d64-a14e-4cea-962f-cc437a9485b2; portion submitter id: TCGA-VD-A8K7-01B-11; slide id: 67a55bcd-f1b3-4d33-875a-082bbc055ee3; slide submitter id: TCGA-VD-A8K7-01Z-00-DX1; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 50.0; percent stromal cells: 0.0; percent tumor cells: 50.0; percent tumor nuclei: 60.0; section location: TOP; | [
1024
] | "oPnSvqPvvD4GmdK97K4DvdQNTz62Cf4+LiM6vrREbT6SXe+97YMkvsZ4mj5KaFo9ZlJPPMRoEr78DIm+KbRlPmx9irxsnqg9xVuQvfJ4bj6iQGy9NhnnPqzphD7muiK+5hF0vsotKL5w+X0+mHsuPmQaij1erBw+6dGFPT+jcT7NE5y+Ju2ZvhRigz0IAtQ+FB9+vn+Yar61YCk+55x3vVBrAz7kP3g+EjsjPox/mb5sgd++0lLAPZSpqzwRWza+5B5ePjGECr6ptBK+EV6DvsDVPL24/Yq+L4QWvCVIwDt0SeY87KqXvvM6yD5cuUU/IMSkPJTGkrwTp9W92tPNPnyV+72vNp0+PP6kvqDKbb7aX5Y+K45+vj7dGL5aMRc+8KyFPsnPzj78VVe+Z5U0PPb9eb1ufbs9HkOCvgb7Vz5INZI98K8QvsW54j1DKBi+Bw5ZvjYLhb74UoS9iQ/Evg6L5T6aNqm+ZHJkPuCCpD5KuJs+Y8CnvXLKhT09wAC+tISpvbronr6MAYU+bkUbu0M4/T5Yddy90UyYuxMvaT1e8fM9lAdPvey437xSk86921mUvRPTCb7GgDo+M3DePje+XD2P5N09dmspvWAf7D1BYQM+umAKvhXj7r7qQsc8lJNXPjbdRj+cvW++1gu8vqYaWL288ke+rmK3Pr5G6j1Fwfe+tKvavGRsjL20gYe+XUiJPcJ63z1eTpS+bOSKPrjfe78kJrO9OFa7vvZhFT0OyOo8KvYkPiJ2NT4bE74+2A25u2jZ5z6yhbu+QCOQvkmcir76Wb8+VzCRvpad5z0SEYc9pA7vvm4g0r2RGBe/wkufPliPwb0IFIw8XdiRPp7kMD1FRQ88pPnyPVn8GT6A7Zm+Pm/nvRRjRz6shxW+MRk8Ps6/Dr1FIcy9NCQnvpLiVj7ShX69UAd+PhhAPDtQvdi95gEsPYWoJj4KPwU/RsOSvJrBET9mxLO+VUvbPZ6oJLyW4XG9/G8Hvq5RG7+Pcba8/c4PPtQDJ74+rVQ+4IhnPkn3Mr0OCLg8xGbHvT7JMr7M5xe+3eyIvDAh7L3vxPe+ulz8vqDyUL6kUO48p8dSPlL81b2Euou+ruV0vZQuh76onay+pjbkvrh/dj0icso+hfTNPaY3QD5mKKy+9B2NvhQm3z1gBwS+heEhPjXrFL+Gjus9PHSAvqiCKL7Vr9693PTdvYCK1L760gs/XtGGPSywJz49BNG9njRZvhoIXDxOsqW+wIBQvXZLP7xOBya9MlF+PhbAXT6eAnE9YvC5PihVZrttSGC+3SLavQb1aT0Oa0o+qENMvdjwyb6ax809HJOOPMdQqD3ARvm90KGIPuRr4b2fIazAagXUPe1t8z7YYwE+9RuVvlTBRr4qJz6+hYuYPdMzrbyBekw9yDQ2PqOm/L1AljQ+tWEvvZbRAj4+cDO+LH5NPn/ESj1cVLG9hYAzvU6J9T2FbiQ/x80jvu6Sjj02wpk+Ns9yvQIIKT5ELTo9PF2EvSylTT4dLVW9cGmmvghe4L2uw8e+g87xvnis9T0XGHy8VKwlvgp2ED1itCG7QYYNPr5Kkz6bXxs+SMgUPL0d4L1og8K9Jg+MPj6ioz7jIGs+qEFfPtL+xj2oFa8+1cjFvkGEUL4R4Ww+5u8APibUIj7e7LS9KmEGvFi1uL7fypO85HkNvgbjEz7u8Pk73PPEvQqjDT+Bcjq+6iWRvXgSZz571RM+GksIP/Razr4sZnU9HK2sPjgWuj4exyG+9BmhPsZ2m75icqc9yc8OvZRLtT5ifCm79T/UO5Fmpj50U18+EnxuvSjDF79ksn2+3qzwvUg5er4i9PA+SsKJPt7G271dO468Dq/4PvPIOT7o8qg94FywPt72YD4UIi4+4CirPuYX2T3at62+9wXKvAoGpj3+9YQ+snndvemFTb6EZQS9tejSPR48Y74PfoU+nDXXPThnNr6wUJe+mhStu7pWfz5Xy6U7hCFbPjmkhL6MEgy/Eo8uvvK5aL5i6289/nQEv2bqKz6N3C28PNBwPrSIIj/4j5m9T2pYvAiofL1pkQI/sIMnvlPqxT20INE+JPkAvnIzaj7iEl0+bIuCvqM6lj25mwE+r7hPvsonDb8jrBw9xKkVO5KgUb0BCXO9JRXwvXIK5b51E4c+BdSlPlobST7G1sW8a8sPvhJj1T7DA4a+17C6veUcFb1Ek489OJS5vRAqzD5AMBK9qpx5Pdz6ez4UUho+PcUXPqLSUL43NMk9KIMPv9Dcszs81FG/kleuPbK3tL5xi/4+uDR3vqiAJrzVeY69HL5EvsLYjr6CZ4q+0EoqPR6krb7ozVc+rqSevqBuXr2Uaiw+jx9ePr+3aT4iydU9bbCOvsjMaj40r50/eEYlvLV6zbw164++2DfPvt+SNz0kVZm8WRIEP1UyET1kob2+3GGGvhmILL3/C7s+JD4APgSEGj487ik8WjlIvEtkeLx/yJE8Dv0FvwT3mr2tNtq+Fb5APtGa8L2+hR090rxBPFrgSj4lfQa99A+UvVkCBr5SKYC9HQadPNebuj5I5p8+lr40PqnKLT6K3x8+6EfJvvSenT3tZgS+G2duPof02L4+V4w+cKVJPgBQlD6jfmI+nIbUu4Ejhz5U/kc+9wUmPL9Lpz1VoNO9KNkkva4QIj5Ynza+zBiKPoS+nT0liLK+pntrPYjFWz4u+z49QDYwPrSxHb8nlwM+JlhEPvzMAr6Gb5U9LJlTPa0Ftb1z+e29xr7wvLi4jj0q0Du+mpUFvtxsgz3iIX89LjeyvojuVb7I3bq9XPDUPdd8aT7om9K97ZTivYJM87yodYA+R/WvPf3Tgb1Ysyc/kx9HvlV/qb3XlDA+xkNqvjJ0HD53CsC95vGUvlW7Ir2CCUq95jTSPVSQ7b3KCi69KiyKvv4y3T7cVGu+TpKjPvZayr5OxN294AqGvZqzDzy5Rdy+gmRbPvPj8T2oAF6+qfrKPlKcqz4M+wm/nHcJvhbUDb5mJQu+eKyGPqKn37zII84+UnGlvQYgizsGnl++GeJyvPbCQr4xjGE+sqGNvXJpAb5g5OQ9SDMZPbSLOD43fTC/+hYKPqiaJL4eL4C+zvKKPk60jr7uUa2+HIbAuwDQxbwY8Z0++QxUvslq0T02F568oUI5PvLjh778n5G9425PPSKqKj3Wq8k9xmO0vW7RQr6i/gK+2pSnvohe4rzhyai+127vvZZGLz5zUFc+dFwyvnUFJb5E3rS+lq7sPsu+wzww+Wm+PJV3PtbeCL9vtog9ywSPvtKi476vpb++xS12PqBwhD9DzL28htuhPmVf6z3gEaO9lPxgvs73nz7O5NC9Yd2CPoRudL4mJo2+Tk7XvPCeJb3rFm0/U3KIvsoEmL7WZtc+JKIMuz/8Ab4+g5Y9TseaPtX4ML5GyZA+bgJAvugEwD0ODXy9k5qfPmZ9qz42xJ09cDsHvU5Yyb3/PYK+RZ7yvnKkqL0U/Py9I4CGvTh6M75vHIq+QoyAPciptT0aW8u+er6oPrHMHj72ep++OpNbvpCTiL61p7i+iDJjvpC8Ij6V8tK+pgjsvpToSD01V1Y+VvyGPgQmjT7cQVG7b3+0vQ5t0r7+6bA+zCS3vB7U1L4qtA0+riAmPOKE8L11ZIW+3CSEPfeYKD7vQ86+xCsGPoyVoL6mvF0+jAA2Ph6aOr4a3ME9RnaVPsl577y9IlG957ghvaiR4T23dOu+P1VgvoO4R74n7fy95U/MvTdBl743YZo+wKO+u9SqLj41iRs+6+4fvyzGvD0MNqO+d4SJPCU3Zb5Q6BY+lZzevoAk3Lx17t8+QLDcPp7rBL6AOzq+hD6SvpEIPb46trk+dHNIPuINRb6qDue9PgNuPWhmZj6qAZe+zHCFPFIHpT48txm+CgoLvfz3Nz6gB3w90CEpvgEqCj6ryV2+4FmfPd4V+72zBdc9QuugvsB9Ez6XCys+nKf8PXhcBz8oBaA+vMrSvaPX5L7s10m+yDf/vebVSz7yZwS+g7XWPwJ9vj6s8sk+QGgcPrbdLb5VBt8+cpUDP9WQyD2g/509nl6PPojRAz8idQS+PRTzvTTCLT+x276+UJvQvcq6o78RbpW9TLGhPSb+HT+eZCg/HdVzvgzanr7gp56+qglJvmRkJr7gD7w9bvgNP6gyP75YzoI90zldPnqo3r1Siiw+GrWGPk5bhL6h3/k9hnAFO2V/pb60wOq8noMMvVBpvT1ufLe+AYQqvtKsqD06ioa+xIlQPphykT76era+JF5zvrIVTz3O+qM9tF6svvDs/D4V/Ba9HGlIPrvAdj71eae+i0KkveTSeL6YFwW+hMSKvn3qkb7Zn3U+S1e6vjRYMj2LCcU9y/67vvLZUD7MGzo++2hIvZ2PZj08cus9po2aPfzudL4b9KW9qojevWO7oD2svqm+IM+/vh60DD+aUgI/OKhJPnczzr01Ynq7DE2VPoqDBj7QAVU9gg/wvhi/Pb7lN0Y+ttyjvpByoj30hYU+GohHPQf5Bz1sl4C+aJJTO/AZIj7sBii9JtpuPl1efL4oLXG9nr+zvhh8Mj1rg6K+cMoVvY8LBz0MSa++CGahvUa/Yb4wS3A+NBOJPTrzJb70Xmm9GIwnvUeGkr4wYDo+TuaBvZgPor74b3G9nh4NPjp/+T204Qo9vMylPb3gFb7ADcA+d/iaPqp5Xr4mlxA/bGAkvnQgl70sgAG/CJtovlKLyb6PL3K+FkCPvtbGab66SGK+USvSPMetdr5zqZU87oPuvCpe9T6ApNu+eBEqO3/Llj0LC2y92EZcPp8+NL5cOJC+sqaRPvzCnrs09a085hJHPnOVSL7rr7s8eaWHvuW2Qj374sg+prhuvj43lD0YGCc+mLdsPeDvyj7X3Hs92B4Yv0p6kT4hTgs+FmJZvhMSFr6u46K9QlZuPbOEmD6Z1r89qQc6Ps5C1j2hpBQ+AL/xPV5TGDyGp+a9jCGJPUx0d7uti5+9/rwgPTwOUb5tvBq97cctPQxdCj+WfcQ9bj6LuxwuvL1wBCe9xB2cPaPJMb6jl5m8Ek+XvopGUr48OIS+zCatPKpMUT74FkQ+ulhyvyBU371QLh2+ZMrSPbSPuj1JePc8xD6rvhOb3TxKhSo+fab5vYgLhr4SgFo+LjSIPgZ1Rr62p1e+C9FjPsYnmT2BvFS+QINOPtqhgj4WlQa+etZGPq6FkD797+C9XPZOvnJeSr5se609plsXPwA0tLelhAk+Cy+qPrwAYL5ex2G+oHqjPfZw4L6Mh9q9hrykvnfTQz4EdTQ8g613PllqFD517Ww9yyWavf/VCb/4Rjo7fvZyvkJolD4gkeI90mYnvtCViL7bfrk+LFfHPkKryr0Q7hA+gNdqPp2lEz0uI6K+22qDvg5qcz3g9Dq+U3gzvjpLQj7s7hm+B7frPTTSST5AWt89Ut3Au/r77z3wVtm+sj8Yvg==" | null | 1459.0 | null | 1b626599-ec44-409d-8123-ed69d8442c19 | TCGA-VD-A8K7-01B | c4781d64-a14e-4cea-962f-cc437a9485b2 | 67a55bcd-f1b3-4d33-875a-082bbc055ee3 | TCGA-VD-A8K7-01Z-00-DX1 | TOP | null | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4a | null | null | null | null | null | null | N0 | Stage IIIA | null | null | null | null | null |
TCGA-UVM | 9b1ecfb2-9dfb-4e71-b51a-d2a0c5a7940e | TCGA-VD-A8K8 | true | 23 | released | 1.92 | Yes | 1.4 | 8.1 | 56 | -20454 | 1377 | not reported | female | not reported | Dead | 1955 | null | 20454 | M0 | NX | Stage IIB | T3a | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2011 | no | Not Reported | false | Not Reported | 763 | 0 | 20.0 | 859216F2-7122-4F06-B65E-380D3F22F4ED | TCGA-VD-A8K8-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 50.0 | 0.0 | 50.0 | 60.0 | project id: TCGA-UVM; case submitter id: TCGA-VD-A8K8; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 8.1; age at index: 56; days to birth: -20454; days to death: 1377; ethnicity: not reported; gender: female; race: not reported; vital status: Dead; year of birth: 1955; age at diagnosis: 20454; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T4a; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 513.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 763; days to sample procurement: 0; initial weight: 20.0; sample id: f23780fd-dfeb-472b-b747-84ece2a6226d; sample submitter id: TCGA-VD-A8K8-01A; portion id: 314444c2-c088-4692-aa3a-27875f573b44; portion submitter id: TCGA-VD-A8K8-01A-11; slide id: 31c5f45c-fc14-4823-978b-9d81e3d4fb7c; slide submitter id: TCGA-VD-A8K8-01Z-00-DX1; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 50.0; percent stromal cells: 0.0; percent tumor cells: 50.0; percent tumor nuclei: 60.0; section location: TOP; | [
1024
] | "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" | null | 513.0 | null | f23780fd-dfeb-472b-b747-84ece2a6226d | TCGA-VD-A8K8-01A | 314444c2-c088-4692-aa3a-27875f573b44 | 31c5f45c-fc14-4823-978b-9d81e3d4fb7c | TCGA-VD-A8K8-01Z-00-DX1 | TOP | null | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4a | null | null | null | null | null | null | N0 | Stage IIIA | null | null | null | null | null |
TCGA-UVM | fa9089fa-9af9-4932-8ab7-0e7f2fd6b121 | TCGA-VD-A8K9 | true | 23 | released | 1.9 | Yes | 1.8 | 8.8 | 71 | -26292 | null | not reported | female | not reported | Alive | 1940 | null | 26292 | M0 | NX | Stage IIA | T2a | not reported | 0 | C69.30 | not reported | 8774/3 | Spindle cell melanoma, type B | no | No | not reported | Choroid | No | Choroid | Not Reported | 2011 | no | Not Reported | false | Not Reported | 763 | 0 | 20.0 | 61A48B84-57BF-4E16-A371-137B18DA0011 | TCGA-VD-A8K9-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 50.0 | 0.0 | 50.0 | 60.0 | project id: TCGA-UVM; case submitter id: TCGA-VD-A8K9; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.8; rna integrity number: 8.8; age at index: 71; days to birth: -26292; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; year of birth: 1940; age at diagnosis: 26292; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3a; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1424.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8774/3; primary diagnosis: Spindle cell melanoma, type B; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 763; days to sample procurement: 0; initial weight: 20.0; sample id: 25bddcb7-2759-42f7-a8eb-d67f0d973802; sample submitter id: TCGA-VD-A8K9-01A; portion id: 99dff7cd-05b9-41f3-897a-a824db7e98fb; portion submitter id: TCGA-VD-A8K9-01A-11; slide id: 2694845f-57e3-41be-aea4-fb2152432823; slide submitter id: TCGA-VD-A8K9-01Z-00-DX1; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 50.0; percent stromal cells: 0.0; percent tumor cells: 50.0; percent tumor nuclei: 60.0; section location: TOP; | [
1024
] | "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" | null | 1424.0 | null | 25bddcb7-2759-42f7-a8eb-d67f0d973802 | TCGA-VD-A8K9-01A | 99dff7cd-05b9-41f3-897a-a824db7e98fb | 2694845f-57e3-41be-aea4-fb2152432823 | TCGA-VD-A8K9-01Z-00-DX1 | TOP | null | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3a | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | af04ca52-8b71-497e-8135-6ddfca9ab221 | TCGA-VD-A8KA | true | 23 | released | 1.88 | Yes | 1.27 | 9.0 | 22 | -8271 | null | not reported | male | not reported | Alive | 1989 | null | 8271 | M0 | NX | Stage IIB | T3a | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2011 | no | Not Reported | false | Not Reported | 777 | 0 | 20.0 | 8741EA47-3E0A-483E-BAA2-59DE9EC904E8 | TCGA-VD-A8KA-01B-11 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-VD-A8KA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.27; rna integrity number: 9.0; age at index: 22; days to birth: -8271; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1989; age at diagnosis: 8271; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3a; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1178.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 777; days to sample procurement: 0; initial weight: 20.0; portion submitter id: TCGA-VD-A8KA-01B-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 1178.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3a | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | 31771082-c094-4749-a9c7-80b67762f4d1 | TCGA-VD-A8KB | true | 23 | released | 1.9 | Yes | 1.94 | 9.2 | 66 | -24393 | null | not reported | female | not reported | Alive | 1945 | null | 24393 | M0 | NX | Stage IIB | T3a | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2011 | null | Not Reported | false | Not Reported | 763 | 0 | 20.0 | C9A25B61-433D-47D7-9F2C-820205292D13 | TCGA-VD-A8KB-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-VD-A8KB; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.94; rna integrity number: 9.2; age at index: 66; days to birth: -24393; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; year of birth: 1945; age at diagnosis: 24393; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3a; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1354.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 763; days to sample procurement: 0; initial weight: 20.0; sample id: 3106274b-1330-4c1d-9d6f-ee36138bc929; sample submitter id: TCGA-VD-A8KB-01A; portion id: fab67181-1e7b-46d1-8bb6-a23d9fb2c01f; portion submitter id: TCGA-VD-A8KB-01A-11; slide id: f581ff22-c343-4dff-8328-8f17927c72aa; slide submitter id: TCGA-VD-A8KB-01Z-00-DX1; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; section location: TOP; | [
1024
] | "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" | null | 1354.0 | null | 3106274b-1330-4c1d-9d6f-ee36138bc929 | TCGA-VD-A8KB-01A | fab67181-1e7b-46d1-8bb6-a23d9fb2c01f | f581ff22-c343-4dff-8328-8f17927c72aa | TCGA-VD-A8KB-01Z-00-DX1 | TOP | null | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3a | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | 73b3e4dd-c53d-4fe3-8607-ee462c9cbbd1 | TCGA-VD-A8KD | true | 23 | released | 1.91 | Yes | 1.32 | 7.9 | 72 | -26457 | 114 | not reported | male | not reported | Dead | 1940 | 2012 | 26457 | M1 | NX | Stage IV | T4a | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2012 | no | Not Reported | false | Not Reported | 603 | 0 | 90.0 | 20DFC61D-E721-4798-A88C-808785CE740A | TCGA-VD-A8KD-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-VD-A8KD; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.32; rna integrity number: 7.9; age at index: 72; days to birth: -26457; days to death: 114; ethnicity: not reported; gender: male; race: not reported; vital status: Dead; year of birth: 1940; year of death: 2012; age at diagnosis: 26457; ajcc clinical m: M1; ajcc clinical n: N0; ajcc clinical stage: Stage IV; ajcc clinical t: T4a; ajcc pathologic m: M1; ajcc pathologic n: NX; ajcc pathologic stage: Stage IV; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 603; days to sample procurement: 0; initial weight: 90.0; portion submitter id: TCGA-VD-A8KD-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M1 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4a | null | null | null | null | null | null | N0 | Stage IV | null | null | null | null | null |
TCGA-UVM | c9bfc2a7-0914-4080-a0a3-1c6a4e58e1ab | TCGA-VD-A8KE | true | 23 | released | 1.88 | Yes | 1.62 | 8.9 | 74 | -27290 | null | not reported | female | not reported | Alive | 1938 | null | 27290 | M0 | NX | Stage IIA | T2a | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2012 | no | Not Reported | false | Not Reported | 609 | 0 | 20.0 | C9CCC817-9FA1-401A-A075-282B0AB10207 | TCGA-VD-A8KE-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 50.0 | 0.0 | 50.0 | 60.0 | project id: TCGA-UVM; case submitter id: TCGA-VD-A8KE; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.62; rna integrity number: 8.9; age at index: 74; days to birth: -27290; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; year of birth: 1938; age at diagnosis: 27290; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIA; ajcc clinical t: T2a; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 821.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 609; days to sample procurement: 0; initial weight: 20.0; sample id: 35dfeb9d-1f64-4d51-b27a-24ad8aa3327b; sample submitter id: TCGA-VD-A8KE-01A; portion id: af6186e1-b9d5-487d-978a-2b5d4e61b01c; portion submitter id: TCGA-VD-A8KE-01A-11; slide id: e1611c2f-76e9-48e3-badf-fa5faa613746; slide submitter id: TCGA-VD-A8KE-01Z-00-DX1; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 50.0; percent stromal cells: 0.0; percent tumor cells: 50.0; percent tumor nuclei: 60.0; section location: TOP; | [
1024
] | "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" | null | 821.0 | null | 35dfeb9d-1f64-4d51-b27a-24ad8aa3327b | TCGA-VD-A8KE-01A | af6186e1-b9d5-487d-978a-2b5d4e61b01c | e1611c2f-76e9-48e3-badf-fa5faa613746 | TCGA-VD-A8KE-01Z-00-DX1 | TOP | null | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T2a | null | null | null | null | null | null | N0 | Stage IIA | null | null | null | null | null |
TCGA-UVM | 78039723-94a9-4903-8bb4-c00852e8e889 | TCGA-VD-A8KF | true | 23 | released | 1.9 | Yes | 1.99 | 9.6 | 68 | -25066 | 40 | not reported | male | not reported | Dead | 1945 | 2013 | 25066 | M0 | NX | Stage IIIB | T4b | not reported | 0 | C69.80 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Overlapping lesion of eye and adnexa | No | Overlapping lesion of eye and adnexa | Not Reported | 2013 | no | Not Reported | false | Not Reported | 309 | 0 | 120.0 | 9FFFF089-4156-4221-BCAC-20EEB748944C | TCGA-VD-A8KF-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-VD-A8KF; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.99; rna integrity number: 9.6; age at index: 68; days to birth: -25066; days to death: 40; ethnicity: not reported; gender: male; race: not reported; vital status: Dead; year of birth: 1945; year of death: 2013; age at diagnosis: 25066; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIB; ajcc clinical t: T4b; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T4b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C69.80; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Overlapping lesion of eye and adnexa; synchronous malignancy: No; tissue or organ of origin: Overlapping lesion of eye and adnexa; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 309; days to sample procurement: 0; initial weight: 120.0; portion submitter id: TCGA-VD-A8KF-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4b | null | null | null | null | null | null | N0 | Stage IIIB | null | null | null | null | null |
TCGA-UVM | 9f57834a-4dc4-45ed-97de-ed4da9d0598d | TCGA-VD-A8KG | true | 23 | released | 1.87 | Yes | 1.3 | 7.7 | 47 | -17417 | null | not reported | female | not reported | Alive | 1965 | null | 17417 | M0 | NX | Stage IIA | T2a | not reported | 0 | C69.30 | not reported | 8774/3 | Spindle cell melanoma, type B | no | No | not reported | Choroid | No | Choroid | Not Reported | 2012 | no | Not Reported | false | Not Reported | 504 | 0 | 40.0 | A71F24D0-ADE3-4608-9941-47B025FD6A16 | TCGA-VD-A8KG-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-VD-A8KG; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 7.7; age at index: 47; days to birth: -17417; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; year of birth: 1965; age at diagnosis: 17417; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIA; ajcc clinical t: T2a; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 19.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8774/3; primary diagnosis: Spindle cell melanoma, type B; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 504; days to sample procurement: 0; initial weight: 40.0; portion submitter id: TCGA-VD-A8KG-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 19.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T2a | null | null | null | null | null | null | N0 | Stage IIA | null | null | null | null | null |
TCGA-UVM | 39af6e0f-908c-4b2b-97b8-a4d1966e47e1 | TCGA-VD-A8KH | true | 23 | released | 1.89 | Yes | 1.55 | 8.6 | 69 | -25388 | null | not reported | male | not reported | Alive | 1943 | null | 25388 | M0 | NX | Stage IIIB | T4b | not reported | 0 | C69.80 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Overlapping lesion of eye and adnexa | No | Overlapping lesion of eye and adnexa | Not Reported | 2012 | no | Not Reported | false | Not Reported | 497 | 0 | 70.0 | 0032F50D-7E01-438A-979B-CAF5D65419DB | TCGA-VD-A8KH-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-VD-A8KH; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.55; rna integrity number: 8.6; age at index: 69; days to birth: -25388; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1943; age at diagnosis: 25388; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIB; ajcc clinical t: T4b; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T4b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1158.0; icd 10 code: C69.80; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Overlapping lesion of eye and adnexa; synchronous malignancy: No; tissue or organ of origin: Overlapping lesion of eye and adnexa; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 497; days to sample procurement: 0; initial weight: 70.0; portion submitter id: TCGA-VD-A8KH-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 1158.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4b | null | null | null | null | null | null | N0 | Stage IIIB | null | null | null | null | null |
TCGA-UVM | 22e7816d-4be9-4f84-b487-baa6ca35452d | TCGA-VD-A8KI | true | 23 | released | 1.9 | Yes | 1.36 | 7.7 | 68 | -24966 | 1113 | not reported | male | not reported | Dead | 1944 | null | 24966 | M0 | NX | Stage IIB | T3a | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2012 | no | Not Reported | false | Not Reported | 518 | 0 | 50.0 | 7F74C718-5BFD-466A-B03F-B61B587D92EC | TCGA-VD-A8KI-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-VD-A8KI; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.36; rna integrity number: 7.7; age at index: 68; days to birth: -24966; days to death: 1113; ethnicity: not reported; gender: male; race: not reported; vital status: Dead; year of birth: 1944; age at diagnosis: 24966; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3a; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 38.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 518; days to sample procurement: 0; initial weight: 50.0; portion submitter id: TCGA-VD-A8KI-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 38.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3a | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | 7289bc25-2551-4c6d-b2fa-c7e13859b9b3 | TCGA-VD-A8KJ | true | 23 | released | 1.91 | Yes | 1.74 | 8.3 | 53 | -19562 | null | not reported | male | not reported | Alive | 1958 | null | 19562 | M0 | NX | Stage IIB | T3a | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2011 | no | Not Reported | false | Not Reported | 791 | 0 | 40.0 | A904183E-A6F0-4EBA-94AB-DD95A8BB58F3 | TCGA-VD-A8KJ-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-VD-A8KJ; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.74; rna integrity number: 8.3; age at index: 53; days to birth: -19562; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1958; age at diagnosis: 19562; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3a; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1150.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 791; days to sample procurement: 0; initial weight: 40.0; portion submitter id: TCGA-VD-A8KJ-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 1150.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3a | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | 8e6d3005-445a-4b7f-95ec-a988a121c628 | TCGA-VD-A8KK | true | 23 | released | 1.89 | Yes | 0.93 | 7.1 | 54 | -19958 | null | not reported | male | not reported | Alive | 1959 | null | 19958 | M0 | NX | Stage IIIA | T4a | not reported | 0 | C69.30 | not reported | 8774/3 | Spindle cell melanoma, type B | no | No | not reported | Choroid | No | Choroid | Not Reported | 2013 | no | Not Reported | false | Not Reported | 273 | 0 | 50.0 | 2C7A9333-9CCF-4E1E-A3DC-BE9ED78858B3 | TCGA-VD-A8KK-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-VD-A8KK; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.93; rna integrity number: 7.1; age at index: 54; days to birth: -19958; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1959; age at diagnosis: 19958; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T4a; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 64.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8774/3; primary diagnosis: Spindle cell melanoma, type B; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 273; days to sample procurement: 0; initial weight: 50.0; portion submitter id: TCGA-VD-A8KK-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "AsGevvGFwz58y1q+OsuSPUJZIz6xgvA+Gv4kvpOmHD5J4QG+5wwYvvLm0T4oT0E9C2sDvND/fr5bSXm+lNB7PrJneL3rG9I9WxgLvhuEaz75tMu9YfbmPmcWUT4+Neq9p+WQvvQJwb2SKng+WOc9PpbCGD2UG6o9TAC8PUJjJz7eP7W+JuqPvjDgfrzevr0+7NdMvjBlVL4QzwY+Ze58vAeIFT7yAKY+fCodPi6FjL52OeC+gzfePbNUt7xV5gK+4Dk6PsLDAb6kN+S93nNBvlnRl72aGY++lWkLPIsiObxHCKS8/ENTvloc5D4MLjc//GcDuzav8ry9YMu9SUHgPrAuEr65OIY+EQ6jvgrymr4xL4w+ELcwvhkTJb5CDT0+bahDPnN3sj7h4zC+EcCMvR9lpr3DCvY9hYthvr/XHT6gnBE8y5YUvgCCbz18Zym+zg2FvqYkir7AbTK9t/+rvhHf4D6dK7i+ZOEkPgFzkD7jzmU+Nn6rvHhZ+Dx+kay96DmevNR7g74fYX4+J+S9Pfps8z5IJI67MNpsPFPQ0DybcNA9RQTSve1fgD1Ctoe9gR39vXJP5L12fk4+k3noPvPrMz3BPNc9p8HUveC+nz2hUdE94LK6vVHy677ljEU9495DPoUXHz9udgW+4MGivsmY4LsRuWe+GsXwPuFCyz2AvAC//G42vWfr0b1JoY2+KJzhPRa3Gz4DppG+/SF5Pkxgd7+T1gu+AfOuvuvhND21LD68/xAVPnV4/j3ODcY+BycTvXHF1z6ZQ6a+rQBnvmNJkL7v948+3Ad7vpDbmj3eTss9gQjvviICi72qftq+/wWVPqVOP7zMNSI9ROysPpE11DtW6mi7TrnDPdmdNT61NY2+jd0zvYgyET6BVDi+3YFLPpNi8bzrTwi+ODJ1vtNqbD5/5VS9Or6LPhLfG7z5Uvm9oM98PZ3iCr2yM/4+Mka5vXSzBj9SIHq+uaZHPUFEYTyhSIq9CnQLvoDiJr/aLxs88pjUPT6XBL5pwZM+N+GfPo2rPrwBXBY+4wvivPQu5r23Hw++CQSzvOjpFr4NOuG+XAIBv3JTJb7YQxI9TrKNPpbIDD0gv6a+GhqhvbmxYr4VamK+Jxz5vg5IjD3MCtM+O072PacFrT2PZzm+R7fPvv+8Pz2FTzm+89MaPoRNDr9naLI9DJ94vtWh7b3ZLYi96ar5vW6At74fnQU/gDnfPLr4KD7g9xm+8mxcvlLC5T0iH56+rm7gvbAVa7245Ne9+vJBPkjrbT4N7Kk9cpeOPjDntL0Pfnu+h+MnvRh0Jbzjt9A9XJoAPL4xxL7ZLaM9BJhNPRf1KD7HHg29QWCuPm8MjL66LLLAyV2bPKdADz+mFDc+5Vtxvg5hcL7+mii+ka0rPkv2/Dy5Qkq9MLakPTikXr49wgc+y9p3vWHH/D0mhCa+a/+KPglgFT3Luca9zngWvR9kXz7ckSY/4JWCvRooSj1Hkpc+HlAQvi5afD1MlB8+TBB+vd6/Lz7FvxW9B3KfvvXdP75kfpS+SwfTvuxS3zuk2KK8HtoLvpkH2r0RhlS9e7I4PeYypj5hM0M+xEUOPNy8LL4RqhA9btOYPiyKoj6qzH0+6ebzPRje5j3zLr4++sOuviAgH77+oPg9kZfYPRRa9D32Pzy+MOyKPc5BtL59rW49ol24vZeaBz6dnIM8Iw9WvnH75j6ddYS+lyf1vZmmFT6XosM8aOTjPqnnyr5zEhk+UKWbPt0rkz7Vhja+wYhbPqdBQ75fcVk95+SEOiyTij7/5pg9o2KBvdyFcT7bxfs9CxGAvVuBDb8NEaG+peI9vu9Lhr7cHgA/jp8oPitGF77u0TC9OdLGPk3eAj56t7o96BWRPjwzWD4UzCA+I4GrPub9lD1kQZC+JywCPKQ7QT3l5oM+yXz6vaPBW75BVkK9NJisPSfWOb5S7po+QNWgPfgo/71v5ma+rdiave3FfD4kjHu9BkpEPtgDRr7uZg6/xi4BvryhZb4GFvo9xUcBvyZwVz6wfqm9Qts0Pi1bIz9f2Ay+2N+rPXpXrb06Owc/1OALvoQfpz122as+WyftvQ4laT7U+BI+V40xvqHV9D2CUN499N4ivpGxF7/gVng8og/0OxTBBj2aF3C9WqU0vl/I+r5icIA+Pj2dPjBmuD2R2yE973RevnYZwj6yDoG+dYyIveOfDL0VC7c9g44qvrM+6T7X9gu8cplXPpv/eD7UDa88N7EVPuvjar4WN/+8eyENv/Dy/z2LmzK/IGbZPT6Wp76PSPQ+n19/vhTfTL0cmpW91Kpjvt+swr5brYm+0S8hPfI21L7HQLY9tcKVvomoVr3PeAo+Vz8LPu6KIz56j/I8SWmCvmqPbz6nraM/Hue6PIRpSr3wa46+rc75vrDnSj0p9J47WXvRPtKKlbwi67m+Faikvsz3lL2p06I+aWldPs7KHj64r7s9MoMLPWG5Ab2ynjc9QkfvvjnZQ75TTcq+ijXlPdVDUL4S66Y819rYuzwsDT5jc2U8yqw5vhLn9r3u1R+9u+5Su+JbtD6IMo8+NXYqPjsA0j1Ieys+Po/XvlPwHz0mslC+2ltoPmBcmL5Nt4A++RxBPt6vjz6P0Xo+ykgFPrvjLz5kRmg+9rjEvdysMD0a4a29GGFPPUOd0T3fHhm+AYutPoHhaD3r8bm+Y5jMu+4Uaz4L5ZM9C3z+PTGl074PHcQ8A8VEPoYBzr3gD6Y9Otl+PK6YDjzr+cm94uuuO4tOgD1RIxu+UyPCvY4/S7yPxLU9xkOwvlGzHr5qiou9n5YIPudKZT72rFG9mOUOvhxEkLwYvpU+XTiKPSWGqbw6QhI/24/OvcEa071kGUU+N6aFvthAMj7gEz29xr6lvp982bwlrmi9mhWAPatmz72AdwE80qNSvrxzAD+OQJO+y1aePg5zu74+eoC9LqkTvmIDaD0mGby+x/9MPmHrdT0BEiO+Lv6SPoUvlT4Fkx2/dcOzvaoQoL10UTO+2uOgPoEnZ707prA+OKyvvXx3Vjye7mS+0JUmPhpVQL4oXBY+tOO7PAOrXb3z57A9OxH0PGF90D1Xh1K/kHHRPWM51b0cAoG+PBluPmKdO74Q8Ja+kH3IvTT1AL7uSIE+MRxOvk7bSj4VeiG9uIqTPYs3Hb6zCfC9cpn4Oy/UCb3kVyk+yjyfvWqoBL7i1B++n/eKvg146705P52+FYY/vh16+z37VmU+ryg7vgcINr5EL6y+WlHPPpPSkTxt0Xu+BH6XPjo6Db8W9hs+H3h3vp2n2b7NGsG+W5Z5Pu83hj8sVY29JWSiPv9Ukj2MqIS9VNKDvqU3gj7v/rG96pWHPjveTL6+mZ2+4IMavUd57TtazE8/G860vVr0o76OTQw/MEKFPUiX2b1J6Jc8WqChPi2jML4YpnM+zh1fvvy1LT6UPa29JGhiPmrjyz7KwBA9NDd6vQbgQzwfTo6+CLrSvoVv37wRNAe+XnoVveMC372yHGm+zRAmPkZRND6EBbe+ZAWcPi4D/D2e/4S+oZhqvrdiP74wBsa+DDxOvT+o1j2tAOa+Z/LCvmkDvT3zQdc9gR6kPlbIwj4Gqpm8UgkPvgF5nL6fSHg+OZsFvoq1l75nLb49/nP4vCsfG74V9kG+S5fkPb6cJz5N4Iy+z3bfPWgVo76A8Ag+yAUbPjpAW76pnwg+73R6Pn5vy71fvhm+7w6yPG15nz0+pPm+K8sNvuixQ74y22C+cjYEvth3i75SLJs+YXomPAO7ij4ibAc+krIRvyd/Ez3Qpty+5yPTPaF5Qb76ns89c3ftvg/Arj2IKt4+EengPk+XPr5kLUy+HciDvqP9bL6g8sU+9oBlPuOa472FDve9TnUXPYpegz2hD5W+VyyOPQmcyj7HvBG+BvWgvdDAlj1YwcU97gIYvrsKNT7ej7C+rvkqPiqOB74C/Uw+8Uqsvnr/Dz35eDU+OS5BPvzP6T7j/qw+L6wwvQsy4b69C769jXhYvQmOKz6kqc29xtPFP/KUyT5o/9M+9h0uPkjQcb6qfgE/ETYTPwo9zD2nqwQ+wCqFPuUA3D6Wcg68MP4lvegSGD/jt6y+sUaJvYn8p7+XSJq9QMoDPQ8JED+Wkyc/fJsuviyDpr42s2q+Q7Qtvt1QEb5MkeY9Qo8rP35vb769AL89GLljPsCp8bygVj0+8G9fPtf9Sb5loOA9ypvJvPyFlb4eZCm83Y1OvUT6tz2T3q6+ReCrvQ0MLD5RS5e+nLuHPsHTpz7Wxp++EGKDvnqvtT2ta/g9qqGgvoE9Aj+ugcO859BHPqXqUT7A+62+pPjdvUkFQb75lNW9m9CGvt3hcL6BPX0+Fc+PvhNiaz39Fow8Ad2xvpUm9z1/QAo+6y38vFY92D1C/mA+8+7uPAuTcr4dMCe+HM7nvRFuqD0yeVS+BS3FvirlKT/jiQA/MZ11Pk0GK77MwYQ9G697Poi2Dz5MIow8lsi/vkVZHr4R9mM+aDu+vqZPNLu4P5c+pyIwPef4GD1li7+9Jw6DPTfuFz7YB/q9FoSUPrwRUb4IzZu9xw61vn6nEj2Wz4u+Nsg7vQPghz2F+qa+iZNjvSFFYr4qB58+bzcGPsfBK77ahto9jksOvj4AgL74oOE9YFkPPPrzl76Mnq48vKwlPqlSFj7HuoC9ou23Pak8A76Rwa8+qduSPrnhNL4SYAM/0+OTveNuEL1WdMq+hE2Hvnnot76+mZy++mSKvmzUT75aveq9SyEpPVDZ/70XLyG9uiEGPbtTxz6Ja7S+lXCmPWSegTpprYs7zkAzPgGJTL5qhzm+PGCcPn3a5LzmWf086Fd8PntkLL5TJIW9JoVnvq1nyz21wNY+X4aTvpY3/D1wkBM+/RawPLl2yj5G77Q9nxzpvjnvsj6RFpg9nPS5vrAwNr7Vl9m9g4azOhp+KT4fsL49d67tPVOjmL1lIos9yj1DPgwuxbt6ZQG+UV9zPG2QVD0kKMc8Emv0PClOIb63EKW9806mPWfaED+/Kx097/8CPfG9772ybS+++/SjPWFCM77cko29biOdvj+A+b3aGoO+RIIVvMqTMz6a30w+9nlev57Syr3o8vy98yZdPhq2DD5egGA7pJeDvr91KD0tRD0+mY7tvcX1jr4u3ms+V7SiPvze4r2nFiC+ltEDPrZPkj3KfBW+OEYOPgv4Qz6Q/2++IsuaPs/hkz69N8S9oUGCvqOFTb4zDQs+ohvqPq9YUrwc1lA9ndmfPrpaZ74fEG2+V3bvPQ4xy770Gm++3LjXvg7nlj5cpTu9I8krPnVK4T3TDJ8967TJvVrH177LCo28s5BJvguXWz7TFQg+ueJgvT4WlL6HIZ4+iaeiPrhvIb5V0x0+poSGPrkCjTz0Z9a+s36JvjdbhD1J0Ue+S7aevaDkQj6kAOC9JLDePBZOBT5bpEM9hVD0PJVALj7vFN6+QipKvg==" | null | 64.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4a | null | null | null | null | null | null | N0 | Stage IIIA | null | null | null | null | null |
TCGA-UVM | a9f956a0-660f-4185-a843-d9911d2484de | TCGA-VD-A8KL | true | 23 | released | 1.89 | Yes | 1.34 | 7.8 | 77 | -28450 | null | not reported | female | not reported | Alive | 1936 | null | 28450 | M0 | NX | Stage IIB | T3a | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2013 | no | Not Reported | false | Not Reported | 273 | 0 | 60.0 | 6B270354-A072-4FB0-8AB1-CEBECFF87DF1 | TCGA-VD-A8KL-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-VD-A8KL; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.34; rna integrity number: 7.8; age at index: 77; days to birth: -28450; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; year of birth: 1936; age at diagnosis: 28450; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3a; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 638.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 273; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-VD-A8KL-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 638.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3a | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | 1a2ce30c-5891-4bf6-8c97-6d1f34d4fe48 | TCGA-VD-A8KM | null | 23 | released | 1.87 | Yes | 1.3 | 8.5 | 65 | -24047 | null | not reported | male | not reported | Alive | 1948 | null | 24047 | M0 | NX | Stage IIB | T3a | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2013 | no | Not Reported | false | Not Reported | 200 | 0 | 10.0 | 519C82A6-289D-4DB7-B484-8FDFDA1A1B40 | TCGA-VD-A8KM-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 50.0 | 0.0 | 50.0 | 60.0 | project id: TCGA-UVM; case submitter id: TCGA-VD-A8KM; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 8.5; age at index: 65; days to birth: -24047; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1948; age at diagnosis: 24047; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3a; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 4.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 200; days to sample procurement: 0; initial weight: 10.0; sample id: 6c2b6953-a382-4a96-a578-c6a50464bf75; sample submitter id: TCGA-VD-A8KM-01A; portion id: 7efa6629-4223-4a39-8c3e-569eddc2a7aa; portion submitter id: TCGA-VD-A8KM-01A-11; slide id: 1d881a73-fe65-4cc3-aa03-4f4bc168205a; slide submitter id: TCGA-VD-A8KM-01Z-00-DX1; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 50.0; percent stromal cells: 0.0; percent tumor cells: 50.0; percent tumor nuclei: 60.0; section location: TOP; | [
1024
] | "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" | null | 4.0 | null | 6c2b6953-a382-4a96-a578-c6a50464bf75 | TCGA-VD-A8KM-01A | 7efa6629-4223-4a39-8c3e-569eddc2a7aa | 1d881a73-fe65-4cc3-aa03-4f4bc168205a | TCGA-VD-A8KM-01Z-00-DX1 | TOP | null | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3a | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | b26cb5f2-4ff0-4476-8d02-7256ace7d8a3 | TCGA-VD-A8KN | null | 23 | released | 1.92 | Yes | 0.87 | 7.7 | 60 | -21935 | null | not reported | female | not reported | Alive | 1953 | null | 21935 | M0 | NX | Stage IIA | T2a | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2013 | no | Not Reported | false | Not Reported | 179 | 0 | 20.0 | 78FF7875-29D1-4636-89A2-5D19ACACA019 | TCGA-VD-A8KN-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 50.0 | 0.0 | 50.0 | 60.0 | project id: TCGA-UVM; case submitter id: TCGA-VD-A8KN; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.87; rna integrity number: 7.7; age at index: 60; days to birth: -21935; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; year of birth: 1953; age at diagnosis: 21935; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3a; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 68.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 179; days to sample procurement: 0; initial weight: 20.0; sample id: 3dd23c74-0b1d-40f4-8e8e-a5032cc7c87d; sample submitter id: TCGA-VD-A8KN-01A; portion id: 50075cc6-96e3-4e0a-a2bc-eb2ee6b1ef36; portion submitter id: TCGA-VD-A8KN-01A-11; slide id: 0afbbd8d-dab9-424d-bfe1-632c283b24a7; slide submitter id: TCGA-VD-A8KN-01Z-00-DX1; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 50.0; percent stromal cells: 0.0; percent tumor cells: 50.0; percent tumor nuclei: 60.0; section location: TOP; | [
1024
] | "qOrIvmwg1j60whm+pswZPHopUD6U9tk+LtxKvhFTXj4tHfu9QHIQvrPtvD5Fq/08VBlaPYBaM74OL42+1HhFPgwhC73omo89ZEj4vedHhD4IY9C9lSHnPksbWD4anze+Yi2ovoy9F75R7J8+9TUrPmyhrT1eaws+YMsEPZT4Zj6GP62+bJaVvhO1Vz0Mre0+IfJtvuJYSL7Pnxg+zmT8vP9oBD48Ppg+sfoIPvgZl76C5e2+5qS2PRKP3jtOczm+J+I3PrC+D75GUPm9KpVtvupYFL2Gr5C+HJcOPYK7Cb1dg6Q8UpOEvg892T7iu0Y/wRULPSC1ib0ic729sFcBP5krG77974o+r3W0vhQ4hr4k+Y8+aIdsvpCP+r2Uzkw+WjaDPiBbvD6cHja+D/1XvFxdeb099dY9z7hYviBHKD6bv589NA8avnjZ8j19qQ2+3qJ3vk7Jgb7do5+9Wd6/vrBN1z6wZ52+u8NuPgo5pD6N+ZY+ok+dvXRPaT1Y2sq9yF2fvRCwgr6LHos+ujWzPIXH+T6fNhG99jnnvArvVz3oJ8Q93eCVveh8yLyY0LO9Be/gvQw8Fb5M1DI+AAHdPh9ocT07cac9OoOdvV1Y/T0RLRs+zB7hvYkA9r7IREQ9MRYrPo5gPz8wFGS+yuatvnvuL71gu06+KNjKPmruRz3YIAG/mkhPvXRv073U352+uOrDPY68DD5BRYG+3hmDPoBTb79jb9K9OpGwvg8mW7zy9hE97VzfPabcHD6aK8I+lsEdvcyc7D5cSry+6cSMvvqPm77Z2bI++MmNvtjukj3Hrus9EF/3vsKUmr3yJwa/tEuUPhamq71MK1Y9InyiPuHgAT2SitE8VpwOPk+W/T2bDqO+CvuQvSRtSD608Di+vPdAPk+84zrc6f29NoErvr5UiD5Sywm9TL9qPsrUoLwtreK9XlamPb/O3T1GwwM/LC16vMIoED+QOLC+tJWGPSgYNb2l98682q/rvebpIr9AH4S9RT3pPd4UVL6l4WI+eV+CPnvDZb2SDZs9XCqyvdk0ML6zKwq+4MW+ubNOBr72686+/E/5vt1sOL5+Cp89eOB9Pu5tJL2Zz5K+F3uUvVJ0bL4m1ZK+Ipv0vkZCoT0jH9M+vlUNPo3GCz74U5m+nAa5vl45qj0m/TO+nYEnPvfNGb9qhuk9UQJWvmN0Db718um9pocRvuZYtb6DTwU/qA1QOkQcHT6Q8M69a4WEvsH1ojwmJpK+hEV0vdIhNr1RiJK9opVHPhbyWD5c9YI9HDOlPnXcI73nl5C+o1gQvTDmxTxCC08+UMaUva/Qxr78VPg9PGmbPHYXvD3GVIy99KSqPrrKCr6CnK3ARjbyPN5vBz8+diU+0jGCvrTBRr4y/z6+RQQZPkBvXL32AnM7jPQ6PiKnOb7szhw+XmlcvPYK1D1fG0S+StVDPgBhiD3GPge+DdMKvW63FT7ycyY/oTQovn5Eyz3DHaU++p+CvesxHT68znc95vd3vWwuUz6lRBi9RjuzvhRQ/b3Tb8e+D8DgvrB7mD1pKY69nCIYvhLdCbx8Lpm8zq+xPSZ/mj6HTUo+EKlauz69ur0iFUq9puizPr4rlj5uxok+f7FLPpdV/j10org+/pCvvsZIO75CQC8+sV7EPdH7DT44SRa+JQ3wPNZhsr5gzHq7qxMpvi58Kj4g3so54nQdvlBFAT8oAFW+QKbbvfwsWz7dq709jtUEP7c+yL7sA389SiK5PsIpuz6MLha+IbiJPri3oL6uXps9VteXvaYNrT7qY988d/RwvCCthz5mIiA+gsWCvd6hDr9uDqe+en4AvmbGir5SywI/KpNwPoDcB76T+BC8s2HzPmHHMD5u7es9hsWaPkIVcj7yHEc+SUTNPkSF4Tzjop2+Kn7YvMAEnz2o7mI+lAnwvRjnZL4v3Se9HIecPSb3KL7qpJg+oaa0PTo+Dr5DcY2+FQN9vA5uWz5L2UO93vmCPmYnfL65jxG/nmo2vr63i75oVNE9Nh4Lv34HWD5WW+28vpZ5PkpqMT/qIDC+TNMPPa3Z8bzsywg/VQMmvqws3T1TuMk+aLHxvTnkWj59wjM+re1yvrbamj3tCB8+2ktDvgYeIr+k3sg8HbGzO1ssLr1GGZq9bWAQvkOP3763Koc+OfO0PuIvWj415em7Xy8Xvjac4z5P8Yu+BhG6vUjVIb0OpRE9XtMLvkyt2T7EzC88BcAGPsbjOT4zaQs+LvIiPgH7VL5UcLo9Hj8Fvw85bT1HPEO/jfvQPbJBq76xkAk/wOBvvsKweL3KSp69x19Cvjo8vL701ZC+bJWPPW5iub4kGgM+ft+QvrhP5bx0nEI+Js0mPghpQT5ybMM84zBwviLkgD7/Lp4/F6KDPGtRN70SV4e+l+cHv35AaD0UABe9aI/ZPgBt3DxmbcG+9R+NvnaioL20p7s+tjDMPb0uPj6C2F89CLedPAttijw9Wok9ku4Jv0YrC74C8uS+JM0nPj4EBL5NkTg98IMRvBK+DT46nIs7rAUVvg6/Jb7lf6q9qcyIPB7AtD7qP5M+hOcwPlJdmz3/axA+Fe7Xvo4zIj01kBO+LoprPu9/uL5TWaU+XNg6PpwKkj5uI0E+FE57PQs+kD5Txkw+TsBHugejpT0ADQq+9+fNvMakNj5qDzi+47eOPo0pAz4RKqq+FsmZPThwcT42OlM9oUYaPkPXCr887Lg9ErtQPtuD670irLk9oH0SPcTdrLx3O8C9pupBvc9vgD3+V0K+WiqLvcP+c7wowoQ9nuSuvnsyK77yp++9BhmPPWohQT5UIwS++3KvvVZKMr0XuY8+NhWYPQMhSL3u6x8/1ksjvnxps70R6CU+BXhsvowiGj5KRQu9VE+hvqjyF7q7Fda9ZkzFPXkCr73Icr68hI+Dvr4L5D5f6Ya+SGK2PhhQrr5edHW97f6hvSHq4jyLidy+1AJLPl4w3z3Y+lO+Po7KPtf9nT5nuQu/D08Dvsh7171e2Ce+ePh+Phs8kb3V19Y+3pVavaxlKD2g4lS+BrkSPcZCKb4k8TY+s8S4vBYY3b24rc496KTfPU+FBj7nYja/v2sNPmweor1IDYa+ZOB+Pr00db7Imp++INMovZ0lf73KIJ0+OptqvnVzLT68j0I8jeMJPjrseL6bWsu9JoDbPEKE5T2AAh8+kqcFvjxRSL7L9ge+8EGjvltacb3Doqy+yP0mvpX3Cj4u0TE+jMxJvgAZLr6qJLW+49/nPvj0Q70c816+yviPPmsYEL/WjL09NEdrvvPq7L76/by+TL9XPtY8gz9ey3G9eJaDPmqeez1Vn+G9XzCAvpz8jT4FDmO9SS2GPiQ9hL5SM36+Nv4evanFMLwlZWk/58RXvvvsdL43V/s+TfVhvN+h4722ksM9CCTEPrBOA77uBno+MmVHvrqtBT76mye9zsijPmRLuD4Db9U9mE5XvZzsC713AYK+//XjvsI7o70UBNu9QsmvvbHS3L3O05G+S9zmPV5iuj0Jd9G+u5GzPvyRIz5kM52+rG9bvvnbkr7mB5e+o+YBvpdzAj5AF9K+I7vsvgIOnT0nHj4+ErKVPr5Bsz6/iBg8ZqoUvtTIsb5pa7s+B5Rlvey5p76o7rE9ph1sPIIw/70mCXe+9kDAPdPncD47sNa+U4g1PsyllL4c/3g+zykgPgxhWr7XyBk+DECDPmB3jL2sPKS9WpmCvEf24D2/Quq+5CVUvq8zeL6R0Sa+ZM8BvrI9j742dqo+JvCIvE0LZj4yESM+htsXv8v0XTwcTaq+Y/NxPGIOhr64tyY+wJ7ovvLxYzsj3tE+KMfjPgH6Wb6MPge+Y1+RvlQEUr7sDrg+vsNiPtBTFL7iNNK9j8GWPaXWVD6MqaG+1JVIPByAvD6b9hW+eqk7vW8z6z1kdkI9fsgGvl1IHT4D55W+cAmfPagQFb5wLRY+Wo+4voaZ7T1/C1M+QDIpPsV3DT/4ILc+//+xvdzt0b6/mV6+4Sj8vVhMJD782oG9c5TOP4QbrT4gv7A+9uM8PlcCY76NO9s+iNQMPwG2kz2vlN492+ScPl6b9z66WA++i9blve42KT+BF7y+yf24vY+crL+4fie9MtctPYEjEj84UzU/1jI+vtzqqr6FAoe+OBQyvrXNCL4u0tE9nLERP+RFUL5wOcc9LidYPoyNAb4Vglw+QseXPsI3gb58VpE982zevCjWmr5MP8u84j6mvKY35j0a8s++fEj+vUxn0T3Q/pm+9bxpPp02nz4kW7S+R1WAviL0HD0+PIE92aCwvnFLCz8ibdU8selkPtAriT6xwpK+GrmFvRikZ77G1Ba+eLpzvpSflb6QzXM+S3uavnZ0NTwZ+6o9CnK6vjP9Lz5SEWM+uCR5vZH0jj2aRlA+7yQjPN6vgr5oi+m90PjYvWBiBD2Uy4i+eSe5vgqZGD8MghM/cnpYPmNpxb0MyXQ85tmLPp0Y+j2YsZs9+3fwvjLmE76OgFs+OH3JvgJBIj0StIo+6h4rPeKhvDyqpDS+UUVyPFNHDT7cAgW98q6FPlmUZr7ej669Q97GvpmuMj0mv6y+tHxGvTQhiD22jcO+7QGlvdqeWb7wVnw+69LpPeiEdL52yZy8DMGLvTJEob7Yuy8+4oqDvRAHp74/pNy8A5MyPgjjFT58xic8yjHVPfML/r2hf6E+SbOVPnaWV76SKQo/6NEsvsEfAb4HFei+lth0vnq+3r7vF32+poSCvszpbr7W5E2+spfMPDw7Yb6/MRa88caAPOyD9D6W/M++ijxFPaaOiT1sRk69lA9lPik2Jb5qioS+YEKKPr2NNr2VTyE94AFMPoesRr4Qkso8xKdwvjGNgT1Mask+TWBzvmzk3T10rgk+ojsVPCY26D6h8Xs9kh0Ov4S2rT6Y6dQ9z3aAvnLwL77yy6u9oaxePWyfeT7qAPs9CsQUPlCgtD1gFPU9EykKPuvp8Ds/fiO+0JFfPbyDzjw1/Ai9XKNlPO3sWb5GAwq9usZgPGlcAz/8qcY94ihIPAKxC76ipNK9ZiazPcq6Dr5I7HW9jgeZvnjdLr4AZme+17nXvIjlZT5gXDw+fJNnv1Qa0b1YscC9dXsWPqml+j2qJ3I7+kSvvpmrMb0qLRE+bplQvV6ahL6GcUQ+VtiOPsqWUL6vozS+2ShDPhgWBj3i3hO+iXhgPtLrjT6v4yu+ZpJhPrnwnT7FeJq9CLh8voqPWL5y/Go9baEPP/rUpDyA3aI9av+gPkY2Lr4EiEC+ZK2UPXgG5L4AcBe+/g+2vjpdgD4DCsO8lM1VPoKXBD7TbC49HQEHvrwW9r5+Y6K9ngddvu9Uez54mbo9Rp0Mvke7k76ArMM+DO7BPvKj170M/CE+hDuDPoncJD1keqW+XV2Gvk9gjz0k/WS+LhAIvrYQQz5PHSO+xgG0PSP/HT5Ea8U9dJyfvKg3CT4QzPO+JU0vvg==" | null | 68.0 | null | 3dd23c74-0b1d-40f4-8e8e-a5032cc7c87d | TCGA-VD-A8KN-01A | 50075cc6-96e3-4e0a-a2bc-eb2ee6b1ef36 | 0afbbd8d-dab9-424d-bfe1-632c283b24a7 | TCGA-VD-A8KN-01Z-00-DX1 | TOP | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3a | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | 014d4b17-d683-438b-9287-33fcec82bf5a | TCGA-VD-A8KO | true | 23 | released | 1.8 | Yes | 1.55 | 9.1 | 51 | -18844 | null | not reported | male | not reported | Alive | 1961 | null | 18844 | M0 | NX | Stage IIA | T2a | not reported | 0 | C69.30 | not reported | 8774/3 | Spindle cell melanoma, type B | no | No | not reported | Choroid | No | Choroid | Not Reported | 2012 | no | Not Reported | false | Not Reported | 373 | 0 | 30.0 | 21AF9D90-AD49-4757-B96A-F536F40408E7 | TCGA-VD-A8KO-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-VD-A8KO; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.8; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.55; rna integrity number: 9.1; age at index: 51; days to birth: -18844; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1961; age at diagnosis: 18844; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T4a; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 795.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8774/3; primary diagnosis: Spindle cell melanoma, type B; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 373; days to sample procurement: 0; initial weight: 30.0; portion submitter id: TCGA-VD-A8KO-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 795.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4a | null | null | null | null | null | null | N0 | Stage IIIA | null | null | null | null | null |
TCGA-UVM | 9dc5cc23-c903-4fe2-8354-64f8316ff0d4 | TCGA-VD-AA8M | true | 23 | released | 1.92 | Yes | 1.15 | 9.2 | 64 | -23507 | null | not reported | male | not reported | Alive | 1949 | null | 23507 | M0 | N0 | Stage IIA | T2a | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2013 | no | Not Reported | false | Not Reported | 132 | 0 | 60.0 | F501AF08-A89D-4B4B-9A18-07DC938DB233 | TCGA-VD-AA8M-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-VD-AA8M; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.15; rna integrity number: 9.2; age at index: 64; days to birth: -23507; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1949; age at diagnosis: 23507; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 6.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 132; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-VD-AA8M-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 6.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3a | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | 1dbd7b0e-9234-47d9-bdca-5b17f5af619b | TCGA-VD-AA8N | true | 23 | released | 1.9 | Yes | 1.68 | 9.1 | 86 | -31475 | null | not reported | male | not reported | Alive | 1927 | null | 31475 | M0 | N0 | Stage IIB | T3a | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2013 | no | Not Reported | false | Not Reported | 118 | 0 | 40.0 | ED92C74C-5F12-4163-8894-1F538D2451B9 | TCGA-VD-AA8N-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-VD-AA8N; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.68; rna integrity number: 9.1; age at index: 86; days to birth: -31475; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1927; age at diagnosis: 31475; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T4a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 44.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 118; days to sample procurement: 0; initial weight: 40.0; portion submitter id: TCGA-VD-AA8N-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 44.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4a | null | null | null | null | null | null | N0 | Stage IIIA | null | null | null | null | null |
TCGA-UVM | 99d1bfcc-1989-4dd2-a5e9-78e08f6ce7cf | TCGA-VD-AA8O | true | 23 | released | 1.94 | Yes | 1.55 | 8.4 | 77 | -28250 | 606 | not reported | male | not reported | Dead | 1936 | null | 28250 | M0 | N0 | Stage IIB | T3a | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2013 | no | Not Reported | false | Not Reported | 72 | 0 | 40.0 | 47696668-32A5-44CB-8141-3613B07CC231 | TCGA-VD-AA8O-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-VD-AA8O; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.94; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.55; rna integrity number: 8.4; age at index: 77; days to birth: -28250; days to death: 606; ethnicity: not reported; gender: male; race: not reported; vital status: Dead; year of birth: 1936; age at diagnosis: 28250; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 228.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 72; days to sample procurement: 0; initial weight: 40.0; portion submitter id: TCGA-VD-AA8O-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 228.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3a | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | b224e42d-8b6d-4578-963c-bf528b954900 | TCGA-VD-AA8P | true | 23 | released | 1.9 | Yes | 1.86 | 9.7 | 64 | -23555 | null | not reported | female | not reported | Alive | 1949 | null | 23555 | M0 | N0 | Stage IIB | T3a | not reported | 0 | C69.30 | not reported | 8774/3 | Spindle cell melanoma, type B | no | No | not reported | Choroid | No | Choroid | Not Reported | 2013 | no | Not Reported | false | Not Reported | 104 | 0 | 90.0 | EAADA209-BED3-4FA3-B39C-2428BF278EF7 | TCGA-VD-AA8P-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-VD-AA8P; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.86; rna integrity number: 9.7; age at index: 64; days to birth: -23555; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; year of birth: 1949; age at diagnosis: 23555; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 86.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8774/3; primary diagnosis: Spindle cell melanoma, type B; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 104; days to sample procurement: 0; initial weight: 90.0; portion submitter id: TCGA-VD-AA8P-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "Ad+Vvjh0yz4Hiky+sHOXPZiZGz7+eu0+UN8ivt/ZFD7OCwi+Ho4TvtAY2D7fHz4971IMvJr8gr7QMGW+1jJ/PuQnWL0GX9w9maELvhhyZT72qbS9j8PjPvQMWj6fKNu9uO2LvpUMyL3X32U+dPo3PrdBJz12IKY97+igPTANLz7pGrW+zIeUvvqBvby/3Ls+45hNviLCTb4n3gw+4hbGvOZUHj52t6I+vR4QPr5Jj76Qlt6+PZPVPdrqAL2pNue9CbxBPr71Br6QFMq9czw0vubCjb2Dx4i+U0sYuutCf7wLlHi83lZcvpbr5z6adDg/itV2O74o3bzekaa9nunePiznHr4+FYc+g+WcvroQmL6YBYY+gZs6vlp6H774ZDI+1oBAPvtusz4uqSe+wfeevTLhnb0HvvA9L7VbvtL1HD5YeUk8QqIbvgfYaD00MSi+xCOGvmsGkL4m80e9duarvmuy5D7VSrW+ZSAqPqAviD4X8nI+j5mGvPLL+jvj4Ky9kQLYu0Suh74diXQ+gm/LPXEg+D6MA/C7lwGDPMaw+TwRNuc9/X7LvZjplj1M+6C9MaMBvq7u2L2nqFU+x8ryPvs4Pz19ztM9G5zVvUZUrT3osOs96We+vWSe6r7FxA09GotFPrdkHD+jqgi+hFqZvolkJ7xkRWG+H1nqPlPrwj1kKv2+3CV8vflW1L1mwI6+Z0XGPfGhHj7VLpy+BOuEPoHUdr+GrxO+YWmlvv7mEj2Eev27H3UOPmLX9D1kQcY+qgUFvVdC2D7DpK2+WuxdvosPjb7CNpY+huVzvn2Pcj3O/9A9QE3vvvrqlL2nDNi+8lGOPlLQArw8CzU9ulOlPqaz6rteqRm827PDPQUdJz6j6ZG+ci7SvKcDGD403Du+udFLPpUJGb3/1QG+YFOAviJlbz7bNkC9efSIPs1x4rw5bAO+aqlWPSCFZb2w3Pg+vl3LvVKGAz8HtIC+2nMePegsqjzAGWe9Zn4MvukqJL8Y3mU8W0LJPaYl/r1EoZQ+1mGWPudatbqcjAs+8PrPvH8gBr4DaxG+cBHnvKyECb6MPea+624Cv+w3IL5/fIA8rJ6SPj4CQzweHaW+bpeOvTnZWr7kPVa+8o/1vsOSgz3ofdc+RdoKPgFGuD2S9za+ucXSvmKygj2/Szu+RLshPgVkEL+1O7Q9XDt+vppzAr7wkoi9qRgAvlU5vL5soAk/axKpPGAnHj4YVRy+saJgvmZt7j1GpqG+ICL8vdAKLr3p7uy9HkRDPrbTcz5y9589UEeJPgtaq71uq3m+H9s0vSldkbxmS8g9N5Q+PLlgxL4SQKo9DZdaPRrgLD4Cwd68HEmpPtf6g75ZirLAIcqoPI7NDj9Dxz0+lShovli6Xb6r0hy+A/0mPsBOpDzAXyy9jMqrPTNyZr7ebAg+fRFovYdQ7D2NLxa+0o+KPntnFz2fIsu9WgQqvYy1Wz5+XCk/rLyKvQ/WWD08npU+mw8RvhdMaz2GBx8+ozRcvR34Mz5UKRS9G66eviTkQr4sUZK+O6jVvl3VUzsTXrO83OULvukD4b2Y4Ii9uwxvPRAzpz7c2Ts+T3zPOh5ALr4qK+88k2WZPoOrpD4ZF3g+/RDqPTwO7T2+rrQ+pGCwvhT1JL5lH+49BZjpPSS6/D2+fT6+N/6VPfF5ub5qBT4926njvYNIFD5iJAA9B3FDvk6/4T4CHIe+tw3WvfyUCj4PCsA8OUbfPkdmzr7nNxw+GPObPuwWlj677Cq+jAVmPlWfML4GCnI9fc+QO6pGhD6MsLA9wqOPvT4LcD5P0Rg+gcmUvcyfCr9wJZ6+pVE6vmHQj75BhPk+n9ccPuAKEL5pH2G9K8/MPmYZ6j0C1MM9PDySPn8hVD7DJyA+nxWxPvDQlz12Cpa+ObsXvKgITz00EoU+oNT/vTK5Vr49ERu9vfS7PT2wML6FS5k+KJeuPad6Cr5eL2W+qteTvaU2fz4M0W+9R7JCPsA7O75m8g2/tdQTvgxCX77zpO49QpsBv78eTz5TNbS9ddwuPkcfIj/inQC+I7OiPbU0rr2YgwU/besSvpQAjz0cW6M+BSgAvgEZZj7kWRU+VIE1vska5j32dPI9IBskvtdyFb+sF8w8UQ5DOwMpNT0Up2O9U5hCvkeL+L4ZWYA+1nWXPhh1zz0foUs9/qpUvnLdvz7kkHu+jYKdvSYeBL2vv5o9pEwjvv+R5z7jfAi8kGBVPrdihD7biCc960odPsiJer76Dya9zF8Mv/6r/z13Ezi/UzT4PaXOpL4+g/Y+kayEvu/cSb0DaaW9wnhovlN7x76u1oq+n58fPa1vy74hm9s9Ac6UvilLfr23/Rg+4XYJPiX7KT4PRhA91/t7vkHQdz6zGqM/mreUPB/vZL14FpS+i7fwvgbkWT2/spE8o6TPPkpX07xGWLW+Ttujvvjri70nWaM+pFBYPunEDz6szb097nMQPfgAtryMZEY9aePovn+eRr75Osu+XowBPjGLPL69BQQ9mHePu9mBAz5pNmw7doFLvsRQDL5EGhG9IzK3vBAprD4RO5A+bYQhPkBm7z2RWi4+P5zXvpSBMz3Q/lu+Ydx0PhLImb553II+E6FFPnBRjj6ttng+abMPPp7ULz72JmY+GI6zvY02Sz2gaaC9u2cjPSWF3z02WBO+fKSqPrskQz2+Lq++8kaCvPJdXT5Pm50929cGPqftyb4p2K48rXxBPiq+373lJ7Q9IeArPCPepTxpUc29TSNBvJZmgz00jwe+P6SzvZvj07wLxMM9zmiyvnpIHb4fy4e9jIgIPiHWZj7Al1G97gsZvjIhL7gvn5E+HUd0PSaWKLz+Ew8/Bv7bvcjLur1NPEY+7DGJvgIjQD4A4BO97r2pvqlWCL1R4Ja9nqyBPeCrxr07Nsk7sUFOvpiu/j59ZJi+zGGfPjx0vb6/b1e9AtMbviYofz1IBr2+bdxaPoYgeT0UUDS+O3GWPrZIjz4zSR6/skjIvb8Yqb16vjm+18KoPozrU721q7M+OG6vvcXNDjxcYFO+/KQzPn9JS76F3xY+sBbkPI5UX721jqw9D1G9PNvO9D2Ri1e/2ePOPRHuy72DGYG+ME1qPklORr65ZZy+/tTTvV+8Fr5TnH4+rIFHvoYOSD5qJj691ZKLPW5vEb6NMOm9/IQ1PCpCqbx8JUQ+3BWpvaFGDL4G0SO+8VqavnEd7b2XpJG+9pZHvjVACT4Eb14+eO4uvkZ+L74GQ62+2wnPPmsTAD0m226+d9SbPkkHEL+FlSM+YsB1vnKK177Vcrq+xEx+PprshT8Yjqq9xpKdPhMARz2xi2q9+NiFvgE1iD75YcO9jiSIPno6Xr7ZYZ6+WN73vAppdDxzSE8/pMCevQRbpr4FCw0/tE+HPbP/9b2MUKs8zu6kPn+uM75GC2M+UPd5vgIrFz6JM569b3FcPiyPxj4pCuQ8BfOIvc19+TyDhJG+/zDNvkvB6bznc/+93P8uvR7+3b0BHGG+vEYnPjTpOj4exba++bKbPkFvAz7dCou+r0tuvgpwO77QGrm+0K5KvWlAzj2q4Nu+yQa/vs73sj0dZ+89+r2fPhXqwD7EUo28F4AFvhUKmr6wA3M+L0f5vVfXmr6oKr49A5kQvTBSFr5gv0e+XRjWPduWJT4qDpu+JznjPfaOqr7snhI+jQYhPlg4Ur54KAU+yjd0Pn7u270rMQy+45zOPLUPiT0yVQC/Yf8Yvks2PL7lOVC+XpMQvkXNgr5XQZ8+vSL2O9eZhj5ub/49l78Pv03NtTx/heK+aiHFPZpWUr6asbE9XWzxvp4Jqz1NgN8+iO/aPpo5L74Usky+zMyGvhuEbb5cuL8+CWRqPlzr5L1JG/i9dmE/PYembj31iJC+8TGaPfatzT6G+Qi+1zTCvUGcpz0vALU9d7wZvt+jPT6dtbO+BbsuPr55CL79AkI+vNaqvvQQgTzVkig+PvxKPh7r5z6Y1rk+Nd8ovQ8p5L4FoMe9UyNfvTWbPj6TFtS9ikrHP863yj6ZsM4+1NJEPknOdb4NkQM/0G0SP0Fr4T1qig4+kV6APk+d3j5u56u8QtcRvfjsGj/4naa+nulzvXCjqb/WLYy99HnZPI9SEz8MGSo/O20ivsaMp75ED2S+PBQ2vsz7C74U3OU9/DwqP3dIar5aqNg9+OtrPuthuLwG8zQ+wJ1bPvCtTb7YYN89BdvUvCUXmL45pqm8Lbp1vcIL1D23166+9nywvSHGOj4lLZm+aIOCPoazpT4DV56+cQqBvsuvuT1rsP49NgicvgDtAD/aveq8fjROPisAUT6AjKq++8aqvd40Or43H9+9BvKAvjpter7LPYE+M5SSvqiKbz0CoWY8VsauvoB97j0d7Q8+EAXovN3x4z3PtGo+4QwLPcOod763gh6+IlYCvjl/oT1itlu+pwzCvt8HKD+EGAA/g6h3PrqXGr58xkI9Edh4PtbQDT67FyA9djq+vopkIb5bh2g+ZBO+voacTDtTjJY+Uww0PThtCT2zAsa9A4mGPQX5Ez4s8OS9QcuVPlQiZr5vU6K9+GC0vlbyCD0DM4++FM9AvT4/hj2WCai+0zFgvWCWVL7i2aI+I58JPslaJb6ZhPY9yeYbvkEKiL6tq7Q9S3xovFX/mb574gE9uE0dPsA+Hj5sQHm9r82nPSUZBL7MJag+U9GJPjL0T75omQQ/ywiZvccmIL369Me+0q2FviNzwL5m6Ja+vg6GvpeZV74+DvO9u+wBPcS9+r19Iiu9OVYTPfDOzj4LLK2+UIauPRCCzjvx7Xg8PG4rPrRiRb5qITi+WtCcPoMht7xfnjM9Wwl+PlCmMr6yFH+9wOFhvtar1j3JddM+Ue6WvsZCAT4r8B0+JBbzPLmUwz528No9AxbrvnARrj4B3Yk9+463vtnnOr45E9O9PWQ9PDNmKz6o7qw9J5zwPSufib0gTKU9myRBPuU/wbuSqgi+tRHcO0FkaT0fjQE9rf2tPJv8Jr7toKm9PQihPbqIEj8UOy49tIMGPaM6z72NnzO+oD+kPUXPQL4jm4e92FqYvhGC7L3yFoC+A00qvDOKNj5puk0+GQlhv4966b1bBfu9w/pnPlW7Bj6Xqfa7j/R+vqcNzjx/rTc+qSvVvfvviL4uwXA+Bf2XPufu1r2vNSq+stj5PRxMmz17/w6+CdYIPk1pPD4lrHq+YGqXPlc2kD7z/La9tHSBvkfyVL7VvQY+cgvtPgoOzbsSnlc9+2+pPrsAa76za26+YNgDPqtYx76VLYC+XGzZvt86kD7x+Dm9fnwpPqS35T1iP4g9ckfHvc7u1r5n8ya8pJNQvslaXD5Yyw0+QKFfvcZEir49yaE+I6ehPvgVJr57eiU+vNWGPojB5jwcLdC+J+uIvj0tdz098ke+BdiQvSqHRT5Z9tO9FMwWPYoAAz4fiU09+eoUPQE+Fj4wnd2+rHJCvg==" | null | 86.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3a | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | 1d00217f-28df-4d91-aeb9-0d9a83a907e6 | TCGA-VD-AA8Q | true | 23 | released | 1.91 | Yes | 0.82 | 8.1 | 71 | -26285 | 636 | not reported | male | not reported | Dead | 1942 | null | 26285 | M0 | N0 | Stage IIB | T3a | not reported | 0 | C69.30 | not reported | 8774/3 | Spindle cell melanoma, type B | no | No | not reported | Choroid | No | Choroid | Not Reported | 2013 | no | Not Reported | false | Not Reported | 104 | 0 | 30.0 | BA6A5CAA-0D65-4F4F-A15B-EB0D4ABC1D87 | TCGA-VD-AA8Q-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-VD-AA8Q; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.82; rna integrity number: 8.1; age at index: 71; days to birth: -26285; days to death: 636; ethnicity: not reported; gender: male; race: not reported; vital status: Dead; year of birth: 1942; age at diagnosis: 26285; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 7.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8774/3; primary diagnosis: Spindle cell melanoma, type B; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 104; days to sample procurement: 0; initial weight: 30.0; portion submitter id: TCGA-VD-AA8Q-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 7.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3a | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | 995fcbf5-90aa-4d4a-b57b-46a7129209e0 | TCGA-VD-AA8R | true | 23 | released | 1.93 | Yes | 1.7 | 9.4 | 78 | -28841 | null | not reported | female | not reported | Alive | 1935 | null | 28841 | M0 | N0 | Stage IIB | T3a | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2013 | no | Not Reported | false | Not Reported | 90 | 0 | 20.0 | 17015647-C660-4661-B739-0A58A88FC1EB | TCGA-VD-AA8R-01A-11 | 4.0 | 1.0 | 0.0 | 3.0 | 5.0 | 20.0 | 75.0 | 75.0 | project id: TCGA-UVM; case submitter id: TCGA-VD-AA8R; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.93; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 9.4; age at index: 78; days to birth: -28841; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; year of birth: 1935; age at diagnosis: 28841; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 6.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 90; days to sample procurement: 0; initial weight: 20.0; sample id: 30822e80-8ef8-4ac9-af5d-304aa7f8c1dd; sample submitter id: TCGA-VD-AA8R-01A; portion id: f6868863-9cdc-41ed-9a24-c5ac7cf94dc8; portion submitter id: TCGA-VD-AA8R-01A-11; slide id: b2072ea5-0af2-433c-b5f2-81125ace37c2; slide submitter id: TCGA-VD-AA8R-01Z-00-DX1; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 3.0; percent normal cells: 5.0; percent stromal cells: 20.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0; section location: TOP; | [
1024
] | "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" | null | 6.0 | null | 30822e80-8ef8-4ac9-af5d-304aa7f8c1dd | TCGA-VD-AA8R-01A | f6868863-9cdc-41ed-9a24-c5ac7cf94dc8 | b2072ea5-0af2-433c-b5f2-81125ace37c2 | TCGA-VD-AA8R-01Z-00-DX1 | TOP | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3a | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | 9752c320-79eb-49ea-aa1f-d7a79bead901 | TCGA-VD-AA8S | true | 23 | released | 1.82 | Yes | 1.36 | 9.0 | 40 | -14681 | null | not reported | male | not reported | Alive | 1973 | null | 14681 | M0 | N0 | Stage IIA | T2a | not reported | 0 | C69.30 | not reported | 8772/3 | Spindle cell melanoma, NOS | no | No | not reported | Choroid | No | Choroid | Not Reported | 2013 | no | Not Reported | false | Not Reported | 201 | 0 | 20.0 | F0CF61C8-9797-4AF1-A206-0AFA8E361046 | null | null | null | null | null | null | null | null | null | project id: TCGA-UVM; case submitter id: TCGA-VD-AA8S; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.36; rna integrity number: 9.0; age at index: 40; days to birth: -14681; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1973; age at diagnosis: 14681; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 427.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8772/3; primary diagnosis: Spindle cell melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 201; days to sample procurement: 0; initial weight: 20.0; sample id: e99cec16-645e-4684-988b-fd8877a395c2; sample submitter id: TCGA-VD-AA8S-01Z; portion id: a713d76a-094b-54cd-bbcb-0d2e76e8e235; slide id: f2ab811f-94d4-4cfa-942c-79e0bdeff82a; slide submitter id: TCGA-VD-AA8S-01Z-00-DX1; section location: Not Reported; | [
1024
] | "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" | null | 427.0 | null | e99cec16-645e-4684-988b-fd8877a395c2 | TCGA-VD-AA8S-01Z | a713d76a-094b-54cd-bbcb-0d2e76e8e235 | f2ab811f-94d4-4cfa-942c-79e0bdeff82a | TCGA-VD-AA8S-01Z-00-DX1 | Not Reported | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3a | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | 9e35ef82-55b0-460b-8ab9-8cd708efa3b1 | TCGA-VD-AA8T | null | 23 | released | 1.83 | Yes | 1.28 | 7.8 | 83 | -30475 | null | not reported | female | not reported | Alive | 1930 | null | 30475 | M0 | N0 | Stage IIA | T2a | not reported | 0 | C69.80 | not reported | 8772/3 | Spindle cell melanoma, NOS | no | No | not reported | Overlapping lesion of eye and adnexa | No | Overlapping lesion of eye and adnexa | Not Reported | 2013 | no | Not Reported | false | Not Reported | 69 | 0 | 40.0 | FFC65F78-4178-4E52-B5AF-1808C61EAED0 | TCGA-VD-AA8T-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-VD-AA8T; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.28; rna integrity number: 7.8; age at index: 83; days to birth: -30475; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; year of birth: 1930; age at diagnosis: 30475; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 49.0; icd 10 code: C69.80; last known disease status: not reported; morphology: 8772/3; primary diagnosis: Spindle cell melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Overlapping lesion of eye and adnexa; synchronous malignancy: No; tissue or organ of origin: Overlapping lesion of eye and adnexa; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 69; days to sample procurement: 0; initial weight: 40.0; portion submitter id: TCGA-VD-AA8T-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 49.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3a | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | 3eb7aded-8887-4c27-a464-1b50ec090133 | TCGA-WC-A87T | true | 23 | released | 1.79 | Yes | 1.1 | 8.0 | 64 | -23409 | null | not hispanic or latino | male | white | Alive | 1943 | null | 23409 | M0 | N0 | Stage IIB | T3a | not reported | 0 | C69.30 | not reported | 8774/3 | Spindle cell melanoma, type B | no | No | not reported | Choroid | No | Choroid | Not Reported | 2007 | no | Not Reported | false | Not Reported | 2154 | 0 | 40.0 | C97D9B9F-544A-471A-9F51-88389EC7630C | TCGA-WC-A87T-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 15.0 | 85.0 | 85.0 | project id: TCGA-UVM; case submitter id: TCGA-WC-A87T; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.79; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.1; rna integrity number: 8.0; age at index: 64; days to birth: -23409; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1943; age at diagnosis: 23409; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2600.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8774/3; primary diagnosis: Spindle cell melanoma, type B; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2154; days to sample procurement: 0; initial weight: 40.0; portion submitter id: TCGA-WC-A87T-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 85.0; percent tumor nuclei: 85.0; | [
1024
] | "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" | null | 2600.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3 | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | 4498044c-1607-403e-867e-befd7fad275a | TCGA-WC-A87U | true | 23 | released | 1.82 | Yes | 1.23 | 7.2 | 73 | -26933 | 1581 | not hispanic or latino | male | white | Dead | 1934 | 2011 | 26933 | M0 | N0 | Stage IIIA | T3b | not reported | 0 | C69.80 | not reported | 8774/3 | Spindle cell melanoma, type B | yes | No | not reported | Overlapping lesion of eye and adnexa | Not Reported | Overlapping lesion of eye and adnexa | Not Reported | 2007 | no | Not Reported | false | Not Reported | 2199 | 0 | 20.0 | ACEB9450-95DD-483A-A7FD-99EA22359785 | TCGA-WC-A87U-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 95.0 | project id: TCGA-UVM; case submitter id: TCGA-WC-A87U; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.23; rna integrity number: 7.2; age at index: 73; days to birth: -26933; days to death: 1581; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1934; year of death: 2011; age at diagnosis: 26933; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T3b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C69.80; last known disease status: not reported; morphology: 8774/3; primary diagnosis: Spindle cell melanoma, type B; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Overlapping lesion of eye and adnexa; synchronous malignancy: Not Reported; tissue or organ of origin: Overlapping lesion of eye and adnexa; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2199; days to sample procurement: 0; initial weight: 20.0; portion submitter id: TCGA-WC-A87U-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 95.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3 | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | 60d7b6cf-d605-4837-9061-612f6bbb7393 | TCGA-WC-A87W | true | 23 | released | 1.82 | Yes | 1.0 | 7.7 | 57 | -20872 | null | not hispanic or latino | female | white | Alive | 1953 | null | 20872 | M0 | N0 | Stage IIA | T2a | not reported | 0 | C69.30 | not reported | 8772/3 | Spindle cell melanoma, NOS | no | No | not reported | Choroid | No | Choroid | Not Reported | 2010 | no | Not Reported | false | Not Reported | 1115 | 0 | 10.0 | 49A74B5C-B59F-414D-B578-45A843529582 | TCGA-WC-A87W-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 95.0 | project id: TCGA-UVM; case submitter id: TCGA-WC-A87W; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.0; rna integrity number: 7.7; age at index: 57; days to birth: -20872; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1953; age at diagnosis: 20872; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIA; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1703.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8772/3; primary diagnosis: Spindle cell melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1115; days to sample procurement: 0; initial weight: 10.0; portion submitter id: TCGA-WC-A87W-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 95.0; | [
1024
] | "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" | null | 1703.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | N0 | Stage IIA | null | null | null | null | null |
TCGA-UVM | 3a161c85-2544-4283-a10d-e332c9dd1692 | TCGA-WC-A87Y | null | 23 | released | 1.81 | Yes | 1.1 | 7.5 | 59 | -21865 | 1314 | not hispanic or latino | male | white | Dead | 1952 | null | 21865 | M0 | N0 | null | T3 | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2011 | null | Not Reported | false | Not Reported | 896 | 0 | 20.0 | BE3CE26C-C3EC-442E-A618-BB6DEC18C2E7 | TCGA-WC-A87Y-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 95.0 | project id: TCGA-UVM; case submitter id: TCGA-WC-A87Y; source center: 23; state: released; a260 a280 ratio: 1.81; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.1; rna integrity number: 7.5; age at index: 59; days to birth: -21865; days to death: 1314; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1952; age at diagnosis: 21865; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T3; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 955.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 896; days to sample procurement: 0; initial weight: 20.0; portion submitter id: TCGA-WC-A87Y-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 95.0; | [
1024
] | "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" | null | 955.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3 | null | null | null | null | null | null | N0 | Stage IIIA | null | null | null | null | null |
TCGA-UVM | d8e15178-d8c5-4e4e-895c-57ffe5bc80c2 | TCGA-WC-A880 | true | 23 | released | 1.85 | Yes | 1.51 | 8.3 | 63 | -23325 | null | not hispanic or latino | male | white | Alive | 1948 | null | 23325 | M0 | N0 | Stage IIIA | T4a | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2011 | no | Not Reported | false | Not Reported | 728 | 0 | 30.0 | A0BBA530-98EA-4989-9ABC-26A92615EF27 | TCGA-WC-A880-01A-11 | 2.0 | 1.0 | 0.0 | 1.0 | 0.0 | 20.0 | 80.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-WC-A880; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.51; rna integrity number: 8.3; age at index: 63; days to birth: -23325; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1948; age at diagnosis: 23325; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1258.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 728; days to sample procurement: 0; initial weight: 30.0; portion submitter id: TCGA-WC-A880-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 1258.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3 | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | 56ed4ea2-18ce-48d4-bf72-9ffabe576ca9 | TCGA-WC-A881 | true | 23 | released | 1.89 | Yes | 1.0 | 8.0 | 75 | -27443 | null | not hispanic or latino | male | white | Alive | 1936 | null | 27443 | M0 | N0 | Stage IIB | T3a | not reported | 0 | C69.30 | not reported | 8772/3 | Spindle cell melanoma, NOS | yes | No | not reported | Choroid | Not Reported | Choroid | Not Reported | 2011 | no | Not Reported | false | Not Reported | 680 | 0 | 30.0 | 6D728871-8D6D-47B7-8A29-66870CA78A91 | TCGA-WC-A881-01A-12 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 15.0 | 85.0 | 85.0 | project id: TCGA-UVM; case submitter id: TCGA-WC-A881; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.0; rna integrity number: 8.0; age at index: 75; days to birth: -27443; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1936; age at diagnosis: 27443; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T4; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1065.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8772/3; primary diagnosis: Spindle cell melanoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: Not Reported; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 680; days to sample procurement: 0; initial weight: 30.0; portion submitter id: TCGA-WC-A881-01A-12; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 85.0; percent tumor nuclei: 85.0; | [
1024
] | "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" | null | 1065.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4 | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | 7f1e74d4-8789-4954-8a63-b0ca5f0373c3 | TCGA-WC-A882 | true | 23 | released | 1.71 | Yes | 0.99 | 7.5 | 50 | -18612 | null | not hispanic or latino | female | white | Alive | 1962 | null | 18612 | M0 | N0 | Stage IIB | T2b | not reported | 0 | C69.80 | not reported | 8772/3 | Spindle cell melanoma, NOS | no | No | not reported | Overlapping lesion of eye and adnexa | No | Overlapping lesion of eye and adnexa | Not Reported | 2012 | no | Not Reported | false | Not Reported | 610 | 0 | 50.0 | BCFE115C-4472-4221-86B3-75B122F9B425 | TCGA-WC-A882-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 10.0 | 90.0 | 90.0 | project id: TCGA-UVM; case submitter id: TCGA-WC-A882; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.71; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.99; rna integrity number: 7.5; age at index: 50; days to birth: -18612; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1962; age at diagnosis: 18612; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T2b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1112.0; icd 10 code: C69.80; last known disease status: not reported; morphology: 8772/3; primary diagnosis: Spindle cell melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Overlapping lesion of eye and adnexa; synchronous malignancy: No; tissue or organ of origin: Overlapping lesion of eye and adnexa; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 610; days to sample procurement: 0; initial weight: 50.0; portion submitter id: TCGA-WC-A882-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0; | [
1024
] | "r2GcviXRuD6QIXu+EnA6PZtpKD4ERuA+bWcVvsEIEz40++29cDAZvnog1D5vzTA90wQuO78dgb5dyF6+ZxFhPtILQb38MWY9LKMavpljSz7NfFq9gunRPrDCVz6cdNm9rDGOvvBcjL1Qjm8+OA5SPpwRDT3WC7c9Om/SPZScKz6/jKe+ODyTvobp47yrUK0+mjRWvkxMWr7QWRg+cV9Xvbu8LT7KEJo+ErgPPsXAf74pedu+CXjfPQFERr1bEPW9lb9MPkLGyL3Ff5q9uXQevsmahb1CC4a+bACWPEIqLL16fHA7gqJqvqNZ5j5iqzw/mBeevH+ozDwtwa+9NmDZPiRlDr5PsoY+QHyfvupah756KYQ+VtI+vjnKDr7C5x8+VQA8PkMppD44gw6+n3mivSM8pr2IDsI9GSddvs3NGT6qyvM8ZUwgvjHxoT20Lvm96x+Avp6XiL659lW9W8ulvmRd+D4xzLS+xU0qPnGjhz5u/IU+pVKQvJ0BCrtkWo+9ZUnqvGydhr7tUIo+jFXqPTzf7j7Gv4I8fkQ7vIpM/zzjjBU+1wS9vTs0lz37Nai9CZAOvuFN6r2TAkw++ZfwPpLEbj38ebQ9/bDvvRnn2j1gO/Y9ogVIvX3S4r5uRws9qdIzPhCPGz+fXQ6+dr6ivhlSAL0AdSm+fcT4Pr8+5z3xRgO/foGMvWeY/r01pYa+tsCnPVVWDD5grpy+Gy6QPo5hd79cB8y9rCuhvijfZj04xW+4rBnrPcwi6z3gXbU+3DyuvBUp3T5o1Z6+NCF5vm51hr60AZk+uXGFvvTqej3HQdQ9hOPsvjRnk70JE9O+XZqQPpAAkrysZ0E9UUSePldpmLtmB8m8IY+cPdEKGD4QpIm+kfeDvBuAOT4VZzm+Eyk3PqLVYr1szAy+yVp/vu4mkD66K229FreQPtQyFb1Knt69V801Pcx0NL28w/0+YwTtvWYt9z5s+JG+UrGvPLUnmLz+8bO9aTgavt4KJb+jzok8tKagPT93+r1hBoo+1vV5Psn+GTxhRQY+0YjdvKmxAr47EQO+03J3vXQUGr7Ql+u+YXIDvwEnIL5hGls8jOOJPtpajrqmeZe+JFxZvWWpYL5D20m+f+wBvx1d0D2Gatg+7LIuPv9Yuz1tPki+ZZLUvgd5Rj14YFC+mFg3PteJC7/EvXc9IQdmvgfcH74Jjhm9QvjhvX21vb7ihQ8/8l4KPZ+SCz7dax++aBx1vv9Vxj1nbpW+1boYvlQOL71CWKG93SU0PoP3YT4H84s9dxyBPo+Cir25RnO+HzS9vNwdyzwqYMQ9CRrDvCgkvL46bZQ9j2IhPcy0PT73bgq9TiC0Plg0eb5l8LPAN0C8PA/NBD+2YDg+04tivqOGQb7Kth++ymocPqau7jxEMkC9MeZePc9jb77hpBY+AgKRvSlF+j1mERq+dzyPPiE2Ij0j7u+9I506vSbvaj5juCY/DghavZ+lkD27iZU+0gAJvtMGqDxHnCk+1z+JvZwkMD6OVBW9cEqfvkQ4M77bo4m+Osfhvioon7z2zSy7M0b1vYG5c70b66O9PRmHPeJupT5ds1o+zX5VvJjhHr4aiws9glyZPsszoj5mCIA+/rqPPW89rj2Rrq4+AlG4vuMHNL7PtRI+4NvtPf7LAD4xL0O+1vCLPeu+wb5RZ5c9A4HevRjAFj5sdM48A/dRvpHM3z5LbIO+fv7PvaLs3j0svgE9m1faPk3ewr58wgc+wa+LPgwRkT72vzG+TyhnPhXgQ761V4g9ji+APKBokj7TFm09UvSHvZeIXz5sthA+DYSJvYd3Cb+Xmou+nIA3vkaekL43nuc+Gic5PkMVEL5uwiq9/pvIPk9WsD1D1tQ9B7OHPtDnaD6puxo+1JCkPiK3yD3ThYq+WTAnvDupRD3ka4k+A+22vWaAbL7aGP+8Nvq8PXH6G747HJ4+f46IPR8WEr5iEWC+jDX7vegCZj4JrG29D3lKPq8lV77aiA2/UZcJvhgIar6ZEbI9wckAv3FnMz564LS9YuU2PvyYHT8bT/+9wWWTPYmhtr2aBP0+YgodvgQlrT3bTao+2HbgvUdncz7tcSI+ITQ4vjnW7j3H8f09Gy4+vpN1FL/qtwY9WFinPBtEhTz7pH69ZQIfvtJZ+r4+uoM+Zl+WPooYkz04xQI9tR8rvsrswT7HFW6+qMmZvVFCs7zXQpY9gkoxvsAp3D4gi168jm9XPn5PdD4o4mA9xGrzPdyhTL4wJ/G8A70Hv0638T3CKDS/BCgKPjS8r76dXfE+qDppvhILX70ll4a9qd85vrTQrr5lDJW+5ltYPE41wr6QfeE9ihKGvgzVfL3RDyE+W7z+PeYuFD5LgTk8ZJ+DvpWLhj7riJ8/KZLHPJA9Zb1eiJK+qa73vk+KID00DQm8hinZPpM/tbyVZqa+qeamvjnVgb23mpg+QF9KPvjsLD6juI89SoNvPd2d3Lw6bEs9Oq3Wvv5aW77rgr6+UL/dPclxOL7RFEI9/f3vPLJ9KD7uzUC8l4M9vhfiDb7zANe8a0kVvW7onz54/5Y+mG4hPmVI9D1oIC4+JEXbvo0MlD3KUE++93Z7Pkd1pb5EXIQ+FfkmPnpRkD6Y3YU+DMPvPcLKIz5vQ2s+Za7YvbUgRD2fvJO9hELvPCaA+T2BASu+6UKpPr6iLj3QLZ2+7co+veP9Tj7lbnk9TDsaPgPs174knUc97c40Pj+s8b33Y9k97UWHPIz8ObwBt4C93qcSPKmeLD2iwRi+SUuGvcokIL3UEt09xyKxvu6JHb77LIa9jLjwPdsMeD5odWG9iAUOvneESL0vNJY+z1B0PXAqMbzIVAs/rMDmvWVn2r0s2E0+v4aHvtTuVD7o6vG8NpGqvhdn4LyfH0W98sBPPZNbGL6RBXQ8nWpTvuZP7D704Yi+Tf6hPgqlwL4EG1m9g5/4vbnwJj1Ugq6+p3NIPnGXDD38OTm+CMGTPrMMkz6FySC/HknfvVbPz73hlU6+Xi2fPl7+lr2RZqs+CCHYvS8RabxHUE6+LJEdPv6fTb4HjiQ+ABC2PDucrb3AZbg9/SCyOwwj8z2oW1C/r1K/PVBhwb0jvne+CCp2Ppz3Rb7iLZa+0WcAvtdwFL5+430+3T9EvuEoSj40zoy9ZOuxPZe9870IaeS9xTEiPY2HMbxu7FM+ze1ovUO7Fb5BxjO+icmSvvGHC76Iypq+y3VBviHH8j2ZPEc+8PgkvjBqKb4M/6O+JvfNPgkosTkIClW+CI2mPqfFBr9inw8+u+J8vtvo3r5azq2+PLOHPgqshj/G97i9tbWbPly4DT2cNpG9kXKMvmGfhT6OSfC9zwWDPpFtUr6od5u+uaamO7W3sjwl0E4/ZGumvSaspr5RHQ0/XJmkPbq52r2+/8w8fyOrPj6iV77sX1o+ID93vhOrKj6X4Ke9Ap5nPiV81T7Y3Ps80gc5vaMKeTx5doG+D+TLvsQwcL26K869MaMjvckwwr1/9Gi+Dmc8PqQyJT7pXMS+g5OhPqIHCj4ARYW+bVl+vhUmQ75V08C+692IvJq1sT3QZ+K+Fiq8vg3wqT3eev89KZOdPn75wj60CiS9L7sKvgdrn753qYY+cBPsvXLPnr5aHew9XckCvcQgEr5KDVO+1gPUPU9XVT4bT5G+xNvlPVX/rb6o3S8+qzgVPi2mSL69If09OChhPsAF1L0mAwO+OM+kPCv3nz0Zfva+FEQhvjpDG74Bu06+Hq0Pvm/XjL7emqI+VJyFPMf7iT5pxNE91foOv850Az0tZc++cd2NPZlVWL5vCK49RdrtvhJ6kj0WHN8+FX/hPo67HL6r6E6+mSmAvsQebL4Xsbw+3vuDPkc53r2cPOO9ulAtPWfoiz2YiZi+XSGGPYhH1T5UpwG+0e+uvWInbT3MIck9eEYKvit+OT4bMbu+fpcdPhVACr7Mdlc+aaKmvtfSOzv0HC8+ipYpPtFg2z5SJ7g+BJbqvJX02b5mar69hvl1vaTrQz6mYMG94cPHPx3Wzj5KUN4+wRRCPoSkdL58rAU/g/IVP2FevT0NDRI+Yt1tPtNe3D4h4h29ymyJvNFWGD8rwqK+rFN/vQqqrL97oDO9tUHFPEUkDj+PACc/4U8bvp2Jp77ho1S+utYpvsu+r72wiN89lcwnPzl4V76KXrA9Jh9XPofuaDwr204+CB9DPtXtTr5HIqE9ZzklvesNnb7h35i8a/kqva+NzD1NUbq+TtfHvdDZMj59p4q+CINjPqAepz7SL5G+LWCGvrGLyj1wLsw92vKQvhfR9T4XJiW9mY87Pp+3UD5yDaq+7LPDvQnsV77yFAu+M0mBvtrNer4AIV8+I02IvqTBwjw2rx49mTKpvl4e9D3qLx8+hfN2vCFlAT67umU+O2TmPEwxb769Qja+zQ25vVdqxD26a06+5wK8vsgBID85AgA/btt7Pp0MMb40L0s9wkV8Pgcs8T2IYsM8tFrAvjixH77AAXs+7Iq+vonfrzuM5ZE+/DndPL4lxjy+yba9QPHKPYM5FD4kiw2+q/x4PvbYYr5Rmam9iPeovtzL2TsJTZ++uU6jvbEchz2/nqe+pGBVvZHgUb5Uc54+Ax0KPuA6L74Jxvg9IuckvtHgjL7FUqc9Y1JNvEvanL66ex48lKoZPrbFCj4jnhu9Xo4sPZBOHr60SpU+HwySPso0H75gQQQ/EgakvbJxK70lTsm+Ob6AviaBtb4wHpW+BROUvueLWr6Gp+y9PH+gu2CpEr4Wbzi9SkYSParg1z4svqG+UNmEPagZB7yz1TQ8qKIhPvUuSb4U80O+bs2LPuGtyrysNUI9DGyCPn03L74d0Di9+9xYvh+15D0449k+nnaTvqe2/D2/cj0+qKn7PM3AvD5Ja+E9G9/svgcfrT6EMZQ9/zaivhUvTL5iiMW9n5mJu3o5Lz4dGZM98I3yPdhVKr0o6b09YvIuPjGDgLuPjxO+1xGnPI1qmz20QrQ7taEXO7eZLL5C4Z29QqJmPQhKCj8a/lU9e4nePLmarr0M0zW+4SXFPWNEOr7jtaS9h/eVvo7fzL3jtma+ebRuupHlKD7BWks+salfv8vIEL7fD9e9vSRuPqv+8z3J8Nk8we2MviSozDz3800+GAoNvqvtf75pLHk+BBObPmtZwr0FRxe+7dMGPj9Iqj1eJBi+YfwpPn07OT4CboW+PrOKPk9OhD6Rfoq98IyCvhl8Vb5PkfI9ivrtPvxfvjqX7XA9LtCcPnuUbb40uGK+wvQRPrREzL5wg3e+DX7QvqZvkz6/eie9E4UdPoSW/D38tTM95QjBvR383b6unhu9mP1KvvLzbT6vz/o987wLvaQTgb6oPKw+W5yiPu0ZFb6KcjU+xdx9PqMwXj1Hlr6+RDt0vjLDgT1Xw0K+SRsWvQ9qaD6CDbe9t1s5PQ4S/D0mCIE9Y79dPKTIBj7V4da+fShAvg==" | null | 1112.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3 | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | a08e4c1d-5d92-43ec-b0b9-87b2286d685e | TCGA-WC-A883 | false | 23 | released | 1.92 | Yes | 1.22 | 8.2 | 76 | -27953 | 241 | not hispanic or latino | female | white | Dead | 1936 | 2012 | 27953 | M0 | N0 | Stage IIIA | T3c | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2012 | no | Not Reported | false | Not Reported | 300 | 0 | 30.0 | FDE93561-B0B0-495F-8BBD-932EA3B7D02D | TCGA-WC-A883-01A-12 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 95.0 | project id: TCGA-UVM; case submitter id: TCGA-WC-A883; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.22; rna integrity number: 8.2; age at index: 76; days to birth: -27953; days to death: 241; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1936; year of death: 2012; age at diagnosis: 27953; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIC; ajcc clinical t: T4; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T3c; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 300; days to sample procurement: 0; initial weight: 30.0; portion submitter id: TCGA-WC-A883-01A-12; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 95.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4 | null | null | null | null | null | null | N0 | Stage IIIC | null | null | null | null | null |
TCGA-UVM | a83802da-0219-4cf1-9560-16295363491d | TCGA-WC-A884 | true | 23 | released | 1.71 | Yes | 1.25 | 7.7 | 35 | -12840 | null | not hispanic or latino | female | white | Alive | 1978 | null | 12840 | M0 | N0 | Stage IIIB | T4b | not reported | 0 | C69.80 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Overlapping lesion of eye and adnexa | No | Overlapping lesion of eye and adnexa | Not Reported | 2013 | no | Not Reported | false | Not Reported | 238 | 0 | 30.0 | 21C6D225-052E-4E12-A639-A1B671E22CE4 | TCGA-WC-A884-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 96.0 | project id: TCGA-UVM; case submitter id: TCGA-WC-A884; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.71; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.25; rna integrity number: 7.7; age at index: 35; days to birth: -12840; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1978; age at diagnosis: 12840; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIB; ajcc clinical t: T4b; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T4b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 12.0; icd 10 code: C69.80; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Overlapping lesion of eye and adnexa; synchronous malignancy: No; tissue or organ of origin: Overlapping lesion of eye and adnexa; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 238; days to sample procurement: 0; initial weight: 30.0; portion submitter id: TCGA-WC-A884-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 96.0; | [
1024
] | "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" | null | 12.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4b | null | null | null | null | null | null | N0 | Stage IIIB | null | null | null | null | null |
TCGA-UVM | f78d8541-b317-4c8a-aa66-f172a8eaf14f | TCGA-WC-A885 | true | 23 | released | 1.71 | Yes | 1.04 | 8.0 | 60 | -21978 | null | not hispanic or latino | male | white | Alive | 1953 | null | 21978 | M0 | N0 | Stage IIA | T2a | not reported | 0 | C69.30 | not reported | 8772/3 | Spindle cell melanoma, NOS | no | No | not reported | Choroid | No | Choroid | Not Reported | 2013 | no | Not Reported | false | Not Reported | 196 | 0 | 50.0 | 1D5AEA80-D8C7-444F-BFB4-1B3822C8D17B | TCGA-WC-A885-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 15.0 | 85.0 | 85.0 | project id: TCGA-UVM; case submitter id: TCGA-WC-A885; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.71; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.04; rna integrity number: 8.0; age at index: 60; days to birth: -21978; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1953; age at diagnosis: 21978; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 686.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8772/3; primary diagnosis: Spindle cell melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 196; days to sample procurement: 0; initial weight: 50.0; portion submitter id: TCGA-WC-A885-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 85.0; percent tumor nuclei: 85.0; | [
1024
] | "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" | null | 686.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3 | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | 339490ef-6cf5-4d05-81b1-5e339e95f678 | TCGA-WC-A888 | true | 23 | released | 1.72 | Yes | 1.05 | 7.2 | 76 | -28117 | 575 | not hispanic or latino | male | white | Dead | 1937 | null | 28117 | M0 | N0 | Stage IIB | T3a | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2013 | no | Not Reported | false | Not Reported | 140 | 0 | 80.0 | 513B512E-E9DF-4628-BD36-CADBF3725D9A | TCGA-WC-A888-01A-11 | 3.0 | 2.0 | 0.0 | 0.0 | 0.0 | 20.0 | 80.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-WC-A888; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.72; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.05; rna integrity number: 7.2; age at index: 76; days to birth: -28117; days to death: 575; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1937; age at diagnosis: 28117; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 512.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 140; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-WC-A888-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 2.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 512.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3 | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | 4e531546-56f1-4165-94a2-ee45abd5e0f7 | TCGA-WC-A88A | true | 23 | released | 1.71 | Yes | 1.31 | 7.4 | 75 | -27722 | 82 | not hispanic or latino | male | white | Dead | 1938 | 2013 | 27722 | M1b | NX | Stage IV | T4d | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2013 | no | Not Reported | false | Not Reported | 57 | 0 | 60.0 | 8A79DCBE-B2F9-48B3-AA7C-1F16608CF1C7 | TCGA-WC-A88A-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 15.0 | 85.0 | 85.0 | project id: TCGA-UVM; case submitter id: TCGA-WC-A88A; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.71; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.31; rna integrity number: 7.4; age at index: 75; days to birth: -27722; days to death: 82; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1938; year of death: 2013; age at diagnosis: 27722; ajcc clinical m: M1b; ajcc clinical n: NX; ajcc clinical stage: Stage IV; ajcc clinical t: T4d; ajcc pathologic m: M1b; ajcc pathologic n: NX; ajcc pathologic stage: Stage IV; ajcc pathologic t: T4d; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 57; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-WC-A88A-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 85.0; percent tumor nuclei: 85.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M1b | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4d | null | null | null | null | null | null | NX | Stage IV | null | null | null | null | null |
TCGA-UVM | 01b18f83-da8a-4d3f-b722-f00fe7559c60 | TCGA-WC-AA9A | true | 23 | released | 1.91 | Yes | 1.22 | 9.1 | 70 | -25641 | 453 | not hispanic or latino | female | white | Dead | 1941 | 2012 | 25641 | M0 | NX | Stage IIA | T2a | not reported | 0 | C69.30 | not reported | 8772/3 | Spindle cell melanoma, NOS | yes | No | not reported | Choroid | Not Reported | Choroid | Not Reported | 2011 | no | Not Reported | false | Not Reported | 959 | 0 | 30.0 | A910FE6E-4D5B-43F9-88D9-679147FEA50F | TCGA-WC-AA9A-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 97.0 | project id: TCGA-UVM; case submitter id: TCGA-WC-AA9A; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.22; rna integrity number: 9.1; age at index: 70; days to birth: -25641; days to death: 453; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1941; year of death: 2012; age at diagnosis: 25641; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIA; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8772/3; primary diagnosis: Spindle cell melanoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: Not Reported; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 959; days to sample procurement: 0; initial weight: 30.0; portion submitter id: TCGA-WC-AA9A-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 97.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | N0 | Stage IIA | null | null | null | null | null |
TCGA-UVM | 4480d290-5e8a-4289-8e3c-de087e0de412 | TCGA-WC-AA9E | true | 23 | released | 1.91 | Yes | 1.79 | 9.2 | 60 | -21976 | null | not hispanic or latino | male | white | Alive | 1953 | null | 21976 | M0 | NX | Stage IIA | T2a | not reported | 0 | C69.30 | not reported | 8774/3 | Spindle cell melanoma, type B | no | No | not reported | Choroid | No | Choroid | Not Reported | 2013 | null | Not Reported | false | Not Reported | 272 | 0 | 60.0 | 28ADDF38-07FD-4354-8F17-C0E4310514C9 | TCGA-WC-AA9E-01A-11 | 0.0 | 0.0 | 10.0 | 0.0 | 0.0 | 0.0 | 90.0 | 97.0 | project id: TCGA-UVM; case submitter id: TCGA-WC-AA9E; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.79; rna integrity number: 9.2; age at index: 60; days to birth: -21976; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1953; age at diagnosis: 21976; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIC; ajcc clinical t: T3; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 838.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8774/3; primary diagnosis: Spindle cell melanoma, type B; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 272; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-WC-AA9E-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 10.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 90.0; percent tumor nuclei: 97.0; | [
1024
] | "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" | null | 838.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3 | null | null | null | null | null | null | N0 | Stage IIIC | null | null | null | null | null |
TCGA-UVM | e00ce846-9a0e-48b5-be9f-84d443a0f78a | TCGA-YZ-A980 | null | 23 | released | 1.76 | Yes | 1.07 | 7.2 | 75 | -27716 | null | not hispanic or latino | male | white | Alive | 1935 | null | 27716 | M0 | NX | Stage IIIA | T3b | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2010 | no | Not Reported | false | Not Reported | 1307 | 0 | 90.0 | A0ADAAFB-31A4-468A-9543-F4DFCCBCF0DC | TCGA-YZ-A980-01A-11 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-YZ-A980; source center: 23; state: released; a260 a280 ratio: 1.76; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.07; rna integrity number: 7.2; age at index: 75; days to birth: -27716; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1935; age at diagnosis: 27716; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T3b; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T3b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1862.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 1307; days to sample procurement: 0; initial weight: 90.0; portion submitter id: TCGA-YZ-A980-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 1862.0 | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3b | null | null | null | null | null | null | N0 | Stage IIIA | null | null | null | null | null |
TCGA-UVM | cba920f4-c57f-47bc-958d-9b7872df01c8 | TCGA-YZ-A982 | true | 23 | released | 1.87 | Yes | 1.16 | 7.2 | 79 | -28938 | null | not hispanic or latino | female | white | Alive | 1934 | null | 28938 | M0 | NX | Stage IIIB | T4b | not reported | 0 | C69.90 | not reported | 8772/3 | Spindle cell melanoma, NOS | no | No | not reported | Overlapping lesion of eye and adnexa | No | Overlapping lesion of eye and adnexa | Not Reported | 2013 | no | Not Reported | false | Not Reported | 178 | 0 | 90.0 | 6D118D76-61C0-4643-A525-53E3313C149D | TCGA-YZ-A982-01A-11 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-YZ-A982; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.16; rna integrity number: 7.2; age at index: 79; days to birth: -28938; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1934; age at diagnosis: 28938; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIB; ajcc clinical t: T4b; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T4b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 495.0; icd 10 code: C69.90; last known disease status: not reported; morphology: 8772/3; primary diagnosis: Spindle cell melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Overlapping lesion of eye and adnexa; synchronous malignancy: No; tissue or organ of origin: Overlapping lesion of eye and adnexa; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 178; days to sample procurement: 0; initial weight: 90.0; portion submitter id: TCGA-YZ-A982-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 495.0 | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4b | null | null | null | null | null | null | N0 | Stage IIIB | null | null | null | null | null |
TCGA-UVM | df291bbf-fc62-4c40-9582-289ac78225fd | TCGA-YZ-A983 | true | 23 | released | 1.77 | Yes | 1.45 | 8.4 | 51 | -18769 | null | not hispanic or latino | female | white | Alive | 1962 | null | 18769 | M0 | NX | Stage IIB | T3a | not reported | 0 | C69.30 | not reported | 8771/3 | Epithelioid cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2013 | no | Not Reported | false | Not Reported | null | 0 | 40.0 | 04B1F253-2351-4BA6-A289-A22BC1E19C35 | TCGA-YZ-A983-01A-11 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-YZ-A983; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.77; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.45; rna integrity number: 8.4; age at index: 51; days to birth: -18769; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1962; age at diagnosis: 18769; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3a; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 798.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8771/3; primary diagnosis: Epithelioid cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to sample procurement: 0; initial weight: 40.0; portion submitter id: TCGA-YZ-A983-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 798.0 | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3a | null | null | null | null | null | null | N0 | Stage IIB | null | null | null | null | null |
TCGA-UVM | 743fc661-9ba2-4fa8-966e-508fb4b965e0 | TCGA-YZ-A984 | true | 23 | released | 1.76 | Yes | 1.42 | 8.3 | 50 | -18342 | 1396 | not hispanic or latino | female | white | Dead | 1961 | null | 18342 | MX | NX | Stage IIB | T3a | not reported | 0 | C69.30 | not reported | 8770/3 | Mixed epithelioid and spindle cell melanoma | no | No | not reported | Choroid | No | Choroid | Not Reported | 2011 | no | Not Reported | false | Not Reported | 971 | 0 | 30.0 | ECC9EDD8-CE51-49B8-9B3A-52D69920080F | TCGA-YZ-A984-01A-11 | 3.0 | 0.0 | 0.0 | 0.0 | 20.0 | 0.0 | 80.0 | 75.0 | project id: TCGA-UVM; case submitter id: TCGA-YZ-A984; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.76; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.42; rna integrity number: 8.3; age at index: 50; days to birth: -18342; days to death: 1396; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1961; age at diagnosis: 18342; ajcc clinical m: MX; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T4a; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1280.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 971; days to sample procurement: 0; initial weight: 30.0; portion submitter id: TCGA-YZ-A984-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 20.0; percent stromal cells: 0.0; percent tumor cells: 80.0; percent tumor nuclei: 75.0; | [
1024
] | "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" | null | 1280.0 | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4a | null | null | null | null | null | null | N0 | Stage IIIA | null | null | null | null | null |
TCGA-UVM | ebdabfcb-1c68-4ca1-8b7f-3ea9cdac3a6a | TCGA-YZ-A985 | true | 23 | released | 1.78 | Yes | 1.48 | 8.0 | 41 | -15164 | null | not hispanic or latino | female | white | Alive | 1971 | null | 15164 | M0 | NX | Stage IIIA | T4a | not reported | 0 | C69.30 | not reported | 8772/3 | Spindle cell melanoma, NOS | no | No | not reported | Choroid | No | Choroid | Not Reported | 2012 | no | Not Reported | false | Not Reported | 595 | 0 | 40.0 | 61572A15-D011-4E41-A539-1FDB521F64F7 | TCGA-YZ-A985-01A-11 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-UVM; case submitter id: TCGA-YZ-A985; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.78; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.48; rna integrity number: 8.0; age at index: 41; days to birth: -15164; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1971; age at diagnosis: 15164; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T4a; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1184.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8772/3; primary diagnosis: Spindle cell melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 595; days to sample procurement: 0; initial weight: 40.0; portion submitter id: TCGA-YZ-A985-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 1184.0 | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T4a | null | null | null | null | null | null | N0 | Stage IIIA | null | null | null | null | null |
TCGA-CESC | 5aeac31a-176a-4f93-a376-a93a670821bb | TCGA-2W-A8YY | false | 23 | released | 1.83 | Yes | 1.19 | 7.2 | 51 | -18886 | null | not hispanic or latino | female | white | Alive | 1962 | null | 18886 | null | N0 | null | T2a2 | not reported | 0 | C53.9 | not reported | 8560/3 | Adenosquamous carcinoma | no | No | not reported | Cervix uteri | No | Cervix uteri | Not Reported | 2013 | yes | Not Reported | false | Not Reported | 93 | 0 | 120.0 | C24A4F00-23CD-44A4-B8B3-580A9CEAB16A | TCGA-2W-A8YY-01A-11 | 30.0 | 20.0 | 10.0 | 30.0 | 0.0 | 20.0 | 70.0 | 70.0 | project id: TCGA-CESC; case submitter id: TCGA-2W-A8YY; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.19; rna integrity number: 7.2; age at index: 51; days to birth: -18886; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1962; age at diagnosis: 18886; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic t: T2a2; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 533.0; figo stage: Stage IB2; icd 10 code: C53.9; last known disease status: not reported; morphology: 8560/3; primary diagnosis: Adenosquamous carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 93; days to sample procurement: 0; initial weight: 120.0; portion submitter id: TCGA-2W-A8YY-01A-11; percent lymphocyte infiltration: 30.0; percent monocyte infiltration: 20.0; percent necrosis: 10.0; percent neutrophil infiltration: 30.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; | [
1024
] | "6DigvuRUtz5lZVG+yzCJPfFvWj7zz8Y+WCY5vq0jIT6kHRC+L58HvqQY0j4eYck7HCsePTUYWb4w3Wy+HlAlPqo8zbt4wT88MJE3vvasSz7BcgS+Y2rlPkElKD68eYK98uqBvk+Sub1XOKA+9z51PqdDuD2E1rA9/aEMPjoaQT6Ad4y+ISicvmEYUL3jNuQ+u/BxvoQpNL5hHUc+17fKO0bwvj2wZ5g+uqUnPsEXXr5Zm9++ad6HPdgaN7ytQDW+euIuPiERGb6VUNO9T++rvVZUZb0uVpG+GDDTPQO1db0oBZY8rI9vvqqgyz5cXEY/nYVfvPNQxDvpzPm9KrUGP4QjKb6bPYI+rAmWvgtMoL56vYk+zxdcvklR6r0tC2U+IsuKPqJqiT4jyDi+MERzu4Kbar3feAE+MAgYvgd9AT4HS5k9QucKvtoizT1SWeC9kb6Avio7kr4wwT69rF3IvuCj1j4aGaW+cQ0xPk6vlT4H4VM+KKF9PGC9MTxt3Hi9+IArvQOKM77S5pk+Xw++PZfO0z7b0yI9jYQnvTmARzzrdwM+GEnvvdEykD14mcu9OVIyvuQPG76lvBM+h7/GPvaZ77sdiAw9bipMvR5w/j2joTQ+1pX6vNAIAb8U0DW8BMoyPhKqNz+e7Ei+PyuGvt6cgTyv0kG+/LgKP0gK4D1huQ2/0oN+vf6jSr6RmIi+VH/jPdJXFT48N3u+XFmuPpF2eb+CfgS+36CFvin0UTxec089yYnlPSZt7D1nPcU+SNUMvb5qwj7EAKq+Gkh5vsvdiL47tW0+zL1rvqpuzTxMCeA8wT/wvi3BL7z2WNe+0TukPhz5Z70bZpI8m36qPvJu2bneeCu877qAPbkh4D0cwq++f29IvQj29D3ttFW+JUhIPjuFbLzfvTu+UH16vpDbjD5bBZu9lPSMPghEo71U6Mm9wPEyPSo+aLy5Mus+U/X2vSmD/D4nOpu+R8tavAIter3DQI07u4wpvtuxMb/WOYc8TXSRPQyML77ZbWQ+pfu6PjUngb39ipU9j/LAvea1CL7o7K29uc35uquq771HZva+OL0BvybuGL6dl4k8UJiyPmJwoj3JD6m+9959vd39NL45YF++a6X5vrKnIz4nVck+fLBcPvhgPz3Beo2+SqTGvp22wD0TpT2+7C4NPikPGb/xV1U9t+FHvr28Bb64Uj+9A94IvvDrs77a1vY+Has+vPJRoT2avAC+keeJvtjmCz0ULYy+vIkDvuNvx71aldu9LIMJPllHcj6KcSw9zBuDPhwkYb0jkUy+gTUMvfsVyjwH8xA+FmmzvYHonb405eg9+XcgOgCckz37nGO9Cue3PhTiW75t1rLAaWGDvUftCz/4I0E+08hMvhVOY76k0jO+wJYnPoRH87wQIWC9x7KgPYNzh75HHdI9WCEsO29hwz1N0YC+yVliPmWR0D1snxi+GO6rvSoFYz46UiU/twcGvjktCj1TAIU+aFjnvU+2kTxlngc+wz+pu7+X4T0jqBS8VSSevrjb7r21d5K+p8Pevsu/p71xxPS8MQcMvtlLG72xKMO9GY4/PVkJoj6M/GU+RzGCPRsN3b1mwMY80SO0PugEgz7VnrE+PoIuPiFNnT3JKZs+AGbKvsAvRb6LHxA+zznGPSDf8D2anT6+L7o3PY/3mL524uQ9AY5SvpauCD4rP988B8F7vsNzwj7xdFi+FLksvtrCOD6KEwU9L3XgPjmhtb4c2xA+pyScPm+jlz4c6wu+9RiAPg4cNr6OWgI+9+K9PDOpcz5iQJk9moMMvrE5ZD7TBL09qniOvbKoEb/EHoS+HF4nvpzniL73tfc+iYwpPjpc/b337v087zTaPsQ1Rz5ZENw92Y2VPsWGkj43Mlw+tODNPle8xj1E47W+uv8hvOAJsztITYA+WZuivVB0mb4cmNQ70wUXPWfOB75mt5w+rK6tPdQKtb3ViEe+4sjkvZUnND5c5hW+SY2bPqcLfb7iaBu/IpUAvugjmL5qV3k9IJbrvuwzXD73Eom9Od4sPoGULD9+JlO+4TY/PRMlBL3bL+0+wNwDvgat/z2xjpE+m37kvSOJbT7kZ0E+R/5vvhiPgT261kA+aOxSvjFqKr/YsKs8dze6vDFSiToGe2m9CuchviU4374IfJc+ZzCgPiblQD13q2c9oIduvrm+rT7Gex++qngrvbjIBLy7XIw7VeMovtj63j6lSDK7Hek5Pl7DUj7nrcw9HR7xPaFyhb6kfIA90kQBv7+fmz3l7za/Tz86PgX8x76yHgE/WMNkvpR0ub2mLWa9vv32vZJVuL4UkY2+JZjBPM7hwb5Myk8+Uu9mvgln7TxhQpQ9vG7XPf0JJj6HRJC9keyDvvjgpT5iqJ4/Dw12PY9Dwr3Zo5++LL0Lv1IBLD1zjoG7tgK6PjOQQj0dvbm+P5uGvprw0r2KXq4+cyCpPag2Jj74UQ4+qp7IPVLf1bwYr3Q9b0nPvv36Q75OG8S+krCPPfapDL5sdw67dvosOtgq+D1Pdvu67i32vcaRGb7uqt29rraKvd1eoj7ywHo+VloiPvX6bz2RdjI+zsm+vsWhbDw2zIK+N92IPqqPmb5doXI+m1xUPk6vpT5wZFE+pH/SPUr+ej4F8I0+irosvYjnsT2xgAi+AS2ePMmLHz7aihm+uNKyPuI32D1ZE6q+jAVDPATFbD6RlaE9AjPRPcITkr6+hls96jE/PmCB/r1mBZ898JcYPepeYD1fn8e9fyE1vZRtoz2sf02+9TapvN84fL1iXPk9VGfMvn4aSb5BOTO+xNdzPaBhgz5voda954O5vUOmAL2JYYM+ndGdPUF8H71jxw8/9MMWvvDUBr5TxTI+iAeVvgoPXj75ikM8B1qRvoEW0byfl7q9dZCLPZvcn70odJs8exqBvpEu9T51d4C+npqePuqWlL7fRfS85nkIvr0rhDzFlsm+x95dPqQMND1Urme+2v+yPsPKnz46WAm/oNQdvpgW772Vy1O+QheEPtHFtb2GjrA+dShgu5+s0zuqwTG++ZbRPQPXJ752zjo+gtCau8+qcb1uNZY9F6d6PYvHGj7oxke/1ofqPdkbCb7yFIC+sRpDPrhOLr5aQ6e+M+GYveanBL49hoo++fZXvsAdjD6R88a9uRjWPRGkVr66/hm+WknfO0CAJD2KsFo+AhcTvWYN4L38ViS+e5mRvp0pEL7WPpm+I71SvljPJz4OdQ4+2p4MvkwiMr4cZZa+dZ7TPnYtjrtf7zq+J0i0PowyBb9HgxI+VzRyvpDZ2r5yPK++RDlAPl9chD8qXdW94+5/PrydIz2tHL69mX6LvtfrLj5GqTK8LFWQPrJ/lr5z5KS+X0ypPDbpLj3gCF0/LYPRvWXzmr5dqAU/F4OjPW/4FL436pA9ikDBPvaREr65kY4+k5o1vrciRz6ZGgy+v/6GPjqA5j4RYDC7wGVtO3mHpbycHZ++25e7vtTKqL11Wbi97DbDve3SP71Ur22+81hFPtq6BD5PeNe+CXufPtA2NT4N0YW+Lq9bvi3ue76dnLu+aTxgvMlfpD3zK/G+w9TAvt87PD6BfSk+8IK3Puby2T7RsgM81+8WvrdAr75DmW8+iwRCvouvm7418aE99TuIvNq9Nb6wc2++LbbRPdaVZD5m96i+U4M8Pny+s77SsG0+3w9wPXlzPL507Uc+/PtBPn/Zs72RpMq9FlRGPa/QWT3Pm/2+gOAKviI7Yr56umu+Gt9Hvvg2db5tUJs+5P88vRH6ij65TaQ9d+scv3piA75kFNK+P+yTPZpskL4N68s9WpbvvqdQ9T3MP9w+4uPqPkMHg76FdUq+QLZfvnTsO74SxcE+UBJsPu9Ltr2GFxS+aB5zPUIG4D0EHZO+QyYqPfuP3j7IHYW95F0KvB4DDj0ioBU+X9LRvYSmDD6tt8O+va/MPahJKL7sf1I+EY+vvrgLCjzq/1s+gzUrPoHZFT9a8bU+IymiOtGK0r6Lg1K+Zfegvb8hXD6Knja9lKDAP2l2pT6maMw+gkc/Pizxor4wZ/A+jR4YP/eqlT2ExB4++cp/Pjh50z50RM29Uhb3uwOVJD8keq2+1uLQveDZsr+jk3y9F0xpPaGYFj8uazg/DGItvuoOtr6m0Uy+HW8Xvsnhsr22EtE9ThAWP/CWPr4e9y8+TO9GPhg0qb2zmqE+toGBPhhhfb564f89ATa2vbYmfL6stS89QQiGvHwI1D0H9Nq+6LICvrMiMD6Ehoq+BwCBPotkrj7ds6y+MXagvr/Hoj2GJTw95z2qvrggED8HoIM8KjCCPt7/gD64w2y+HLn5vWj2Yr7sEyG+Ewdqvln7gr6IQDs+NbtlvkLeID0YeOQ99Q6ovsQaEz6IF0A+2If8vFxSFj5a+qs+QDEWvfMMgr7cICa+jOCKvQ0nWz1GADO+ZnDcviqKKT+EGxE/68F3PmUL+71nZTQ9xspBPr73DD7ux4U9oB7uvlqhCb4SlnE+GOPAvkA3Tjy1pY8+65H+vA4Igj0aqLG9IKzAPTo9DD73m829yqRSPtnPU75UluK9iZS1vplJYbxDb9W+aUJCu9F1gz33/qG+3bVWvZMSXL5zYaA+FKy/PXypab68qqI9UtfzvQF1kb5jE+s9EKZnvOI8o763yEe9E7sNPq/mDT5Ek6S8MtjLPEgQOr5vVJw+q6KlPo2lW75q2+4+G6jFverD1r0i5ca+FvWdvuSP5L4La5i+vmZ+vsrHeb5FpQe+brZPvPD89r3+71y9TsyGPeNy6D6gmqW+Ei4lPXIqgzyr2gw8PQkePni3VL59zle+3z6OPtdkN73Wapk9rzxJPkHQGL5hKl89vhUYvhfRpT2ekeM+WmmCvvb1ID6SZ1g+JMy7O8492D76FnI9/bX2vgn52D4gu509EqaZvj0IRL6HOOK92YtBvZQNAT4gEh0+awXaPe2spzx5UxE+rf4yPjN/eD01AiO+/DqCu1xdAT3eXOE9WJHhvMXTD77aIqK7QB1bPKx6/z6fTgk9pzsuPDir572LZEi+AnxYPQmwRr40IBi+JAKcvvWnnb1+yT6+sAvIuzilDT6M4Tg+uA5Sv3L3Db6GjIC9wwY5PlZxIj4kU088CyJ5vonUobxsy2w+MOnavTYrh75R9Vo+PK+KPsK/9b0IP+295a+SPZS7qj3Wu8e9XBVuPmpjhz5JD5a+dDZhPvaRgD4wjse8/iqBvudFeb7PLSQ9x9oOP0u2TbwAeC895WyQPl/YQr76dAy+l0PuPZlz277qHoG+kckBv9WMvz5P3Sa9x+ENPumxBz7b51k9N92wvT0/0b5MpBu9bShYvnov3z264zI+vK76vOi6jL7lIas+0h/EPr6y3L2phX0+C4hpPqx9pDwo5cS+duJLvv/GCD6dDym+htt2PPvveT7jMGi92eYvPQQE4j19xgw9Dx4YvQM6wD3My+m+aQpVvg==" | null | 533.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | M0 | null | null | null | null | null | null | null | null | Stage IB2 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-CESC | 53eac147-7eb8-4c54-a982-5e058d6749f8 | TCGA-4J-AA1J | false | 23 | released | 1.82 | Yes | 1.92 | 9.4 | 31 | -11611 | null | not hispanic or latino | female | white | Alive | 1982 | null | 11611 | null | N0 | null | T1b2 | not reported | 0 | C53.9 | not reported | 8070/3 | Squamous cell carcinoma, NOS | no | No | not reported | Cervix uteri | No | Cervix uteri | Not Reported | 2013 | null | Not Reported | false | Not Reported | 80 | 0 | 590.0 | A052742F-3CD5-4881-B004-A7E13ECDC9C2 | TCGA-4J-AA1J-01A-21 | 5.0 | 0.0 | 5.0 | 0.0 | 5.0 | 20.0 | 70.0 | 70.0 | project id: TCGA-CESC; case submitter id: TCGA-4J-AA1J; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.92; rna integrity number: 9.4; age at index: 31; days to birth: -11611; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1982; age at diagnosis: 11611; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic t: T1b2; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 542.0; figo stage: Stage IB2; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 80; days to sample procurement: 0; initial weight: 590.0; portion submitter id: TCGA-4J-AA1J-01A-21; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 5.0; percent stromal cells: 20.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; | [
1024
] | "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" | null | 542.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | M0 | null | null | null | null | null | null | null | null | Stage IB2 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-CESC | 39a3120c-0889-4a10-816a-e07528a35f7a | TCGA-BI-A0VR | false | 23 | released | null | Yes | 1.5 | 7.5 | 53 | -19473 | null | not hispanic or latino | female | white | Alive | 1953 | null | 19473 | null | N1 | null | T2b | not reported | 0 | C53.9 | not reported | 8070/3 | Squamous cell carcinoma, NOS | no | No | not reported | Cervix uteri | No | Cervix uteri | Not Reported | 2006 | yes | Not Reported | false | Not Reported | 1554 | 0 | 100.0 | BA4A1AA9-C1C7-4F84-A375-02B51FB95494 | TCGA-BI-A0VR-01A-11 | null | null | null | null | 0.0 | null | 70.0 | 70.0 | project id: TCGA-CESC; case submitter id: TCGA-BI-A0VR; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 7.5; spectrophotometer method: UV Spec; age at index: 53; days to birth: -19473; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1953; age at diagnosis: 19473; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic t: T2b; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1505.0; figo stage: Stage IIIB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: yes; alcohol history: Not Reported; cigarettes per day: 1.095890410958904; pack years smoked: 20.0; is ffpe: false; composition: Not Reported; days to collection: 1554; days to sample procurement: 0; initial weight: 100.0; portion submitter id: TCGA-BI-A0VR-01A-11; percent normal cells: 0.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; | [
1024
] | "v2vPvv61xD64MVW+Ojs1PRvAgj4DMtk+3qoTvmH0Mj4oLwW+d/sPvgUjzj6sLvM8Vc20PAqWCL4nJIS+MsYDPs16Lb2em4S72jFHvq2cMj4eOQG+lIvbPhDEMz7GXcC9+ZKGvlv+8r1UHZo+cJB0PsJ45z2JGLY9WrcSPqAUXj7Ha2q+2e6Tvl03xrxkXdw+ieCBvnekUr7WmTg+W4+GvP4kqz3nE7Q+m8YmPkVVg74IiuC++XpOPaf3cLxQ4E++bNtZPl9PBb5NPe699z/NvfPwX701D6m+7n6iPfqhNb2w2hQ9l1dnvmcb2D4i0Eg/NixVPRxTs7yfPbW9wSjpPo/lDr6RRWk+WFqTvjKhk75wNpU+GwFivr146b1vB1g+P7l3Pt9HiD4/mVm+Dwb2OnddSL1TAgA+MvMFvsTZAz4i5as9sPskvukAxz3lFMK9ZKlbvqSLgr6o5iq9P0azvjUV1j6B2qC+UxArPteRoj4stlk+GXSHvDS1s7zPaYi8kaZNvS5mPb4Cma4+wbD2PZZlxD6iJ5I8XhCkvZGBV7sQgAw+vMEKvgrbaD1nj7G9S75MvuN1BL40kRg+I1LmPm9Gl7u1DiA96WYVvaZeDj7rtzY+8RBnvP6bBr9l6QK8pf4aPj3FOT+teGy+urprvt47AbqKfhy+oqsMP0Pf0D1P8gu/56d9vYkMZb52c4m+0A/DPRyvFj7nRmG+EQuwPqmOf78iUwq+futuvv3vo7u2CGw98svSPUmOdT3q3bo+1VVRvbIzyz6FzKa+9rx+vuAsS74nFJQ+AneCvg0F4TzwfYE9fLLmvoRjd712+dy+9YqqPonrYr2h9GI9Wv+nPvVjwby5+c67Dje7PREXkD0AbKC+HKuMvdSB+z0HxYC++AcwPkLR2jvv8iq+mzB2vvWJiz6UJ4i90Sx+Pm1FTb3SK7K9yGKePfM5ej3rTAY/holvvZyZCT9nOLS+R8PhuUdvcr0o7gk8uH0KvkR/Ib9kWmo8yZHMPZRK7705UFE+lkOtPskHoL1/bmE9uk3xvQQdE757HKK9tavSOz7fD76JgPq+FKwEvwUULb6FmQw9R7SnPmOTRD3tmq6+xDykvc9PPL4cl2G+9HD5vjJ5Uj5W7do+Z3djPoC7MT0FrJy+IS6tvnuRqz0eaU6+Ojk6Pgo0Gr+NlSE9/+xKvp1qHb45SD+9xsn4vQVNtr5CXgw/0ja0vIy7gj12Uc+9Mw+ivufwgDy83Y2+UPDQvaKyIL39/fe99loIPgbVjj6NNMI9XxyDPumbLb0fmmC+/qDjvEo+Oz3qmBg+z7/Qvf7osr6ccOY9aGagvPH7Vz22KLu8bXqnPqKuK746ULfA1FrRvDQEDj8zWS8+Q09zvij5I74evkW+7QAgPgEaU70vEaW9jlvJPd7bdr6pC+c9sNtyu/ub0j2L0XW+KUwtPvry0D0RFyq+b0ytvTS9HD48mCk/7Vn5vagNsj1N1IA+AUPVvZV3xzzgrvI9Zr+FvEKZ8z1sfjS8rA+rviS7Bb6nU5a+yj7eviZurr247r682+w3vivUJryB5DG9AZevPZkQlz7EfG8+h/MLPTYuX732PgY8Os+0PmBtjz6en60+cGciPs3Ssz0gb7I+5qy7vjlgU76u4yA+sWqQPUYDBT6xe0i++7uWPeOjfb6sJY49N4hRvhU45T1vOro8+yNxvpUm0D4FFHa+yeoCvkqqOD52Zdg7wnfkPjzitr7/JRE+1kCyPs6ymD7AyBK+wh9hPoy8V77kYgI+suv3PBk8gD4+V0g9Rl0Wvt3NXT4OTFo91vmpvRn4F7/WLI6+BKMavj6ukb4Dl+8+WM4uPg/i5r3uCPc8TqDuPufpMz4zBuU9FViZPmPLiz5sLEQ+IcTZPqNMcT21Eq2+92KTvHv9MTx6+IA++yOpvZOblb6pRhi9gN2iPW3BJb6mgJk+FgTNPUix4r1yhkm+I9f5vVhQET5VP629is6HPtRIf74kfSi/8m/uvWGjib59YYs9hAzwvrPOUD6jBlW9rMH2PZckLT+e93W+VE2VOzqTJb1rbQA/Ebf7vbUYCD7dLYg+vFqnvfdLcj6m7ic+3RaIvs2idj0kETE+9UJcvgvEJ78NWR48VxKavNnLDLyDKaa9stj9vbzCxL4aF54+ItWvPgCq7j0r2JY8szp+vjfsxD7vfSq+OH7WvLi9cTypZBq8UzoCvkaN0T5qIoM7LtUtPms9LD5aB+c9pAGpPf28Rb4bmN89a/ULv/LjVT1h9jm/Bw9XPmFb277xWws/PuNhvg1ZtL2/1+C8iWDbvX7jrL6U35G+IxvLO8NozL4Zw0c+NpJIvhPvfDtBMsM9e7HrPU+pEj4P3ja9+rmDviVppz6siZw/eGrePHF8hL1/2pm+zdEJv87n5jwp0sk8/jyuPtX6oz3miMa+H+p4vkSIGb4m6cM+bceMPUePOD7O3xI+h+TPPbJtbjyugzE9Hh/evuKbIb6gvsS+h2PZPfPCGr4hXmg87RlBOzmcJj4Lboc8lfALvuDBW76X7Iu9QNVBvaUYoj5BenE+Pz4jPtREzjyVLhk+8PvBvjq/Xj21ynW+HmuFPjaQjb69NIA+Fj1lPta0kD4UbVE+Y8/RPcBQhj4b7Is+e+w/vcGWpz0+NBq+sSlWugPAAz6s5C2+teWgPmomKj5n07a+5xCtPIlFcz5lN9Q9o6bjPb2InL55/JE9zMFXPpTUob36otg9/sODPUoloDzuvfG9TYVVve4mlj3zsFa+J3YEPHD3r717hBQ+7yLRvsX2ab7EBxu+F/rcPA+UbT4ebwi+6NGkvXhtKrx4V40+jOTBPR4dcr0JvxI/ZU41vqCMyL3Tki0+cWaSvnNaaT7G1fW6QCmdvlR3C7yDfzu9viZiPX/h5r1Ggd28qxaCvg8e+z6DC4S+pvaNPtC3pb4jZuC8kLDNvay3hjwHz7S+5a5XPuK+rDvq2V6+l9C9PtRRfz4RbAS/xCsNvvQoM76UIyu+sfR6PhmHzr1wULQ+hccFvfrVVT1IRTu+ndXcPZWqQL5YCzg+J+6HvNsQr73gJJo95vGjPamrHT5K1kS/xruNPWTQ9b3F+IC+JStWPkrXW76NjaW+HZq7vYIs/b1dMYM+tMxpvjM1ez6WZdC9aR0IPpgkUb7nrCq+rw3kOu8k9j3AN00+Ge2LvdiO3L0DXCS+m8ifvnDA072w46i+Rm5JvqnjIj477QI+X5wGvgvhW75eCou+5tbSPrr+IL0NrFm+XVXBPv3uBr+Prw8+T1Vtvipt374bA6S+QQY0Pv+NhD8a4oq9R1hxPpfTFD3Oh+e9wrOGvqBBTj7v60O9dZqKPlh+kb5xIae+fJoOPaVHQD21wlg/lKetvVyfmr5YGf8+B8SpPYlrEL639ZM9FcfOPqQvEr4/+YU+GYovvoXNVT5na+O9gOCIPltC2j6RAis80eKBvD+0D73suqu+cza+vjKF2b0XiSm9Ghuyva+JO72u8mS+zQgzPpOvuT0H8t2+r92kPl5YOz7dbpS+QqRsvrKWib69PK2+ZPQJvT8Jxz1PDeq+curVvmFxMz5vvSk+jDq2Pq7tzz6NU5I86xj0vdOCp77WtYM+vgc7vjpPoL5lmnU9ZemYPB0mLr7w/Iu+S8cDPqwJgj48BtC+NnlaPnsttL7FC3M+n57CPY/3K74FDV4+STgzPmPWu73zHsm9cVQTPVP2sT200Oi+qRESvpTtHr52/UO+PfFQvhErg74mZok+dud5vPidfj6pwKc9hY8Yv4QdFL7Uy7S+HXWAPX63qb7Jk+c9/STovusalj3cH9Y+P/H1PkVbQL6mgVS+E6xzviIgR77uV7g+BilQPsiOsb3JrxK+5bqSPY7BJj7KsZa+CxswPZQH3j4PuKi90TOMu1EKsTwrTBM+R+ASvoda7T0yCa6+yL2NPYV6BL7dKTk+meXAvhKNWjwML1I+8BscPoI0Fj/8XKM+YLKFvNqO0L4FyDm+D3XjvdS+fD42XAe9+nXBPxWfmj7JF9M+DoUxPsJvnb5f4uo+VP0ZPxrPxD0Lbdw9G9OUPlsUyj5E2iG+4eJRPFcNHD9Iy6i+1uGrvYVTsL9/2t28ztWDPXOLFT/5kzg/XrhfvkqFr777/1i+Cd/5vZssib02Aaw9vlsQP7zCQL6UTB0+Wq48PkvFsL0+yZI+X1SHPmjeWb5aJpk9oKxfvbYjeb4p1jQ93/aLvIcsyD1LSei+WUQRvuHuPj6lSnC+uWdtPgkOuD7rK5++H5+ovhoXDj79VVU9sCGvvsZkDj+yhQO8a0yIPrIfiD5U+4W+elC3vdziSr62wB2+D5ZyvsbydL4/xUU+4+p9voJcMz2WpZ89F4uqvvdeFD5X7yw+pAg/ve2VJz43aaI+XE/UOtILf747dQ2+6/9rveVPNztoXRe+jRDEvrs2Gz+GSxE/P4RnPoSt9b3uSEY9QuxqPuUnyT1UAqc9/bDhvjptBr5ug3k+qJ3CvvPxlz2g5Xg+ouPkPEXHGj2T6yW+DMe4PXp0Jj63H7G9FlYtPkcQYr50WMy97di8vt7lbjz7i+W+2tRYvBRRmD05GrG+kwMUvWXKYL73hZk+9iQDPsr6S76G4Zs9ZWgBvu7+h756cvE94xTdvOFbsr5+rw692I8DPufhHD5YNrW6PZWcOVQyIL66caw+DUGXPk7/Lb4rhfs+jZ7pvUSrA75+1de+t/6Bvpe8476UfYq+lPeGvtmPer4MUd29f063vGtmJb4bqGO9m5bQPfDZ8T54Maa+G38vPVfxIj20/Um8nCZAPkLlNb7AYGi+xJiYPj6mQb1Lao89xQ4yPuVGJb7Ikkk9J3QvvliiGz2mJ+8+J+Jqvvoaxj1aZ04+X6LdvFb29z5B0rg954P4vhqT2z6fato95s+EvnGNHb5Q/Y+9HlaDvbLf2D3gLB8+bfkIPpmgOD3EnR8+AYslPkT6aj26nmO+b773utGEEj1yrv49mz2evGkjR75Scz28oE+2PGSg/T6GtZ06TLIPPaCzyr1+A1a++nS4PW/6U76hdwC+LDOovls5y71SoFC+DIeZvVgfKT4MIx0+/xtYv7QBEb7b3oK9kFRgPgPj9j2dngI8T5uLvs0xxL1I+X8+hNgSvqT9fL5OXIM+4TV6PoqQ+b26Kv+9CWSPPSxnYT1HhYK9XntqPrH7ej6vmXe+nxV1PpE0kT6M79S8Q/mCvqdth77VMv480msSP4XJursFMV49GGaUPqXSLL59hDO+1CZnPY2s3b5xhWq+6rADvyDNsT5ePT69RIM7Pm5TEz4TACE9NOLuvUZl1r4RKpy8hm9gvum4Dj5SUDc+dRc7vefChr6DUrI+U1jGPvM6871+I28+W61cPubwgz2gBMi+wDJpvgpy3z1rmDK+3GatvDx0Zj7qgd29ZidjPS5imz3r19c7/9ffvBzV6z3mJem+KIVHvg==" | null | 1505.0 | null | null | null | null | null | null | null | null | UV Spec | null | null | false | false | false | false | false | false | false | null | null | null | M0 | null | null | null | null | 1.095890410958904 | 20.0 | null | null | Stage IIIB | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-CESC | 3923a64a-f8d7-4e3e-9218-cee642da21db | TCGA-BI-A0VS | false | 23 | released | null | Yes | 1.4 | 8.7 | 48 | -17839 | null | not hispanic or latino | female | white | Alive | 1959 | null | 17839 | null | N0 | null | T1b1 | not reported | 0 | C53.9 | not reported | 8070/3 | Squamous cell carcinoma, NOS | no | No | not reported | Cervix uteri | No | Cervix uteri | Not Reported | 2007 | no | Not Reported | false | Not Reported | 1247 | 0 | 60.0 | 5E58A8B7-0F96-4604-9BDE-66A8C2DF7B58 | TCGA-BI-A0VS-01A-11 | null | 0.0 | null | 0.0 | null | null | null | null | project id: TCGA-CESC; case submitter id: TCGA-BI-A0VS; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 8.7; spectrophotometer method: UV Spec; age at index: 48; days to birth: -17839; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1959; age at diagnosis: 17839; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic t: T1b1; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1735.0; figo stage: Stage IB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1247; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-BI-A0VS-01A-11; percent monocyte infiltration: 0.0; percent neutrophil infiltration: 0.0; | [
1024
] | "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" | null | 1735.0 | null | null | null | null | null | null | null | null | UV Spec | null | null | false | false | false | false | false | false | false | null | null | null | M0 | null | null | null | null | null | null | null | null | Stage IB | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-CESC | f40468de-3b86-4922-9951-f8ae28da6af0 | TCGA-BI-A20A | false | 23 | released | null | Yes | 1.7 | 8.4 | 49 | -18215 | null | not hispanic or latino | female | white | Alive | 1961 | null | 18215 | null | N0 | null | T1b1 | not reported | 0 | C53.9 | not reported | 8070/3 | Squamous cell carcinoma, NOS | no | No | not reported | Cervix uteri | No | Cervix uteri | Not Reported | 2010 | no | Not Reported | false | Not Reported | 218 | 0 | 60.0 | FA32D74F-9855-489A-8217-F588682F96CE | TCGA-BI-A20A-01A-11 | 40.0 | 10.0 | 10.0 | 30.0 | 0.0 | 20.0 | 70.0 | 70.0 | project id: TCGA-CESC; case submitter id: TCGA-BI-A20A; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; concentration: 0.16; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 8.4; spectrophotometer method: UV Spec; age at index: 49; days to birth: -18215; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1961; age at diagnosis: 18215; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic t: T1b1; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 720.0; figo stage: Stage IB1; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 218; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-BI-A20A-01A-11; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 10.0; percent necrosis: 10.0; percent neutrophil infiltration: 30.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; | [
1024
] | "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" | null | 720.0 | null | null | null | null | null | null | null | 0.16 | UV Spec | null | null | false | false | false | false | false | false | false | null | null | null | M0 | null | null | null | null | null | null | null | null | Stage IB1 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-CESC | 14c65927-b9dd-4ef6-9917-db7bc431ff2f | TCGA-C5-A0TN | true | 23 | released | null | Yes | 1.2 | 7.6 | 21 | -7760 | 348 | not hispanic or latino | female | black or african american | Dead | 1976 | 1997 | 7760 | null | N1 | null | T1b | not reported | 0 | C53.9 | not reported | 8071/3 | Squamous cell carcinoma, keratinizing, NOS | no | No | not reported | Cervix uteri | No | Cervix uteri | Not Reported | 1997 | yes | Not Reported | false | Not Reported | null | 0 | 170.0 | 33FE7DA3-EDB0-4301-BA6A-C51B75312FCA | TCGA-C5-A0TN-01A-21 | 30.0 | null | null | 20.0 | 0.0 | 5.0 | null | null | project id: TCGA-CESC; case submitter id: TCGA-C5-A0TN; selected normal wgs: true; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.2; rna integrity number: 7.6; spectrophotometer method: UV Spec; age at index: 21; days to birth: -7760; days to death: 348; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Dead; year of birth: 1976; year of death: 1997; age at diagnosis: 7760; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic t: T1b; classification of tumor: not reported; days to diagnosis: 0; figo stage: Stage IB2; icd 10 code: C53.9; last known disease status: not reported; morphology: 8071/3; primary diagnosis: Squamous cell carcinoma, keratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 1997; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; weight: 20.0; composition: Not Reported; days to sample procurement: 0; initial weight: 170.0; portion submitter id: TCGA-C5-A0TN-01A-21; percent lymphocyte infiltration: 30.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 5.0; | [
1024
] | "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" | null | null | 20.0 | null | null | null | null | null | null | null | UV Spec | null | null | null | null | null | null | null | null | null | null | null | null | MX | null | null | null | null | null | null | null | null | Stage IB2 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-CESC | 2b6d2c15-8bcc-41ab-84d6-601442f4378b | TCGA-C5-A1BE | false | 23 | released | null | Yes | 2.0 | 8.2 | 64 | -23727 | 2094 | not reported | female | white | Dead | 1936 | 2005 | 23727 | null | N1 | null | T1b | not reported | 0 | C53.9 | not reported | 8072/3 | Squamous cell carcinoma, large cell, nonkeratinizing, NOS | no | No | not reported | Cervix uteri | No | Cervix uteri | Not Reported | 2000 | yes | Not Reported | false | Not Reported | null | 0 | 40.0 | 0A21AE44-27DF-4F41-BAB5-209A25087C0A | TCGA-C5-A1BE-01B-11 | 15.0 | 0.0 | 0.0 | 1.0 | 0.0 | 40.0 | 60.0 | 60.0 | project id: TCGA-CESC; case submitter id: TCGA-C5-A1BE; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.0; rna integrity number: 8.2; spectrophotometer method: UV Spec; age at index: 64; days to birth: -23727; days to death: 2094; ethnicity: not reported; gender: female; race: white; vital status: Dead; year of birth: 1936; year of death: 2005; age at diagnosis: 23727; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic t: T1b; classification of tumor: not reported; days to diagnosis: 0; figo stage: Stage IB2; icd 10 code: C53.9; last known disease status: not reported; morphology: 8072/3; primary diagnosis: Squamous cell carcinoma, large cell, nonkeratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2000; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to sample procurement: 0; initial weight: 40.0; portion submitter id: TCGA-C5-A1BE-01B-11; percent lymphocyte infiltration: 15.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 40.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0; | [
1024
] | "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" | null | null | 30.0 | null | null | null | null | null | null | null | UV Spec | null | null | false | false | false | false | false | false | false | null | null | null | MX | null | null | null | null | null | null | null | null | Stage IB2 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-CESC | 262311a0-7a10-4934-8fba-11ee581ad738 | TCGA-C5-A1BF | null | 23 | released | null | Yes | 1.4 | 7.5 | 46 | -16975 | 570 | not reported | female | white | Dead | 1951 | 1998 | 16975 | null | N0 | null | TX | not reported | 0 | C53.9 | not reported | 8070/3 | Squamous cell carcinoma, NOS | no | No | not reported | Cervix uteri | No | Cervix uteri | Not Reported | 1997 | yes | Not Reported | false | Not Reported | null | 0 | 60.0 | 45EC2A51-EDE1-44E9-8756-A094B998A68B | TCGA-C5-A1BF-01B-11 | 15.0 | 1.0 | 5.0 | 3.0 | 0.0 | 30.0 | 65.0 | 70.0 | project id: TCGA-CESC; case submitter id: TCGA-C5-A1BF; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 7.5; spectrophotometer method: UV Spec; age at index: 46; days to birth: -16975; days to death: 570; ethnicity: not reported; gender: female; race: white; vital status: Dead; year of birth: 1951; year of death: 1998; age at diagnosis: 16975; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic t: TX; classification of tumor: not reported; days to diagnosis: 0; figo stage: Stage IB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 1997; treatment or therapy: yes; alcohol history: Not Reported; cigarettes per day: 1.643835616438356; pack years smoked: 30.0; is ffpe: false; weight: 30.0; composition: Not Reported; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-C5-A1BF-01B-11; percent lymphocyte infiltration: 15.0; percent monocyte infiltration: 1.0; percent necrosis: 5.0; percent neutrophil infiltration: 3.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 65.0; percent tumor nuclei: 70.0; | [
1024
] | "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" | null | null | 30.0 | null | null | null | null | null | null | null | UV Spec | null | null | false | false | false | false | false | false | false | null | null | null | MX | null | null | null | null | 1.643835616438356 | 30.0 | null | null | Stage IB | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-CESC | 91310434-2a99-4e1d-81e6-3d58d097089f | TCGA-C5-A1BI | false | 23 | released | null | Yes | 1.7 | 8.0 | 31 | -11564 | null | not hispanic or latino | female | white | Alive | 1970 | null | 11564 | null | null | null | null | not reported | 0 | C53.9 | not reported | 8070/3 | Squamous cell carcinoma, NOS | no | No | not reported | Cervix uteri | No | Cervix uteri | Not Reported | 2001 | yes | Not Reported | false | Not Reported | null | 0 | 30.0 | 25B6B201-ECCC-44F5-82AF-B9DC7848A117 | TCGA-C5-A1BI-01B-11 | 45.0 | 0.0 | 0.0 | 5.0 | 0.0 | 10.0 | 90.0 | 90.0 | project id: TCGA-CESC; case submitter id: TCGA-C5-A1BI; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 8.0; spectrophotometer method: UV Spec; age at index: 31; days to birth: -11564; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1970; age at diagnosis: 11564; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1112.0; figo stage: Stage IIIB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2001; treatment or therapy: yes; alcohol history: Not Reported; cigarettes per day: 0.821917808219178; pack years smoked: 15.0; is ffpe: false; weight: 30.0; composition: Not Reported; days to sample procurement: 0; initial weight: 30.0; portion submitter id: TCGA-C5-A1BI-01B-11; percent lymphocyte infiltration: 45.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0; | [
1024
] | "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" | null | 1112.0 | 30.0 | null | null | null | null | null | null | null | UV Spec | null | null | false | false | false | false | false | false | false | null | null | null | null | null | null | null | null | 0.821917808219178 | 15.0 | null | null | Stage IIIB | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-CESC | 7941d1c7-5319-4e8d-a15f-60b61cb68a9b | TCGA-C5-A1BJ | null | 23 | released | null | Yes | 1.6 | 8.7 | 34 | -12611 | null | not reported | female | white | Alive | 1963 | null | 12611 | null | null | null | null | not reported | 0 | C53.9 | not reported | 8070/3 | Squamous cell carcinoma, NOS | no | No | not reported | Cervix uteri | No | Cervix uteri | Not Reported | 1997 | null | Not Reported | false | Not Reported | 4972 | 0 | 130.0 | 9F012D5B-DF59-43C3-96FC-4E6EE55BDAD6 | TCGA-C5-A1BJ-01A-11 | 40.0 | 20.0 | 0.0 | 20.0 | 0.0 | 20.0 | 80.0 | 80.0 | project id: TCGA-CESC; case submitter id: TCGA-C5-A1BJ; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.6; rna integrity number: 8.7; spectrophotometer method: UV Spec; age at index: 34; days to birth: -12611; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1963; age at diagnosis: 12611; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 4385.0; figo stage: Stage IIB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 1997; alcohol history: Not Reported; cigarettes per day: 0.547945205479452; pack years smoked: 10.0; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 4972; days to sample procurement: 0; initial weight: 130.0; portion submitter id: TCGA-C5-A1BJ-01A-11; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 4385.0 | 20.0 | null | null | null | null | null | null | null | UV Spec | null | null | false | false | false | false | false | false | false | null | null | null | null | null | null | null | null | 0.547945205479452 | 10.0 | null | null | Stage IIB | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-CESC | 7df6c297-f2d6-43ef-973b-1f95676b0cc4 | TCGA-C5-A1BK | false | 23 | released | null | Yes | 1.5 | 8.5 | 36 | -13297 | null | not hispanic or latino | female | black or african american | Alive | 1958 | null | 13297 | null | N0 | null | T1b | not reported | 0 | C53.9 | not reported | 8070/3 | Squamous cell carcinoma, NOS | no | No | not reported | Cervix uteri | No | Cervix uteri | Not Reported | 1994 | no | Not Reported | false | Not Reported | null | 0 | 80.0 | E6129BB7-CE4E-400A-B8B9-45DE508C995D | TCGA-C5-A1BK-01B-11 | 50.0 | 0.0 | 0.0 | 5.0 | 0.0 | 30.0 | 70.0 | 70.0 | project id: TCGA-CESC; case submitter id: TCGA-C5-A1BK; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 8.5; spectrophotometer method: UV Spec; age at index: 36; days to birth: -13297; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1958; age at diagnosis: 13297; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic t: T1b; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 5385.0; figo stage: Stage IB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 1994; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-C5-A1BK-01B-11; percent lymphocyte infiltration: 50.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; | [
1024
] | "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" | null | 5385.0 | 30.0 | null | null | null | null | null | null | null | UV Spec | null | null | false | false | false | false | false | false | false | null | null | null | MX | null | null | null | null | null | null | null | null | Stage IB | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-CESC | 03c3fe57-ae85-4e45-9657-c3182ab5e124 | TCGA-C5-A1BL | false | 23 | released | null | Yes | 1.6 | 8.4 | 32 | -11723 | null | not hispanic or latino | female | white | Alive | 1962 | null | 11723 | null | null | null | null | not reported | 0 | C53.9 | not reported | 8070/3 | Squamous cell carcinoma, NOS | no | No | not reported | Cervix uteri | No | Cervix uteri | Not Reported | 1994 | null | Not Reported | false | Not Reported | 5950 | 0 | 150.0 | C3312E18-832F-4126-8E9E-F829128F7530 | TCGA-C5-A1BL-01A-11 | 60.0 | 20.0 | 10.0 | 20.0 | 0.0 | 20.0 | 70.0 | 70.0 | project id: TCGA-CESC; case submitter id: TCGA-C5-A1BL; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; concentration: 0.16; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.6; rna integrity number: 8.4; spectrophotometer method: UV Spec; age at index: 32; days to birth: -11723; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1962; age at diagnosis: 11723; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 5271.0; figo stage: Stage IB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 1994; alcohol history: Not Reported; cigarettes per day: 0.6575342465753424; pack years smoked: 12.0; is ffpe: false; composition: Not Reported; days to collection: 5950; days to sample procurement: 0; initial weight: 150.0; portion submitter id: TCGA-C5-A1BL-01A-11; percent lymphocyte infiltration: 60.0; percent monocyte infiltration: 20.0; percent necrosis: 10.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; | [
1024
] | "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" | null | 5271.0 | null | null | null | null | null | null | null | 0.16 | UV Spec | null | null | false | false | false | false | false | false | false | null | null | null | null | null | null | null | null | 0.6575342465753424 | 12.0 | null | null | Stage IB | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
Subsets and Splits
WSI Data with Clinical Details
Combines detailed whole slide image (WSI) data with clinical information, providing insights into patient demographics and vital status related to their diagnostic case.
WSI Data with Clinical Details
The query joins WSI data with clinical data but simply returns the merged dataset with no additional filtering or aggregation, providing limited insight.
WSI and Pathology Report Data
The query retrieves detailed file information for whole-slide images and associated pathology reports, providing basic linking between the two datasets by PatientID.